id	sid	tid	token	lemma	pos
dpc-3385	1	1	dermatology	dermatology	NOUN
dpc-3385	1	2	:	:	PUNCT
dpc-3385	1	3	practical	practical	ADJ
dpc-3385	1	4	and	and	CCONJ
dpc-3385	1	5	conceptual	conceptual	ADJ
dpc-3385	1	6	original	original	ADJ
dpc-3385	1	7	article	article	NOUN
dpc-3385	1	8	|	|	ADV
dpc-3385	1	9	dermatol	dermatol	ADJ
dpc-3385	1	10	pract	pract	NOUN
dpc-3385	1	11	concept	concept	NOUN
dpc-3385	1	12	.	.	PUNCT
dpc-3385	2	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	2	2	1	1	NUM
dpc-3385	2	3	evaluation	evaluation	NOUN
dpc-3385	2	4	of	of	ADP
dpc-3385	2	5	clinicopathological	clinicopathological	ADJ
dpc-3385	2	6	features	feature	NOUN
dpc-3385	2	7	and	and	CCONJ
dpc-3385	2	8	associated	associate	VERB
dpc-3385	2	9	conditions	condition	NOUN
dpc-3385	2	10	in	in	ADP
dpc-3385	2	11	erythema	erythema	ADJ
dpc-3385	2	12	annulare	annulare	NOUN
dpc-3385	2	13	centrifugum	centrifugum	NOUN
dpc-3385	2	14	:	:	PUNCT
dpc-3385	2	15	a	a	DET
dpc-3385	2	16	retrospective	retrospective	ADJ
dpc-3385	2	17	observational	observational	ADJ
dpc-3385	2	18	analysis	analysis	NOUN
dpc-3385	2	19	of	of	ADP
dpc-3385	2	20	63	63	NUM
dpc-3385	2	21	patients	patient	NOUN
dpc-3385	2	22	funda	funda	PROPN
dpc-3385	2	23	erduran1	erduran1	PROPN
dpc-3385	2	24	1	1	NUM
dpc-3385	2	25	ankara	ankara	PROPN
dpc-3385	2	26	city	city	NOUN
dpc-3385	2	27	hospital	hospital	NOUN
dpc-3385	2	28	,	,	PUNCT
dpc-3385	2	29	department	department	NOUN
dpc-3385	2	30	of	of	ADP
dpc-3385	2	31	dermatology	dermatology	NOUN
dpc-3385	2	32	,	,	PUNCT
dpc-3385	2	33	ankara	ankara	PROPN
dpc-3385	2	34	,	,	PUNCT
dpc-3385	2	35	turkey	turkey	PROPN
dpc-3385	2	36	key	key	ADJ
dpc-3385	2	37	words	word	NOUN
dpc-3385	2	38	:	:	PUNCT
dpc-3385	2	39	erythema	erythema	ADJ
dpc-3385	2	40	annulare	annulare	NOUN
dpc-3385	2	41	centrifugum	centrifugum	NOUN
dpc-3385	2	42	,	,	PUNCT
dpc-3385	2	43	clinicopathological	clinicopathological	ADJ
dpc-3385	2	44	features	feature	NOUN
dpc-3385	2	45	,	,	PUNCT
dpc-3385	2	46	associated	associate	VERB
dpc-3385	2	47	conditions	condition	NOUN
dpc-3385	2	48	citation	citation	NOUN
dpc-3385	2	49	:	:	PUNCT
dpc-3385	2	50	erduran	erduran	PROPN
dpc-3385	2	51	f.	f.	PROPN
dpc-3385	2	52	evaluation	evaluation	NOUN
dpc-3385	2	53	of	of	ADP
dpc-3385	2	54	clinicopathological	clinicopathological	ADJ
dpc-3385	2	55	features	feature	NOUN
dpc-3385	2	56	and	and	CCONJ
dpc-3385	2	57	associated	associate	VERB
dpc-3385	2	58	conditions	condition	NOUN
dpc-3385	2	59	in	in	ADP
dpc-3385	2	60	erythema	erythema	ADJ
dpc-3385	2	61	annulare	annulare	NOUN
dpc-3385	2	62	centrifugum	centrifugum	NOUN
dpc-3385	2	63	:	:	PUNCT
dpc-3385	2	64	a	a	DET
dpc-3385	2	65	 	 	SPACE
dpc-3385	2	66	retrospective	retrospective	ADJ
dpc-3385	2	67	observational	observational	ADJ
dpc-3385	2	68	analysis	analysis	NOUN
dpc-3385	2	69	of	of	ADP
dpc-3385	2	70	63	63	NUM
dpc-3385	2	71	patients	patient	NOUN
dpc-3385	2	72	.	.	PUNCT
dpc-3385	3	1	dermatol	dermatol	NOUN
dpc-3385	3	2	pract	pract	PROPN
dpc-3385	3	3	concept	concept	NOUN
dpc-3385	3	4	.	.	PUNCT
dpc-3385	4	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	4	2	.	.	PUNCT
dpc-3385	4	3	doi	doi	NOUN
dpc-3385	4	4	:	:	PUNCT
dpc-3385	4	5	https://doi.org/10.5826	https://doi.org/10.5826	ADV
dpc-3385	4	6	/dpc.1401a39	/dpc.1401a39	PRON
dpc-3385	4	7	accepted	accept	VERB
dpc-3385	4	8	:	:	PUNCT
dpc-3385	4	9	september	september	PROPN
dpc-3385	4	10	25	25	NUM
dpc-3385	4	11	,	,	PUNCT
dpc-3385	4	12	2023	2023	NUM
dpc-3385	4	13	;	;	PUNCT
dpc-3385	4	14	published	publish	VERB
dpc-3385	4	15	:	:	PUNCT
dpc-3385	4	16	january	january	PROPN
dpc-3385	4	17	2024	2024	NUM
dpc-3385	5	1	copyright	copyright	NOUN
dpc-3385	5	2	:	:	PUNCT
dpc-3385	5	3	©	©	PROPN
dpc-3385	5	4	2024	2024	NUM
dpc-3385	5	5	erduran	erduran	NOUN
dpc-3385	5	6	.	.	PUNCT
dpc-3385	6	1	this	this	PRON
dpc-3385	6	2	is	be	AUX
dpc-3385	6	3	an	an	DET
dpc-3385	6	4	open	open	ADJ
dpc-3385	6	5	-	-	PUNCT
dpc-3385	6	6	access	access	NOUN
dpc-3385	6	7	article	article	NOUN
dpc-3385	6	8	distributed	distribute	VERB
dpc-3385	6	9	under	under	ADP
dpc-3385	6	10	the	the	DET
dpc-3385	6	11	terms	term	NOUN
dpc-3385	6	12	of	of	ADP
dpc-3385	6	13	the	the	DET
dpc-3385	6	14	creative	creative	ADJ
dpc-3385	6	15	commons	common	NOUN
dpc-3385	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3385	6	17	license	license	NOUN
dpc-3385	6	18	(	(	PUNCT
dpc-3385	6	19	by	by	ADP
dpc-3385	6	20	-	-	PUNCT
dpc-3385	6	21	nc-4.0	nc-4.0	NOUN
dpc-3385	6	22	)	)	PUNCT
dpc-3385	6	23	,	,	PUNCT
dpc-3385	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3385	6	25	,	,	PUNCT
dpc-3385	6	26	which	which	PRON
dpc-3385	6	27	permits	permit	VERB
dpc-3385	6	28	unrestricted	unrestricted	ADJ
dpc-3385	6	29	noncommercial	noncommercial	ADJ
dpc-3385	6	30	use	use	NOUN
dpc-3385	6	31	,	,	PUNCT
dpc-3385	6	32	distribution	distribution	NOUN
dpc-3385	6	33	,	,	PUNCT
dpc-3385	6	34	and	and	CCONJ
dpc-3385	6	35	reproduction	reproduction	NOUN
dpc-3385	6	36	in	in	ADP
dpc-3385	6	37	any	any	DET
dpc-3385	6	38	medium	medium	NOUN
dpc-3385	6	39	,	,	PUNCT
dpc-3385	6	40	provided	provide	VERB
dpc-3385	6	41	the	the	DET
dpc-3385	6	42	original	original	ADJ
dpc-3385	6	43	authors	author	NOUN
dpc-3385	6	44	and	and	CCONJ
dpc-3385	6	45	source	source	NOUN
dpc-3385	6	46	are	be	AUX
dpc-3385	6	47	credited	credit	VERB
dpc-3385	6	48	.	.	PUNCT
dpc-3385	7	1	funding	funding	NOUN
dpc-3385	7	2	:	:	PUNCT
dpc-3385	7	3	none	none	NOUN
dpc-3385	7	4	.	.	PUNCT
dpc-3385	8	1	competing	compete	VERB
dpc-3385	8	2	interests	interest	NOUN
dpc-3385	8	3	:	:	PUNCT
dpc-3385	8	4	none	none	NOUN
dpc-3385	8	5	.	.	PUNCT
dpc-3385	9	1	corresponding	correspond	VERB
dpc-3385	9	2	author	author	NOUN
dpc-3385	9	3	:	:	PUNCT
dpc-3385	9	4	funda	funda	PROPN
dpc-3385	9	5	erduran	erduran	PROPN
dpc-3385	9	6	,	,	PUNCT
dpc-3385	9	7	ankara	ankara	PROPN
dpc-3385	9	8	city	city	PROPN
dpc-3385	9	9	hospital	hospital	PROPN
dpc-3385	9	10	,	,	PUNCT
dpc-3385	9	11	department	department	NOUN
dpc-3385	9	12	of	of	ADP
dpc-3385	9	13	dermatology	dermatology	NOUN
dpc-3385	9	14	.	.	PUNCT
dpc-3385	10	1	üniversiteler	üniversiteler	PROPN
dpc-3385	10	2	mah	mah	PROPN
dpc-3385	10	3	,	,	PUNCT
dpc-3385	10	4	çankaya	çankaya	PROPN
dpc-3385	10	5	,	,	PUNCT
dpc-3385	10	6	ankara	ankara	PROPN
dpc-3385	10	7	,	,	PUNCT
dpc-3385	10	8	06800	06800	NUM
dpc-3385	10	9	,	,	PUNCT
dpc-3385	10	10	turkey	turkey	PROPN
dpc-3385	10	11	.	.	PUNCT
dpc-3385	11	1	tel	tel	ADP
dpc-3385	11	2	:	:	PUNCT
dpc-3385	11	3	+90	+90	NOUN
dpc-3385	11	4	505	505	NUM
dpc-3385	11	5	228	228	NUM
dpc-3385	11	6	1615	1615	NUM
dpc-3385	11	7	email	email	NOUN
dpc-3385	11	8	:	:	PUNCT
dpc-3385	12	1	fnderdrn@mail.com	fnderdrn@mail.com	X
dpc-3385	12	2	introduction	introduction	NOUN
dpc-3385	12	3	:	:	PUNCT
dpc-3385	12	4	erythema	erythema	ADJ
dpc-3385	12	5	annulare	annulare	NOUN
dpc-3385	12	6	centrifugum	centrifugum	NOUN
dpc-3385	12	7	(	(	PUNCT
dpc-3385	12	8	eac	eac	PROPN
dpc-3385	12	9	)	)	PUNCT
dpc-3385	12	10	is	be	AUX
dpc-3385	12	11	a	a	DET
dpc-3385	12	12	rare	rare	ADJ
dpc-3385	12	13	reactive	reactive	ADJ
dpc-3385	12	14	disease	disease	NOUN
dpc-3385	12	15	that	that	PRON
dpc-3385	12	16	typically	typically	ADV
dpc-3385	12	17	presents	present	VERB
dpc-3385	12	18	as	as	ADV
dpc-3385	12	19	annular	annular	ADJ
dpc-3385	12	20	or	or	CCONJ
dpc-3385	12	21	polycyclic	polycyclic	ADJ
dpc-3385	12	22	erythematous	erythematous	ADJ
dpc-3385	12	23	lesions	lesion	NOUN
dpc-3385	12	24	.	.	PUNCT
dpc-3385	13	1	there	there	PRON
dpc-3385	13	2	are	be	VERB
dpc-3385	13	3	few	few	ADJ
dpc-3385	13	4	studies	study	NOUN
dpc-3385	13	5	about	about	ADP
dpc-3385	13	6	eac	eac	NOUN
dpc-3385	13	7	in	in	ADP
dpc-3385	13	8	the	the	DET
dpc-3385	13	9	literature	literature	NOUN
dpc-3385	13	10	;	;	PUNCT
dpc-3385	13	11	therefore	therefore	ADV
dpc-3385	13	12	,	,	PUNCT
dpc-3385	13	13	data	datum	NOUN
dpc-3385	13	14	on	on	ADP
dpc-3385	13	15	the	the	DET
dpc-3385	13	16	pathogenesis	pathogenesis	NOUN
dpc-3385	13	17	of	of	ADP
dpc-3385	13	18	the	the	DET
dpc-3385	13	19	disease	disease	NOUN
dpc-3385	13	20	are	be	AUX
dpc-3385	13	21	limited	limited	ADJ
dpc-3385	13	22	.	.	PUNCT
dpc-3385	14	1	objectives	objective	NOUN
dpc-3385	14	2	:	:	PUNCT
dpc-3385	14	3	we	we	PRON
dpc-3385	14	4	aimed	aim	VERB
dpc-3385	14	5	to	to	PART
dpc-3385	14	6	examine	examine	VERB
dpc-3385	14	7	the	the	DET
dpc-3385	14	8	demographic	demographic	ADJ
dpc-3385	14	9	,	,	PUNCT
dpc-3385	14	10	clinical	clinical	ADJ
dpc-3385	14	11	,	,	PUNCT
dpc-3385	14	12	pathological	pathological	ADJ
dpc-3385	14	13	characteristics	characteristic	NOUN
dpc-3385	14	14	and	and	CCONJ
dpc-3385	14	15	associated	associated	ADJ
dpc-3385	14	16	conditions	condition	NOUN
dpc-3385	14	17	of	of	ADP
dpc-3385	14	18	the	the	DET
dpc-3385	14	19	patients	patient	NOUN
dpc-3385	14	20	with	with	ADP
dpc-3385	14	21	eac	eac	PROPN
dpc-3385	14	22	.	.	PUNCT
dpc-3385	15	1	methods	method	NOUN
dpc-3385	15	2	:	:	PUNCT
dpc-3385	15	3	we	we	PRON
dpc-3385	15	4	analyzed	analyze	VERB
dpc-3385	15	5	records	record	NOUN
dpc-3385	15	6	of	of	ADP
dpc-3385	15	7	the	the	DET
dpc-3385	15	8	patients	patient	NOUN
dpc-3385	15	9	with	with	ADP
dpc-3385	15	10	eac	eac	PROPN
dpc-3385	15	11	who	who	PRON
dpc-3385	15	12	admitted	admit	VERB
dpc-3385	15	13	to	to	ADP
dpc-3385	15	14	our	our	PRON
dpc-3385	15	15	clinic	clinic	NOUN
dpc-3385	15	16	in	in	ADP
dpc-3385	15	17	the	the	DET
dpc-3385	15	18	last	last	ADJ
dpc-3385	15	19	four	four	NUM
dpc-3385	15	20	 	 	SPACE
dpc-3385	15	21	years	year	NOUN
dpc-3385	15	22	retrospectively	retrospectively	ADV
dpc-3385	15	23	.	.	PUNCT
dpc-3385	16	1	results	result	NOUN
dpc-3385	16	2	:	:	PUNCT
dpc-3385	16	3	a	a	DET
dpc-3385	16	4	total	total	NOUN
dpc-3385	16	5	of	of	ADP
dpc-3385	16	6	63	63	NUM
dpc-3385	16	7	patients	patient	NOUN
dpc-3385	16	8	,	,	PUNCT
dpc-3385	16	9	39	39	NUM
dpc-3385	16	10	women	woman	NOUN
dpc-3385	16	11	and	and	CCONJ
dpc-3385	16	12	24	24	NUM
dpc-3385	16	13	men	man	NOUN
dpc-3385	16	14	,	,	PUNCT
dpc-3385	16	15	were	be	AUX
dpc-3385	16	16	included	include	VERB
dpc-3385	16	17	in	in	ADP
dpc-3385	16	18	our	our	PRON
dpc-3385	16	19	study	study	NOUN
dpc-3385	16	20	.	.	PUNCT
dpc-3385	17	1	the	the	DET
dpc-3385	17	2	mean	mean	ADJ
dpc-3385	17	3	age	age	NOUN
dpc-3385	17	4	of	of	ADP
dpc-3385	17	5	the	the	DET
dpc-3385	17	6	patients	patient	NOUN
dpc-3385	17	7	was	be	AUX
dpc-3385	17	8	47.8±11.2	47.8±11.2	NUM
dpc-3385	17	9	years	year	NOUN
dpc-3385	17	10	.	.	PUNCT
dpc-3385	18	1	the	the	DET
dpc-3385	18	2	mean	mean	ADJ
dpc-3385	18	3	disease	disease	NOUN
dpc-3385	18	4	duration	duration	NOUN
dpc-3385	18	5	was	be	AUX
dpc-3385	18	6	15.54±12	15.54±12	NUM
dpc-3385	18	7	months	month	NOUN
dpc-3385	18	8	.	.	PUNCT
dpc-3385	19	1	the	the	DET
dpc-3385	19	2	trunk	trunk	NOUN
dpc-3385	19	3	and	and	CCONJ
dpc-3385	19	4	thigh	thigh	NOUN
dpc-3385	19	5	were	be	AUX
dpc-3385	19	6	the	the	DET
dpc-3385	19	7	most	most	ADV
dpc-3385	19	8	commonly	commonly	ADV
dpc-3385	19	9	involved	involve	VERB
dpc-3385	19	10	sites	site	NOUN
dpc-3385	19	11	(	(	PUNCT
dpc-3385	19	12	49	49	NUM
dpc-3385	19	13	%	%	NOUN
dpc-3385	19	14	,	,	PUNCT
dpc-3385	19	15	33	33	NUM
dpc-3385	19	16	%	%	NOUN
dpc-3385	19	17	)	)	PUNCT
dpc-3385	19	18	.	.	PUNCT
dpc-3385	20	1	associated	associate	VERB
dpc-3385	20	2	conditions	condition	NOUN
dpc-3385	20	3	were	be	AUX
dpc-3385	20	4	identified	identify	VERB
dpc-3385	20	5	in	in	ADP
dpc-3385	20	6	52.3	52.3	NUM
dpc-3385	20	7	%	%	NOUN
dpc-3385	20	8	of	of	ADP
dpc-3385	20	9	the	the	DET
dpc-3385	20	10	patients	patient	NOUN
dpc-3385	20	11	.	.	PUNCT
dpc-3385	21	1	infections	infection	NOUN
dpc-3385	21	2	(	(	PUNCT
dpc-3385	21	3	n	n	NOUN
dpc-3385	21	4	=	=	SYM
dpc-3385	21	5	16	16	NUM
dpc-3385	21	6	)	)	PUNCT
dpc-3385	21	7	,	,	PUNCT
dpc-3385	21	8	malignancies	malignancy	NOUN
dpc-3385	21	9	(	(	PUNCT
dpc-3385	21	10	n	n	NOUN
dpc-3385	21	11	=	=	SYM
dpc-3385	21	12	6	6	NUM
dpc-3385	21	13	)	)	PUNCT
dpc-3385	21	14	,	,	PUNCT
dpc-3385	21	15	rheumatic	rheumatic	ADJ
dpc-3385	21	16	diseases	disease	NOUN
dpc-3385	21	17	(	(	PUNCT
dpc-3385	21	18	n=4	n=4	NOUN
dpc-3385	21	19	)	)	PUNCT
dpc-3385	21	20	and	and	CCONJ
dpc-3385	21	21	drugs	drug	NOUN
dpc-3385	21	22	(	(	PUNCT
dpc-3385	21	23	n=4	n=4	NOUN
dpc-3385	21	24	)	)	PUNCT
dpc-3385	21	25	were	be	AUX
dpc-3385	21	26	the	the	DET
dpc-3385	21	27	most	most	ADV
dpc-3385	21	28	common	common	ADJ
dpc-3385	21	29	precipitating	precipitating	NOUN
dpc-3385	21	30	factors	factor	NOUN
dpc-3385	21	31	respectively	respectively	ADV
dpc-3385	21	32	.	.	PUNCT
dpc-3385	22	1	the	the	DET
dpc-3385	22	2	most	most	ADV
dpc-3385	22	3	common	common	ADJ
dpc-3385	22	4	infections	infection	NOUN
dpc-3385	22	5	were	be	AUX
dpc-3385	22	6	superficial	superficial	ADJ
dpc-3385	22	7	fungal	fungal	ADJ
dpc-3385	22	8	infections	infection	NOUN
dpc-3385	22	9	and	and	CCONJ
dpc-3385	22	10	helicobacter	helicobacter	NOUN
dpc-3385	22	11	pylori	pylori	ADJ
dpc-3385	22	12	infection	infection	NOUN
dpc-3385	22	13	.	.	PUNCT
dpc-3385	23	1	histopathologically	histopathologically	ADV
dpc-3385	23	2	,	,	PUNCT
dpc-3385	23	3	10	10	NUM
dpc-3385	23	4	patients	patient	NOUN
dpc-3385	23	5	had	have	VERB
dpc-3385	23	6	deep	deep	ADJ
dpc-3385	23	7	type	type	NOUN
dpc-3385	23	8	and	and	CCONJ
dpc-3385	23	9	53	53	NUM
dpc-3385	23	10	patients	patient	NOUN
dpc-3385	23	11	had	have	VERB
dpc-3385	23	12	superficial	superficial	ADJ
dpc-3385	23	13	type	type	NOUN
dpc-3385	23	14	eac	eac	PROPN
dpc-3385	23	15	.	.	PUNCT
dpc-3385	24	1	we	we	PRON
dpc-3385	24	2	determined	determine	VERB
dpc-3385	24	3	that	that	SCONJ
dpc-3385	24	4	the	the	DET
dpc-3385	24	5	disease	disease	NOUN
dpc-3385	24	6	duration	duration	NOUN
dpc-3385	24	7	from	from	ADP
dpc-3385	24	8	the	the	DET
dpc-3385	24	9	onset	onset	NOUN
dpc-3385	24	10	of	of	ADP
dpc-3385	24	11	the	the	DET
dpc-3385	24	12	disease	disease	NOUN
dpc-3385	24	13	was	be	AUX
dpc-3385	24	14	longer	long	ADJ
dpc-3385	24	15	(	(	PUNCT
dpc-3385	24	16	12.3	12.3	NUM
dpc-3385	24	17	versus	versus	ADP
dpc-3385	24	18	16.2	16.2	NUM
dpc-3385	24	19	months	month	NOUN
dpc-3385	24	20	)	)	PUNCT
dpc-3385	24	21	and	and	CCONJ
dpc-3385	24	22	the	the	DET
dpc-3385	24	23	number	number	NOUN
dpc-3385	24	24	of	of	ADP
dpc-3385	24	25	attacks	attack	NOUN
dpc-3385	24	26	(	(	PUNCT
dpc-3385	24	27	1.2	1.2	NUM
dpc-3385	24	28	versus	versus	ADP
dpc-3385	24	29	2.8	2.8	NUM
dpc-3385	24	30	attacks	attack	NOUN
dpc-3385	24	31	)	)	PUNCT
dpc-3385	24	32	was	be	AUX
dpc-3385	24	33	higher	high	ADJ
dpc-3385	24	34	in	in	ADP
dpc-3385	24	35	the	the	DET
dpc-3385	24	36	superficial	superficial	ADJ
dpc-3385	24	37	type	type	NOUN
dpc-3385	24	38	when	when	SCONJ
dpc-3385	24	39	compared	compare	VERB
dpc-3385	24	40	to	to	ADP
dpc-3385	24	41	the	the	DET
dpc-3385	24	42	deep	deep	ADJ
dpc-3385	24	43	type	type	NOUN
dpc-3385	24	44	(	(	PUNCT
dpc-3385	24	45	p	p	X
dpc-3385	24	46	=	=	NOUN
dpc-3385	24	47	0.042	0.042	NUM
dpc-3385	24	48	,	,	PUNCT
dpc-3385	24	49	p	p	PROPN
dpc-3385	24	50	=	=	NOUN
dpc-3385	24	51	0.038	0.038	NUM
dpc-3385	24	52	)	)	PUNCT
dpc-3385	24	53	.	.	PUNCT
dpc-3385	25	1	conclusions	conclusion	NOUN
dpc-3385	25	2	:	:	PUNCT
dpc-3385	25	3	in	in	ADP
dpc-3385	25	4	our	our	PRON
dpc-3385	25	5	study	study	NOUN
dpc-3385	25	6	,	,	PUNCT
dpc-3385	25	7	infections	infection	NOUN
dpc-3385	25	8	,	,	PUNCT
dpc-3385	25	9	malignancies	malignancy	NOUN
dpc-3385	25	10	and	and	CCONJ
dpc-3385	25	11	rheumatic	rheumatic	ADJ
dpc-3385	25	12	diseases	disease	NOUN
dpc-3385	25	13	were	be	AUX
dpc-3385	25	14	among	among	ADP
dpc-3385	25	15	the	the	DET
dpc-3385	25	16	most	most	ADV
dpc-3385	25	17	common	common	ADJ
dpc-3385	25	18	etiologic	etiologic	ADJ
dpc-3385	25	19	factors	factor	NOUN
dpc-3385	25	20	.	.	PUNCT
dpc-3385	26	1	we	we	PRON
dpc-3385	26	2	would	would	AUX
dpc-3385	26	3	also	also	ADV
dpc-3385	26	4	like	like	VERB
dpc-3385	26	5	to	to	PART
dpc-3385	26	6	draw	draw	VERB
dpc-3385	26	7	attention	attention	NOUN
dpc-3385	26	8	to	to	ADP
dpc-3385	26	9	helicobacter	helicobacter	NOUN
dpc-3385	26	10	pylori	pylori	NOUN
dpc-3385	26	11	infection	infection	NOUN
dpc-3385	26	12	as	as	ADP
dpc-3385	26	13	a	a	DET
dpc-3385	26	14	precipitating	precipitating	NOUN
dpc-3385	26	15	factor	factor	NOUN
dpc-3385	26	16	which	which	PRON
dpc-3385	26	17	may	may	AUX
dpc-3385	26	18	be	be	AUX
dpc-3385	26	19	a	a	DET
dpc-3385	26	20	novel	novel	ADJ
dpc-3385	26	21	finding	finding	NOUN
dpc-3385	26	22	.	.	PUNCT
dpc-3385	27	1	abstract	abstract	ADJ
dpc-3385	27	2	2	2	NUM
dpc-3385	27	3	original	original	ADJ
dpc-3385	27	4	article	article	NOUN
dpc-3385	27	5	|	|	ADV
dpc-3385	27	6	dermatol	dermatol	ADJ
dpc-3385	27	7	pract	pract	NOUN
dpc-3385	27	8	concept	concept	NOUN
dpc-3385	27	9	.	.	PUNCT
dpc-3385	28	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	28	2	introduction	introduction	NOUN
dpc-3385	28	3	erythema	erythema	ADJ
dpc-3385	28	4	annulare	annulare	NOUN
dpc-3385	28	5	centrifugum	centrifugum	NOUN
dpc-3385	28	6	(	(	PUNCT
dpc-3385	28	7	eac	eac	PROPN
dpc-3385	28	8	)	)	PUNCT
dpc-3385	28	9	is	be	AUX
dpc-3385	28	10	a	a	DET
dpc-3385	28	11	slowly	slowly	ADV
dpc-3385	28	12	progressive	progressive	ADJ
dpc-3385	28	13	eruption	eruption	NOUN
dpc-3385	28	14	characterized	characterize	VERB
dpc-3385	28	15	by	by	ADP
dpc-3385	28	16	annular	annular	ADJ
dpc-3385	28	17	or	or	CCONJ
dpc-3385	28	18	polycyclic	polycyclic	ADJ
dpc-3385	28	19	erythematous	erythematous	ADJ
dpc-3385	28	20	papules	papule	NOUN
dpc-3385	28	21	and	and	CCONJ
dpc-3385	28	22	plaques	plaque	NOUN
dpc-3385	28	23	[	[	X
dpc-3385	28	24	1	1	NUM
dpc-3385	28	25	]	]	PUNCT
dpc-3385	28	26	.	.	PUNCT
dpc-3385	29	1	eac	eac	PROPN
dpc-3385	29	2	is	be	AUX
dpc-3385	29	3	considered	consider	VERB
dpc-3385	29	4	a	a	DET
dpc-3385	29	5	type	type	NOUN
dpc-3385	29	6	4	4	NUM
dpc-3385	29	7	hypersensitivity	hypersensitivity	NOUN
dpc-3385	29	8	reaction	reaction	NOUN
dpc-3385	29	9	to	to	ADP
dpc-3385	29	10	an	an	DET
dpc-3385	29	11	antigenic	antigenic	ADJ
dpc-3385	29	12	stimulus	stimulus	NOUN
dpc-3385	29	13	[	[	X
dpc-3385	29	14	2	2	NUM
dpc-3385	29	15	]	]	PUNCT
dpc-3385	29	16	.	.	PUNCT
dpc-3385	30	1	the	the	DET
dpc-3385	30	2	term	term	NOUN
dpc-3385	30	3	eac	eac	PROPN
dpc-3385	30	4	was	be	AUX
dpc-3385	30	5	first	first	ADV
dpc-3385	30	6	used	use	VERB
dpc-3385	30	7	by	by	ADP
dpc-3385	30	8	jean	jean	PROPN
dpc-3385	30	9	darier	darier	PROPN
dpc-3385	30	10	in	in	ADP
dpc-3385	30	11	1916	1916	NUM
dpc-3385	31	1	[	[	X
dpc-3385	31	2	3	3	NUM
dpc-3385	31	3	]	]	PUNCT
dpc-3385	31	4	.	.	PUNCT
dpc-3385	32	1	darier	darier	PROPN
dpc-3385	32	2	referred	refer	VERB
dpc-3385	32	3	to	to	ADP
dpc-3385	32	4	eac	eac	PROPN
dpc-3385	32	5	also	also	ADV
dpc-3385	32	6	by	by	ADP
dpc-3385	32	7	a	a	DET
dpc-3385	32	8	synonym	synonym	NOUN
dpc-3385	32	9	“	"	PUNCT
dpc-3385	32	10	érythème	érythème	NOUN
dpc-3385	32	11	papulo	papulo	NOUN
dpc-3385	32	12	-	-	PUNCT
dpc-3385	32	13	circiné	circiné	NOUN
dpc-3385	32	14	migrateur	migrateur	PROPN
dpc-3385	32	15	et	et	PROPN
dpc-3385	32	16	chronique	chronique	PROPN
dpc-3385	32	17	”	"	PUNCT
dpc-3385	33	1	[	[	X
dpc-3385	33	2	3	3	NUM
dpc-3385	33	3	]	]	PUNCT
dpc-3385	33	4	.	.	PUNCT
dpc-3385	34	1	there	there	PRON
dpc-3385	34	2	are	be	VERB
dpc-3385	34	3	few	few	ADJ
dpc-3385	34	4	studies	study	NOUN
dpc-3385	34	5	on	on	ADP
dpc-3385	34	6	eac	eac	PROPN
dpc-3385	34	7	in	in	ADP
dpc-3385	34	8	the	the	DET
dpc-3385	34	9	literature	literature	NOUN
dpc-3385	34	10	which	which	PRON
dpc-3385	34	11	are	be	AUX
dpc-3385	34	12	retrospective	retrospective	ADJ
dpc-3385	34	13	studies	study	NOUN
dpc-3385	34	14	with	with	ADP
dpc-3385	34	15	small	small	ADJ
dpc-3385	34	16	number	number	NOUN
dpc-3385	34	17	of	of	ADP
dpc-3385	34	18	patients	patient	NOUN
dpc-3385	34	19	[	[	X
dpc-3385	34	20	4	4	NUM
dpc-3385	34	21	-	-	SYM
dpc-3385	34	22	6	6	NUM
dpc-3385	34	23	]	]	PUNCT
dpc-3385	34	24	.	.	PUNCT
dpc-3385	35	1	the	the	DET
dpc-3385	35	2	exact	exact	ADJ
dpc-3385	35	3	prevalence	prevalence	NOUN
dpc-3385	35	4	is	be	AUX
dpc-3385	35	5	unknown	unknown	ADJ
dpc-3385	35	6	[	[	X
dpc-3385	35	7	1	1	NUM
dpc-3385	35	8	]	]	PUNCT
dpc-3385	35	9	.	.	PUNCT
dpc-3385	36	1	eac	eac	PROPN
dpc-3385	36	2	is	be	AUX
dpc-3385	36	3	seen	see	VERB
dpc-3385	36	4	in	in	ADP
dpc-3385	36	5	two	two	NUM
dpc-3385	36	6	clinical	clinical	ADJ
dpc-3385	36	7	forms	form	NOUN
dpc-3385	36	8	,	,	PUNCT
dpc-3385	36	9	superficial	superficial	ADJ
dpc-3385	36	10	and	and	CCONJ
dpc-3385	36	11	deep	deep	ADJ
dpc-3385	36	12	[	[	X
dpc-3385	36	13	2,7	2,7	NUM
dpc-3385	36	14	]	]	PUNCT
dpc-3385	36	15	.	.	PUNCT
dpc-3385	37	1	in	in	ADP
dpc-3385	37	2	both	both	DET
dpc-3385	37	3	forms	form	NOUN
dpc-3385	37	4	,	,	PUNCT
dpc-3385	37	5	the	the	DET
dpc-3385	37	6	lesions	lesion	NOUN
dpc-3385	37	7	start	start	VERB
dpc-3385	37	8	as	as	ADP
dpc-3385	37	9	a	a	DET
dpc-3385	37	10	hard	hard	ADJ
dpc-3385	37	11	erythematous	erythematous	ADJ
dpc-3385	37	12	papule	papule	NOUN
dpc-3385	37	13	with	with	ADP
dpc-3385	37	14	centrifugal	centrifugal	ADJ
dpc-3385	37	15	spread	spread	NOUN
dpc-3385	37	16	,	,	PUNCT
dpc-3385	37	17	which	which	PRON
dpc-3385	37	18	begins	begin	VERB
dpc-3385	37	19	to	to	PART
dpc-3385	37	20	heal	heal	VERB
dpc-3385	37	21	from	from	ADP
dpc-3385	37	22	the	the	DET
dpc-3385	37	23	center	center	NOUN
dpc-3385	37	24	.	.	PUNCT
dpc-3385	38	1	the	the	DET
dpc-3385	38	2	superficial	superficial	ADJ
dpc-3385	38	3	type	type	NOUN
dpc-3385	38	4	appears	appear	VERB
dpc-3385	38	5	as	as	ADP
dpc-3385	38	6	erythematous	erythematous	ADJ
dpc-3385	38	7	,	,	PUNCT
dpc-3385	38	8	non	non	ADJ
dpc-3385	38	9	-	-	ADJ
dpc-3385	38	10	indurated	indurated	ADJ
dpc-3385	38	11	plaques	plaque	NOUN
dpc-3385	38	12	.	.	PUNCT
dpc-3385	39	1	on	on	ADP
dpc-3385	39	2	the	the	DET
dpc-3385	39	3	inner	inner	ADJ
dpc-3385	39	4	side	side	NOUN
dpc-3385	39	5	of	of	ADP
dpc-3385	39	6	the	the	DET
dpc-3385	39	7	advancing	advance	VERB
dpc-3385	39	8	margin	margin	NOUN
dpc-3385	39	9	,	,	PUNCT
dpc-3385	39	10	trailing	trail	VERB
dpc-3385	39	11	scale	scale	NOUN
dpc-3385	39	12	is	be	AUX
dpc-3385	39	13	typical	typical	ADJ
dpc-3385	39	14	.	.	PUNCT
dpc-3385	40	1	in	in	ADP
dpc-3385	40	2	the	the	DET
dpc-3385	40	3	deep	deep	ADJ
dpc-3385	40	4	type	type	NOUN
dpc-3385	40	5	,	,	PUNCT
dpc-3385	40	6	there	there	PRON
dpc-3385	40	7	is	be	VERB
dpc-3385	40	8	typically	typically	ADV
dpc-3385	40	9	no	no	DET
dpc-3385	40	10	scale	scale	NOUN
dpc-3385	40	11	,	,	PUNCT
dpc-3385	40	12	and	and	CCONJ
dpc-3385	40	13	the	the	DET
dpc-3385	40	14	advancing	advance	VERB
dpc-3385	40	15	borders	border	NOUN
dpc-3385	40	16	are	be	AUX
dpc-3385	40	17	raised	raise	VERB
dpc-3385	40	18	and	and	CCONJ
dpc-3385	40	19	indurated	indurate	VERB
dpc-3385	40	20	.	.	PUNCT
dpc-3385	41	1	lesions	lesion	NOUN
dpc-3385	41	2	may	may	AUX
dpc-3385	41	3	sometimes	sometimes	ADV
dpc-3385	41	4	persist	persist	VERB
dpc-3385	41	5	for	for	ADP
dpc-3385	41	6	weeks	week	NOUN
dpc-3385	41	7	and	and	CCONJ
dpc-3385	41	8	months	month	NOUN
dpc-3385	41	9	,	,	PUNCT
dpc-3385	41	10	regressing	regress	VERB
dpc-3385	41	11	and	and	CCONJ
dpc-3385	41	12	disappearing	disappear	VERB
dpc-3385	41	13	without	without	ADP
dpc-3385	41	14	leaving	leave	VERB
dpc-3385	41	15	a	a	DET
dpc-3385	41	16	scar	scar	NOUN
dpc-3385	41	17	[	[	X
dpc-3385	41	18	2,7	2,7	NUM
dpc-3385	41	19	]	]	PUNCT
dpc-3385	41	20	.	.	PUNCT
dpc-3385	42	1	paraneoplastic	paraneoplastic	ADJ
dpc-3385	42	2	eac	eac	PROPN
dpc-3385	42	3	associated	associate	VERB
dpc-3385	42	4	with	with	ADP
dpc-3385	42	5	malignancy	malignancy	NOUN
dpc-3385	42	6	is	be	AUX
dpc-3385	42	7	called	call	VERB
dpc-3385	42	8	peace	peace	NOUN
dpc-3385	42	9	(	(	PUNCT
dpc-3385	42	10	paraneoplastic	paraneoplastic	ADJ
dpc-3385	42	11	erythema	erythema	ADJ
dpc-3385	42	12	annulare	annulare	NOUN
dpc-3385	42	13	centrifugum	centrifugum	NOUN
dpc-3385	42	14	eruption	eruption	NOUN
dpc-3385	42	15	)	)	PUNCT
dpc-3385	43	1	[	[	X
dpc-3385	43	2	8	8	NUM
dpc-3385	43	3	]	]	PUNCT
dpc-3385	43	4	.	.	PUNCT
dpc-3385	44	1	eac	eac	PROPN
dpc-3385	44	2	may	may	AUX
dpc-3385	44	3	start	start	VERB
dpc-3385	44	4	years	year	NOUN
dpc-3385	44	5	before	before	ADV
dpc-3385	44	6	,	,	PUNCT
dpc-3385	44	7	simultaneously	simultaneously	ADV
dpc-3385	44	8	or	or	CCONJ
dpc-3385	44	9	later	later	ADV
dpc-3385	44	10	than	than	ADP
dpc-3385	44	11	malignancy	malignancy	NOUN
dpc-3385	44	12	[	[	X
dpc-3385	44	13	9	9	NUM
dpc-3385	44	14	]	]	PUNCT
dpc-3385	44	15	.	.	PUNCT
dpc-3385	45	1	the	the	DET
dpc-3385	45	2	first	first	ADJ
dpc-3385	45	3	approach	approach	NOUN
dpc-3385	45	4	in	in	ADP
dpc-3385	45	5	the	the	DET
dpc-3385	45	6	treatment	treatment	NOUN
dpc-3385	45	7	of	of	ADP
dpc-3385	45	8	eac	eac	NOUN
dpc-3385	45	9	is	be	AUX
dpc-3385	45	10	to	to	PART
dpc-3385	45	11	treat	treat	VERB
dpc-3385	45	12	the	the	DET
dpc-3385	45	13	underlying	underlie	VERB
dpc-3385	45	14	disease	disease	NOUN
dpc-3385	45	15	if	if	SCONJ
dpc-3385	45	16	one	one	PRON
dpc-3385	45	17	is	be	AUX
dpc-3385	45	18	detected	detect	VERB
dpc-3385	45	19	.	.	PUNCT
dpc-3385	46	1	since	since	SCONJ
dpc-3385	46	2	it	it	PRON
dpc-3385	46	3	usually	usually	ADV
dpc-3385	46	4	regresses	regress	VERB
dpc-3385	46	5	spontaneously	spontaneously	ADV
dpc-3385	46	6	without	without	ADP
dpc-3385	46	7	treatment	treatment	NOUN
dpc-3385	46	8	and	and	CCONJ
dpc-3385	46	9	is	be	AUX
dpc-3385	46	10	largely	largely	ADV
dpc-3385	46	11	asymptomatic	asymptomatic	ADJ
dpc-3385	46	12	,	,	PUNCT
dpc-3385	46	13	it	it	PRON
dpc-3385	46	14	can	can	AUX
dpc-3385	46	15	be	be	AUX
dpc-3385	46	16	followed	follow	VERB
dpc-3385	46	17	up	up	ADP
dpc-3385	46	18	without	without	ADP
dpc-3385	46	19	treatment	treatment	NOUN
dpc-3385	46	20	in	in	ADP
dpc-3385	46	21	mild	mild	ADJ
dpc-3385	46	22	cases	case	NOUN
dpc-3385	46	23	[	[	X
dpc-3385	46	24	1,10	1,10	NUM
dpc-3385	46	25	]	]	PUNCT
dpc-3385	46	26	.	.	PUNCT
dpc-3385	47	1	some	some	DET
dpc-3385	47	2	authorities	authority	NOUN
dpc-3385	47	3	recommend	recommend	VERB
dpc-3385	47	4	empirical	empirical	ADJ
dpc-3385	47	5	use	use	NOUN
dpc-3385	47	6	of	of	ADP
dpc-3385	47	7	antibiotics	antibiotic	NOUN
dpc-3385	47	8	and	and	CCONJ
dpc-3385	47	9	antifungal	antifungal	ADJ
dpc-3385	47	10	agents	agent	NOUN
dpc-3385	47	11	even	even	ADV
dpc-3385	47	12	if	if	SCONJ
dpc-3385	47	13	the	the	DET
dpc-3385	47	14	cause	cause	NOUN
dpc-3385	47	15	can	can	AUX
dpc-3385	47	16	not	not	PART
dpc-3385	47	17	be	be	AUX
dpc-3385	47	18	identified	identify	VERB
dpc-3385	47	19	.	.	PUNCT
dpc-3385	48	1	although	although	SCONJ
dpc-3385	48	2	systemic	systemic	ADJ
dpc-3385	48	3	steroids	steroid	NOUN
dpc-3385	48	4	provide	provide	VERB
dpc-3385	48	5	clinical	clinical	ADJ
dpc-3385	48	6	remission	remission	NOUN
dpc-3385	48	7	,	,	PUNCT
dpc-3385	48	8	they	they	PRON
dpc-3385	48	9	are	be	AUX
dpc-3385	48	10	not	not	PART
dpc-3385	48	11	preferred	prefer	VERB
dpc-3385	48	12	since	since	SCONJ
dpc-3385	48	13	the	the	DET
dpc-3385	48	14	findings	finding	NOUN
dpc-3385	48	15	tend	tend	VERB
dpc-3385	48	16	to	to	PART
dpc-3385	48	17	recur	recur	VERB
dpc-3385	48	18	after	after	ADP
dpc-3385	48	19	discontinuation	discontinuation	NOUN
dpc-3385	48	20	of	of	ADP
dpc-3385	48	21	the	the	DET
dpc-3385	48	22	drug	drug	NOUN
dpc-3385	49	1	[	[	X
dpc-3385	49	2	10,11	10,11	NOUN
dpc-3385	49	3	]	]	PUNCT
dpc-3385	49	4	.	.	PUNCT
dpc-3385	50	1	local	local	ADJ
dpc-3385	50	2	tacrolimus	tacrolimus	NOUN
dpc-3385	50	3	,	,	PUNCT
dpc-3385	50	4	calcipotriol	calcipotriol	NOUN
dpc-3385	50	5	,	,	PUNCT
dpc-3385	50	6	oral	oral	ADJ
dpc-3385	50	7	metronidazole	metronidazole	NOUN
dpc-3385	50	8	,	,	PUNCT
dpc-3385	50	9	subcutaneous	subcutaneous	ADJ
dpc-3385	50	10	interferon	interferon	NOUN
dpc-3385	50	11	and	and	CCONJ
dpc-3385	50	12	apremilast	apremilast	NOUN
dpc-3385	50	13	were	be	AUX
dpc-3385	50	14	reported	report	VERB
dpc-3385	50	15	to	to	PART
dpc-3385	50	16	be	be	AUX
dpc-3385	50	17	beneficial	beneficial	ADJ
dpc-3385	50	18	in	in	ADP
dpc-3385	50	19	some	some	DET
dpc-3385	50	20	patients	patient	NOUN
dpc-3385	50	21	[	[	X
dpc-3385	50	22	12	12	NUM
dpc-3385	50	23	-	-	SYM
dpc-3385	50	24	15	15	NUM
dpc-3385	50	25	]	]	PUNCT
dpc-3385	50	26	.	.	PUNCT
dpc-3385	51	1	however	however	ADV
dpc-3385	51	2	,	,	PUNCT
dpc-3385	51	3	it	it	PRON
dpc-3385	51	4	has	have	AUX
dpc-3385	51	5	been	be	AUX
dpc-3385	51	6	reported	report	VERB
dpc-3385	51	7	that	that	SCONJ
dpc-3385	51	8	the	the	DET
dpc-3385	51	9	treatments	treatment	NOUN
dpc-3385	51	10	did	do	AUX
dpc-3385	51	11	not	not	PART
dpc-3385	51	12	change	change	VERB
dpc-3385	51	13	the	the	DET
dpc-3385	51	14	chronic	chronic	ADJ
dpc-3385	51	15	and	and	CCONJ
dpc-3385	51	16	recurrent	recurrent	ADJ
dpc-3385	51	17	course	course	NOUN
dpc-3385	51	18	of	of	ADP
dpc-3385	51	19	the	the	DET
dpc-3385	51	20	disease	disease	NOUN
dpc-3385	51	21	[	[	X
dpc-3385	51	22	6	6	NUM
dpc-3385	51	23	]	]	PUNCT
dpc-3385	51	24	.	.	PUNCT
dpc-3385	52	1	the	the	DET
dpc-3385	52	2	histopathology	histopathology	NOUN
dpc-3385	52	3	of	of	ADP
dpc-3385	52	4	eac	eac	PROPN
dpc-3385	52	5	varies	vary	VERB
dpc-3385	52	6	according	accord	VERB
dpc-3385	52	7	to	to	ADP
dpc-3385	52	8	its	its	PRON
dpc-3385	52	9	type	type	NOUN
dpc-3385	52	10	.	.	PUNCT
dpc-3385	53	1	in	in	ADP
dpc-3385	53	2	the	the	DET
dpc-3385	53	3	superficial	superficial	ADJ
dpc-3385	53	4	type	type	NOUN
dpc-3385	53	5	nonspecific	nonspecific	ADJ
dpc-3385	53	6	findings	finding	NOUN
dpc-3385	53	7	such	such	ADJ
dpc-3385	53	8	as	as	ADP
dpc-3385	53	9	mild	mild	ADJ
dpc-3385	53	10	spongiosis	spongiosis	NOUN
dpc-3385	53	11	,	,	PUNCT
dpc-3385	53	12	microvesiculation	microvesiculation	NOUN
dpc-3385	53	13	,	,	PUNCT
dpc-3385	53	14	focal	focal	ADJ
dpc-3385	53	15	parakeratosis	parakeratosis	NOUN
dpc-3385	53	16	,	,	PUNCT
dpc-3385	53	17	epidermal	epidermal	ADJ
dpc-3385	53	18	hyperplasia	hyperplasia	NOUN
dpc-3385	53	19	,	,	PUNCT
dpc-3385	53	20	minimal	minimal	ADJ
dpc-3385	53	21	superficial	superficial	ADJ
dpc-3385	53	22	perivascular	perivascular	ADJ
dpc-3385	53	23	lymphohistiocytic	lymphohistiocytic	ADJ
dpc-3385	53	24	infiltration	infiltration	NOUN
dpc-3385	53	25	are	be	AUX
dpc-3385	53	26	seen	see	VERB
dpc-3385	53	27	.	.	PUNCT
dpc-3385	54	1	furthermore	furthermore	ADV
dpc-3385	54	2	,	,	PUNCT
dpc-3385	54	3	edema	edema	NOUN
dpc-3385	54	4	of	of	ADP
dpc-3385	54	5	the	the	DET
dpc-3385	54	6	papillary	papillary	ADJ
dpc-3385	54	7	dermis	dermis	NOUN
dpc-3385	54	8	is	be	AUX
dpc-3385	54	9	more	more	ADV
dpc-3385	54	10	common	common	ADJ
dpc-3385	54	11	in	in	ADP
dpc-3385	54	12	the	the	DET
dpc-3385	54	13	superficial	superficial	ADJ
dpc-3385	54	14	type	type	NOUN
dpc-3385	54	15	[	[	X
dpc-3385	54	16	1,4	1,4	NUM
dpc-3385	54	17	]	]	PUNCT
dpc-3385	54	18	.	.	PUNCT
dpc-3385	55	1	in	in	ADP
dpc-3385	55	2	the	the	DET
dpc-3385	55	3	deep	deep	ADJ
dpc-3385	55	4	form	form	NOUN
dpc-3385	55	5	,	,	PUNCT
dpc-3385	55	6	epidermal	epidermal	ADJ
dpc-3385	55	7	changes	change	NOUN
dpc-3385	55	8	are	be	AUX
dpc-3385	55	9	not	not	PART
dpc-3385	55	10	prominent	prominent	ADJ
dpc-3385	55	11	and	and	CCONJ
dpc-3385	55	12	mononuclear	mononuclear	ADJ
dpc-3385	55	13	cell	cell	NOUN
dpc-3385	55	14	infiltration	infiltration	NOUN
dpc-3385	55	15	with	with	ADP
dpc-3385	55	16	dense	dense	ADJ
dpc-3385	55	17	perivascular	perivascular	ADJ
dpc-3385	55	18	aggregation	aggregation	NOUN
dpc-3385	55	19	is	be	AUX
dpc-3385	55	20	evident	evident	ADJ
dpc-3385	55	21	in	in	ADP
dpc-3385	55	22	the	the	DET
dpc-3385	55	23	mid	mid	ADJ
dpc-3385	55	24	and	and	CCONJ
dpc-3385	55	25	lower	low	ADJ
dpc-3385	55	26	dermis	dermis	NOUN
dpc-3385	55	27	which	which	PRON
dpc-3385	55	28	leads	lead	VERB
dpc-3385	55	29	to	to	ADP
dpc-3385	55	30	elevated	elevated	ADJ
dpc-3385	55	31	and	and	CCONJ
dpc-3385	55	32	more	more	ADV
dpc-3385	55	33	indurated	indurate	VERB
dpc-3385	55	34	lesions	lesion	NOUN
dpc-3385	55	35	in	in	ADP
dpc-3385	55	36	the	the	DET
dpc-3385	55	37	deep	deep	ADJ
dpc-3385	55	38	form	form	NOUN
dpc-3385	55	39	of	of	ADP
dpc-3385	55	40	eac	eac	NOUN
dpc-3385	55	41	clinically	clinically	ADV
dpc-3385	55	42	[	[	X
dpc-3385	55	43	1,4	1,4	NUM
dpc-3385	55	44	]	]	PUNCT
dpc-3385	55	45	.	.	PUNCT
dpc-3385	56	1	in	in	ADP
dpc-3385	56	2	addition	addition	NOUN
dpc-3385	56	3	,	,	PUNCT
dpc-3385	56	4	inflammatory	inflammatory	ADJ
dpc-3385	56	5	cells	cell	NOUN
dpc-3385	56	6	typically	typically	ADV
dpc-3385	56	7	accumulate	accumulate	VERB
dpc-3385	56	8	densely	densely	ADV
dpc-3385	56	9	around	around	ADP
dpc-3385	56	10	the	the	DET
dpc-3385	56	11	vessels	vessel	NOUN
dpc-3385	56	12	in	in	ADP
dpc-3385	56	13	a	a	DET
dpc-3385	56	14	so	so	ADV
dpc-3385	56	15	-	-	PUNCT
dpc-3385	56	16	called	call	VERB
dpc-3385	56	17	“	"	PUNCT
dpc-3385	56	18	sleeve	sleeve	NOUN
dpc-3385	56	19	”	"	PUNCT
dpc-3385	56	20	fashion	fashion	NOUN
dpc-3385	56	21	[	[	X
dpc-3385	56	22	1,4	1,4	NUM
dpc-3385	56	23	]	]	PUNCT
dpc-3385	56	24	.	.	PUNCT
dpc-3385	57	1	this	this	DET
dpc-3385	57	2	typical	typical	ADJ
dpc-3385	57	3	infiltration	infiltration	NOUN
dpc-3385	57	4	may	may	AUX
dpc-3385	57	5	be	be	AUX
dpc-3385	57	6	considered	consider	VERB
dpc-3385	57	7	as	as	ADP
dpc-3385	57	8	a	a	DET
dpc-3385	57	9	marker	marker	NOUN
dpc-3385	57	10	for	for	ADP
dpc-3385	57	11	the	the	DET
dpc-3385	57	12	differentiation	differentiation	NOUN
dpc-3385	57	13	of	of	ADP
dpc-3385	57	14	eac	eac	PROPN
dpc-3385	57	15	from	from	ADP
dpc-3385	57	16	other	other	ADJ
dpc-3385	57	17	figurate	figurate	NOUN
dpc-3385	57	18	erythemas	erythema	NOUN
dpc-3385	57	19	.	.	PUNCT
dpc-3385	58	1	since	since	SCONJ
dpc-3385	58	2	fibrin	fibrin	NOUN
dpc-3385	58	3	extravasation	extravasation	NOUN
dpc-3385	58	4	is	be	AUX
dpc-3385	58	5	not	not	PART
dpc-3385	58	6	expected	expect	VERB
dpc-3385	58	7	in	in	ADP
dpc-3385	58	8	eac	eac	PROPN
dpc-3385	58	9	,	,	PUNCT
dpc-3385	58	10	it	it	PRON
dpc-3385	58	11	can	can	AUX
dpc-3385	58	12	be	be	AUX
dpc-3385	58	13	considered	consider	VERB
dpc-3385	58	14	as	as	ADP
dpc-3385	58	15	pseudovasculitis	pseudovasculitis	NOUN
dpc-3385	58	16	[	[	X
dpc-3385	58	17	1,4	1,4	NUM
dpc-3385	58	18	]	]	PUNCT
dpc-3385	58	19	.	.	PUNCT
dpc-3385	59	1	objectives	objective	VERB
dpc-3385	59	2	the	the	DET
dpc-3385	59	3	aim	aim	NOUN
dpc-3385	59	4	of	of	ADP
dpc-3385	59	5	our	our	PRON
dpc-3385	59	6	study	study	NOUN
dpc-3385	59	7	was	be	AUX
dpc-3385	59	8	to	to	PART
dpc-3385	59	9	evaluate	evaluate	VERB
dpc-3385	59	10	the	the	DET
dpc-3385	59	11	demographic	demographic	ADJ
dpc-3385	59	12	,	,	PUNCT
dpc-3385	59	13	clinical	clinical	ADJ
dpc-3385	59	14	and	and	CCONJ
dpc-3385	59	15	histopathologic	histopathologic	ADJ
dpc-3385	59	16	characteristics	characteristic	NOUN
dpc-3385	59	17	of	of	ADP
dpc-3385	59	18	patients	patient	NOUN
dpc-3385	59	19	with	with	ADP
dpc-3385	59	20	eac	eac	PROPN
dpc-3385	59	21	and	and	CCONJ
dpc-3385	59	22	to	to	PART
dpc-3385	59	23	examine	examine	VERB
dpc-3385	59	24	the	the	DET
dpc-3385	59	25	associated	associated	ADJ
dpc-3385	59	26	diseases	disease	NOUN
dpc-3385	59	27	.	.	PUNCT
dpc-3385	60	1	methods	method	NOUN
dpc-3385	60	2	our	our	PRON
dpc-3385	60	3	study	study	NOUN
dpc-3385	60	4	was	be	AUX
dpc-3385	60	5	designed	design	VERB
dpc-3385	60	6	as	as	ADP
dpc-3385	60	7	a	a	DET
dpc-3385	60	8	retrospective	retrospective	ADJ
dpc-3385	60	9	study	study	NOUN
dpc-3385	60	10	in	in	ADP
dpc-3385	60	11	a	a	DET
dpc-3385	60	12	tertiary	tertiary	ADJ
dpc-3385	60	13	referral	referral	NOUN
dpc-3385	60	14	hospital	hospital	NOUN
dpc-3385	60	15	.	.	PUNCT
dpc-3385	61	1	we	we	PRON
dpc-3385	61	2	analyzed	analyze	VERB
dpc-3385	61	3	data	datum	NOUN
dpc-3385	61	4	of	of	ADP
dpc-3385	61	5	the	the	DET
dpc-3385	61	6	patients	patient	NOUN
dpc-3385	61	7	over	over	ADP
dpc-3385	61	8	the	the	DET
dpc-3385	61	9	age	age	NOUN
dpc-3385	61	10	of	of	ADP
dpc-3385	61	11	18	18	NUM
dpc-3385	61	12	years	year	NOUN
dpc-3385	61	13	who	who	PRON
dpc-3385	61	14	were	be	AUX
dpc-3385	61	15	followed	follow	VERB
dpc-3385	61	16	up	up	ADP
dpc-3385	61	17	with	with	ADP
dpc-3385	61	18	a	a	DET
dpc-3385	61	19	diagnosis	diagnosis	NOUN
dpc-3385	61	20	of	of	ADP
dpc-3385	61	21	eac	eac	NOUN
dpc-3385	61	22	between	between	ADP
dpc-3385	61	23	january	january	PROPN
dpc-3385	61	24	2019	2019	NUM
dpc-3385	61	25	and	and	CCONJ
dpc-3385	61	26	january	january	PROPN
dpc-3385	61	27	2023	2023	NUM
dpc-3385	61	28	.	.	PUNCT
dpc-3385	62	1	we	we	PRON
dpc-3385	62	2	stipulated	stipulate	VERB
dpc-3385	62	3	a	a	DET
dpc-3385	62	4	clinicopathologic	clinicopathologic	ADJ
dpc-3385	62	5	correlation	correlation	NOUN
dpc-3385	62	6	in	in	ADP
dpc-3385	62	7	our	our	PRON
dpc-3385	62	8	study	study	NOUN
dpc-3385	62	9	to	to	PART
dpc-3385	62	10	exclude	exclude	VERB
dpc-3385	62	11	other	other	ADJ
dpc-3385	62	12	annular	annular	ADJ
dpc-3385	62	13	erythemas	erythema	NOUN
dpc-3385	62	14	resembling	resemble	VERB
dpc-3385	62	15	eac	eac	PROPN
dpc-3385	62	16	.	.	PUNCT
dpc-3385	63	1	ethics	ethic	NOUN
dpc-3385	63	2	committee	committee	PROPN
dpc-3385	63	3	approval	approval	NOUN
dpc-3385	63	4	numbered	number	VERB
dpc-3385	63	5	e1	e1	PROPN
dpc-3385	63	6	-	-	PUNCT
dpc-3385	63	7	23	23	NUM
dpc-3385	63	8	-	-	SYM
dpc-3385	63	9	3287	3287	NUM
dpc-3385	63	10	was	be	AUX
dpc-3385	63	11	obtained	obtain	VERB
dpc-3385	63	12	before	before	ADP
dpc-3385	63	13	the	the	DET
dpc-3385	63	14	study	study	NOUN
dpc-3385	63	15	(	(	PUNCT
dpc-3385	63	16	08.02.2023	08.02.2023	NUM
dpc-3385	63	17	)	)	PUNCT
dpc-3385	63	18	.	.	PUNCT
dpc-3385	64	1	statistical	statistical	ADJ
dpc-3385	64	2	analysis	analysis	NOUN
dpc-3385	64	3	calculations	calculation	NOUN
dpc-3385	64	4	were	be	AUX
dpc-3385	64	5	made	make	VERB
dpc-3385	64	6	with	with	ADP
dpc-3385	64	7	statistical	statistical	ADJ
dpc-3385	64	8	package	package	NOUN
dpc-3385	64	9	for	for	ADP
dpc-3385	64	10	social	social	ADJ
dpc-3385	64	11	sciences	science	NOUN
dpc-3385	64	12	(	(	PUNCT
dpc-3385	64	13	spss	spss	PROPN
dpc-3385	64	14	)	)	PUNCT
dpc-3385	64	15	version	version	NOUN
dpc-3385	64	16	24.0	24.0	NUM
dpc-3385	64	17	for	for	ADP
dpc-3385	64	18	windows	window	NOUN
dpc-3385	64	19	program	program	NOUN
dpc-3385	64	20	.	.	PUNCT
dpc-3385	65	1	continuous	continuous	ADJ
dpc-3385	65	2	variables	variable	NOUN
dpc-3385	65	3	(	(	PUNCT
dpc-3385	65	4	age	age	NOUN
dpc-3385	65	5	,	,	PUNCT
dpc-3385	65	6	duration	duration	NOUN
dpc-3385	65	7	of	of	ADP
dpc-3385	65	8	disease	disease	NOUN
dpc-3385	65	9	)	)	PUNCT
dpc-3385	65	10	are	be	AUX
dpc-3385	65	11	expressed	express	VERB
dpc-3385	65	12	as	as	ADP
dpc-3385	65	13	mean	mean	ADJ
dpc-3385	65	14	and	and	CCONJ
dpc-3385	65	15	standard	standard	ADJ
dpc-3385	65	16	deviation	deviation	NOUN
dpc-3385	65	17	,	,	PUNCT
dpc-3385	65	18	while	while	SCONJ
dpc-3385	65	19	categorical	categorical	ADJ
dpc-3385	65	20	variables	variable	NOUN
dpc-3385	65	21	(	(	PUNCT
dpc-3385	65	22	localizations	localization	NOUN
dpc-3385	65	23	of	of	ADP
dpc-3385	65	24	lesions	lesion	NOUN
dpc-3385	65	25	,	,	PUNCT
dpc-3385	65	26	number	number	NOUN
dpc-3385	65	27	of	of	ADP
dpc-3385	65	28	attacks	attack	NOUN
dpc-3385	65	29	,	,	PUNCT
dpc-3385	65	30	histopathological	histopathological	ADJ
dpc-3385	65	31	subtype	subtype	NOUN
dpc-3385	65	32	,	,	PUNCT
dpc-3385	65	33	associated	associated	ADJ
dpc-3385	65	34	conditions	condition	NOUN
dpc-3385	65	35	,	,	PUNCT
dpc-3385	65	36	concomitant	concomitant	ADJ
dpc-3385	65	37	diseases	disease	NOUN
dpc-3385	65	38	,	,	PUNCT
dpc-3385	65	39	treatments	treatment	NOUN
dpc-3385	65	40	received	receive	VERB
dpc-3385	65	41	)	)	PUNCT
dpc-3385	65	42	are	be	AUX
dpc-3385	65	43	expressed	express	VERB
dpc-3385	65	44	as	as	ADP
dpc-3385	65	45	number	number	NOUN
dpc-3385	65	46	and	and	CCONJ
dpc-3385	65	47	percentage	percentage	NOUN
dpc-3385	65	48	.	.	PUNCT
dpc-3385	66	1	chi	chi	ADJ
dpc-3385	66	2	-	-	PUNCT
dpc-3385	66	3	square	square	PROPN
dpc-3385	66	4	test	test	NOUN
dpc-3385	66	5	statistics	statistic	NOUN
dpc-3385	66	6	was	be	AUX
dpc-3385	66	7	used	use	VERB
dpc-3385	66	8	to	to	PART
dpc-3385	66	9	compare	compare	VERB
dpc-3385	66	10	categorical	categorical	ADJ
dpc-3385	66	11	measurements	measurement	NOUN
dpc-3385	66	12	.	.	PUNCT
dpc-3385	67	1	statistical	statistical	ADJ
dpc-3385	67	2	significance	significance	NOUN
dpc-3385	67	3	level	level	NOUN
dpc-3385	67	4	was	be	AUX
dpc-3385	67	5	accepted	accept	VERB
dpc-3385	67	6	as	as	ADP
dpc-3385	67	7	0.05	0.05	NUM
dpc-3385	67	8	in	in	ADP
dpc-3385	67	9	all	all	DET
dpc-3385	67	10	tests	test	NOUN
dpc-3385	67	11	.	.	PUNCT
dpc-3385	68	1	results	result	NOUN
dpc-3385	68	2	we	we	PRON
dpc-3385	68	3	included	include	VERB
dpc-3385	68	4	a	a	DET
dpc-3385	68	5	total	total	NOUN
dpc-3385	68	6	of	of	ADP
dpc-3385	68	7	63	63	NUM
dpc-3385	68	8	patients	patient	NOUN
dpc-3385	68	9	,	,	PUNCT
dpc-3385	68	10	39	39	NUM
dpc-3385	68	11	(	(	PUNCT
dpc-3385	68	12	62	62	NUM
dpc-3385	68	13	%	%	NOUN
dpc-3385	68	14	)	)	PUNCT
dpc-3385	68	15	females	female	NOUN
dpc-3385	68	16	and	and	CCONJ
dpc-3385	68	17	24	24	NUM
dpc-3385	68	18	(	(	PUNCT
dpc-3385	68	19	38	38	NUM
dpc-3385	68	20	%	%	NOUN
dpc-3385	68	21	)	)	PUNCT
dpc-3385	68	22	males	male	NOUN
dpc-3385	68	23	,	,	PUNCT
dpc-3385	68	24	aged	age	VERB
dpc-3385	68	25	between	between	ADP
dpc-3385	68	26	19	19	NUM
dpc-3385	68	27	and	and	CCONJ
dpc-3385	68	28	84	84	NUM
dpc-3385	68	29	years	year	NOUN
dpc-3385	68	30	in	in	ADP
dpc-3385	68	31	our	our	PRON
dpc-3385	68	32	study	study	NOUN
dpc-3385	68	33	.	.	PUNCT
dpc-3385	69	1	we	we	PRON
dpc-3385	69	2	had	have	AUX
dpc-3385	69	3	excluded	exclude	VERB
dpc-3385	69	4	five	five	NUM
dpc-3385	69	5	patients	patient	NOUN
dpc-3385	69	6	with	with	ADP
dpc-3385	69	7	missing	miss	VERB
dpc-3385	69	8	or	or	CCONJ
dpc-3385	69	9	incongruous	incongruous	ADJ
dpc-3385	69	10	histopathological	histopathological	ADJ
dpc-3385	69	11	data	datum	NOUN
dpc-3385	69	12	on	on	ADP
dpc-3385	69	13	the	the	DET
dpc-3385	69	14	eve	eve	NOUN
dpc-3385	69	15	of	of	ADP
dpc-3385	69	16	the	the	DET
dpc-3385	69	17	study	study	NOUN
dpc-3385	69	18	.	.	PUNCT
dpc-3385	70	1	the	the	DET
dpc-3385	70	2	mean	mean	ADJ
dpc-3385	70	3	age	age	NOUN
dpc-3385	70	4	of	of	ADP
dpc-3385	70	5	the	the	DET
dpc-3385	70	6	patients	patient	NOUN
dpc-3385	70	7	was	be	AUX
dpc-3385	70	8	47.8±11.2	47.8±11.2	NUM
dpc-3385	70	9	years	year	NOUN
dpc-3385	70	10	.	.	PUNCT
dpc-3385	71	1	the	the	DET
dpc-3385	71	2	duration	duration	NOUN
dpc-3385	71	3	of	of	ADP
dpc-3385	71	4	disease	disease	NOUN
dpc-3385	71	5	ranged	range	VERB
dpc-3385	71	6	from	from	ADP
dpc-3385	71	7	1	1	NUM
dpc-3385	71	8	week	week	NOUN
dpc-3385	71	9	to	to	ADP
dpc-3385	71	10	10	10	NUM
dpc-3385	71	11	years	year	NOUN
dpc-3385	71	12	with	with	ADP
dpc-3385	71	13	a	a	DET
dpc-3385	71	14	mean	mean	NOUN
dpc-3385	71	15	of	of	ADP
dpc-3385	71	16	15.54±12	15.54±12	NUM
dpc-3385	71	17	months	month	NOUN
dpc-3385	71	18	.	.	PUNCT
dpc-3385	72	1	in	in	ADP
dpc-3385	72	2	19	19	NUM
dpc-3385	72	3	patients	patient	NOUN
dpc-3385	72	4	,	,	PUNCT
dpc-3385	72	5	the	the	DET
dpc-3385	72	6	duration	duration	NOUN
dpc-3385	72	7	of	of	ADP
dpc-3385	72	8	disease	disease	NOUN
dpc-3385	72	9	was	be	AUX
dpc-3385	72	10	longer	long	ADJ
dpc-3385	72	11	than	than	ADP
dpc-3385	72	12	1	1	NUM
dpc-3385	72	13	year	year	NOUN
dpc-3385	72	14	and	and	CCONJ
dpc-3385	72	15	the	the	DET
dpc-3385	72	16	disease	disease	NOUN
dpc-3385	72	17	persisted	persist	VERB
dpc-3385	72	18	for	for	ADP
dpc-3385	72	19	an	an	DET
dpc-3385	72	20	average	average	NOUN
dpc-3385	72	21	of	of	ADP
dpc-3385	72	22	45.8	45.8	NUM
dpc-3385	72	23	months	month	NOUN
dpc-3385	72	24	.	.	PUNCT
dpc-3385	73	1	trunk	trunk	NOUN
dpc-3385	73	2	,	,	PUNCT
dpc-3385	73	3	thighs	thigh	NOUN
dpc-3385	73	4	and	and	CCONJ
dpc-3385	73	5	arms	arm	NOUN
dpc-3385	73	6	were	be	AUX
dpc-3385	73	7	the	the	DET
dpc-3385	73	8	most	most	ADV
dpc-3385	73	9	frequently	frequently	ADV
dpc-3385	73	10	affected	affect	VERB
dpc-3385	73	11	sites	site	NOUN
dpc-3385	73	12	(	(	PUNCT
dpc-3385	73	13	figures	figure	NOUN
dpc-3385	73	14	1	1	NUM
dpc-3385	73	15	and	and	CCONJ
dpc-3385	73	16	2	2	NUM
dpc-3385	73	17	)	)	PUNCT
dpc-3385	73	18	.	.	PUNCT
dpc-3385	74	1	localizations	localization	NOUN
dpc-3385	74	2	of	of	ADP
dpc-3385	74	3	the	the	DET
dpc-3385	74	4	lesions	lesion	NOUN
dpc-3385	74	5	are	be	AUX
dpc-3385	74	6	shown	show	VERB
dpc-3385	74	7	in	in	ADP
dpc-3385	74	8	table	table	NOUN
dpc-3385	74	9	1	1	NUM
dpc-3385	74	10	.	.	X
dpc-3385	75	1	involvement	involvement	NOUN
dpc-3385	75	2	in	in	ADP
dpc-3385	75	3	multiple	multiple	ADJ
dpc-3385	75	4	localizations	localization	NOUN
dpc-3385	75	5	was	be	AUX
dpc-3385	75	6	observed	observe	VERB
dpc-3385	75	7	in	in	ADP
dpc-3385	75	8	eight	eight	NUM
dpc-3385	75	9	patients	patient	NOUN
dpc-3385	75	10	.	.	PUNCT
dpc-3385	76	1	the	the	DET
dpc-3385	76	2	number	number	NOUN
dpc-3385	76	3	of	of	ADP
dpc-3385	76	4	attacks	attack	NOUN
dpc-3385	76	5	of	of	ADP
dpc-3385	76	6	the	the	DET
dpc-3385	76	7	patients	patient	NOUN
dpc-3385	76	8	varied	vary	VERB
dpc-3385	76	9	between	between	ADP
dpc-3385	76	10	1	1	NUM
dpc-3385	76	11	-	-	SYM
dpc-3385	76	12	20	20	NUM
dpc-3385	76	13	attacks	attack	NOUN
dpc-3385	76	14	.	.	PUNCT
dpc-3385	77	1	multiple	multiple	ADJ
dpc-3385	77	2	attacks	attack	NOUN
dpc-3385	77	3	developed	develop	VERB
dpc-3385	77	4	in	in	ADP
dpc-3385	77	5	43	43	NUM
dpc-3385	77	6	%	%	NOUN
dpc-3385	77	7	(	(	PUNCT
dpc-3385	77	8	n	n	NOUN
dpc-3385	77	9	=	=	SYM
dpc-3385	77	10	27	27	NUM
dpc-3385	77	11	)	)	PUNCT
dpc-3385	77	12	of	of	ADP
dpc-3385	77	13	the	the	DET
dpc-3385	77	14	patients	patient	NOUN
dpc-3385	77	15	and	and	CCONJ
dpc-3385	77	16	it	it	PRON
dpc-3385	77	17	was	be	AUX
dpc-3385	77	18	the	the	DET
dpc-3385	77	19	first	first	ADJ
dpc-3385	77	20	attack	attack	NOUN
dpc-3385	77	21	in	in	ADP
dpc-3385	77	22	57	57	NUM
dpc-3385	77	23	%	%	NOUN
dpc-3385	77	24	(	(	PUNCT
dpc-3385	77	25	n	n	NOUN
dpc-3385	77	26	=	=	SYM
dpc-3385	77	27	36	36	NUM
dpc-3385	77	28	)	)	PUNCT
dpc-3385	77	29	.	.	PUNCT
dpc-3385	78	1	in	in	ADP
dpc-3385	78	2	patients	patient	NOUN
dpc-3385	78	3	with	with	ADP
dpc-3385	78	4	multiple	multiple	ADJ
dpc-3385	78	5	episodes	episode	NOUN
dpc-3385	78	6	,	,	PUNCT
dpc-3385	78	7	the	the	DET
dpc-3385	78	8	episodes	episode	NOUN
dpc-3385	78	9	recurred	recur	VERB
dpc-3385	78	10	in	in	ADP
dpc-3385	78	11	an	an	DET
dpc-3385	78	12	average	average	NOUN
dpc-3385	78	13	of	of	ADP
dpc-3385	78	14	9.1	9.1	NUM
dpc-3385	78	15	months	month	NOUN
dpc-3385	78	16	.	.	PUNCT
dpc-3385	79	1	histopathologically	histopathologically	ADV
dpc-3385	79	2	,	,	PUNCT
dpc-3385	79	3	10	10	NUM
dpc-3385	79	4	(	(	PUNCT
dpc-3385	79	5	15.9	15.9	NUM
dpc-3385	79	6	%	%	NOUN
dpc-3385	79	7	)	)	PUNCT
dpc-3385	79	8	and	and	CCONJ
dpc-3385	79	9	53	53	NUM
dpc-3385	79	10	(	(	PUNCT
dpc-3385	79	11	84.1	84.1	NUM
dpc-3385	79	12	%	%	NOUN
dpc-3385	79	13	)	)	PUNCT
dpc-3385	79	14	patients	patient	NOUN
dpc-3385	79	15	had	have	VERB
dpc-3385	79	16	findings	finding	NOUN
dpc-3385	79	17	compatible	compatible	ADJ
dpc-3385	79	18	with	with	ADP
dpc-3385	79	19	deep	deep	ADJ
dpc-3385	79	20	(	(	PUNCT
dpc-3385	79	21	figures	figure	NOUN
dpc-3385	79	22	3	3	NUM
dpc-3385	79	23	and	and	CCONJ
dpc-3385	79	24	4	4	NUM
dpc-3385	79	25	)	)	PUNCT
dpc-3385	79	26	and	and	CCONJ
dpc-3385	79	27	superficial	superficial	ADJ
dpc-3385	79	28	type	type	NOUN
dpc-3385	79	29	eac	eac	PROPN
dpc-3385	79	30	,	,	PUNCT
dpc-3385	79	31	respectively	respectively	ADV
dpc-3385	79	32	.	.	PUNCT
dpc-3385	80	1	it	it	PRON
dpc-3385	80	2	was	be	AUX
dpc-3385	80	3	consistent	consistent	ADJ
dpc-3385	80	4	with	with	ADP
dpc-3385	80	5	clinical	clinical	ADJ
dpc-3385	80	6	deep	deep	ADJ
dpc-3385	80	7	and	and	CCONJ
dpc-3385	80	8	superficial	superficial	ADJ
dpc-3385	80	9	types	type	NOUN
dpc-3385	80	10	.	.	PUNCT
dpc-3385	81	1	we	we	PRON
dpc-3385	81	2	evaluated	evaluate	VERB
dpc-3385	81	3	all	all	DET
dpc-3385	81	4	patients	patient	NOUN
dpc-3385	81	5	diagnosed	diagnose	VERB
dpc-3385	81	6	with	with	ADP
dpc-3385	81	7	eac	eac	PROPN
dpc-3385	81	8	in	in	ADP
dpc-3385	81	9	our	our	PRON
dpc-3385	81	10	study	study	NOUN
dpc-3385	81	11	in	in	ADP
dpc-3385	81	12	terms	term	NOUN
dpc-3385	81	13	of	of	ADP
dpc-3385	81	14	underlying	underlie	VERB
dpc-3385	81	15	diseases	disease	NOUN
dpc-3385	81	16	.	.	PUNCT
dpc-3385	82	1	factors	factor	NOUN
dpc-3385	82	2	that	that	PRON
dpc-3385	82	3	may	may	AUX
dpc-3385	82	4	be	be	AUX
dpc-3385	82	5	involved	involve	VERB
dpc-3385	82	6	in	in	ADP
dpc-3385	82	7	the	the	DET
dpc-3385	82	8	etiology	etiology	NOUN
dpc-3385	82	9	were	be	AUX
dpc-3385	82	10	found	find	VERB
dpc-3385	82	11	in	in	ADP
dpc-3385	82	12	52.3	52.3	NUM
dpc-3385	82	13	%	%	NOUN
dpc-3385	82	14	of	of	ADP
dpc-3385	82	15	the	the	DET
dpc-3385	82	16	patients	patient	NOUN
dpc-3385	82	17	.	.	PUNCT
dpc-3385	83	1	associated	associate	VERB
dpc-3385	83	2	conditions	condition	NOUN
dpc-3385	83	3	are	be	AUX
dpc-3385	83	4	shown	show	VERB
dpc-3385	83	5	in	in	ADP
dpc-3385	83	6	table	table	NOUN
dpc-3385	83	7	2	2	NUM
dpc-3385	83	8	.	.	X
dpc-3385	83	9	eight	eight	NUM
dpc-3385	83	10	patients	patient	NOUN
dpc-3385	83	11	had	have	VERB
dpc-3385	83	12	fungal	fungal	ADJ
dpc-3385	83	13	infections	infection	NOUN
dpc-3385	83	14	(	(	PUNCT
dpc-3385	83	15	tinea	tinea	PROPN
dpc-3385	83	16	pedis	pedi	VERB
dpc-3385	83	17	original	original	ADJ
dpc-3385	83	18	article	article	NOUN
dpc-3385	83	19	|	|	ADV
dpc-3385	83	20	dermatol	dermatol	ADJ
dpc-3385	83	21	pract	pract	NOUN
dpc-3385	83	22	concept	concept	NOUN
dpc-3385	83	23	.	.	PUNCT
dpc-3385	84	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	84	2	3	3	NUM
dpc-3385	84	3	and/or	and/or	CCONJ
dpc-3385	84	4	tinea	tinea	PROPN
dpc-3385	84	5	unguium	unguium	NOUN
dpc-3385	84	6	in	in	ADP
dpc-3385	84	7	7	7	NUM
dpc-3385	84	8	patients	patient	NOUN
dpc-3385	84	9	,	,	PUNCT
dpc-3385	84	10	vaginal	vaginal	ADJ
dpc-3385	84	11	candidiasis	candidiasis	NOUN
dpc-3385	84	12	in	in	ADP
dpc-3385	84	13	1	1	NUM
dpc-3385	84	14	patient	patient	NOUN
dpc-3385	84	15	)	)	PUNCT
dpc-3385	84	16	,	,	PUNCT
dpc-3385	84	17	4	4	NUM
dpc-3385	84	18	patients	patient	NOUN
dpc-3385	84	19	had	have	VERB
dpc-3385	84	20	gastritis	gastritis	NOUN
dpc-3385	84	21	and	and	CCONJ
dpc-3385	84	22	helicobacter	helicobacter	NOUN
dpc-3385	84	23	pylori	pylori	ADJ
dpc-3385	84	24	infection	infection	NOUN
dpc-3385	84	25	.	.	PUNCT
dpc-3385	85	1	there	there	PRON
dpc-3385	85	2	was	be	VERB
dpc-3385	85	3	one	one	NUM
dpc-3385	85	4	case	case	NOUN
dpc-3385	85	5	each	each	PRON
dpc-3385	85	6	of	of	ADP
dpc-3385	85	7	urinary	urinary	ADJ
dpc-3385	85	8	tract	tract	NOUN
dpc-3385	85	9	infection	infection	NOUN
dpc-3385	85	10	,	,	PUNCT
dpc-3385	85	11	upper	upper	ADJ
dpc-3385	85	12	respiratory	respiratory	ADJ
dpc-3385	85	13	tract	tract	NOUN
dpc-3385	85	14	infection	infection	NOUN
dpc-3385	85	15	,	,	PUNCT
dpc-3385	85	16	coronavirus	coronavirus	NOUN
dpc-3385	85	17	disease	disease	NOUN
dpc-3385	85	18	2019	2019	NUM
dpc-3385	85	19	(	(	PUNCT
dpc-3385	85	20	covid-19	covid-19	PROPN
dpc-3385	85	21	)	)	PUNCT
dpc-3385	85	22	,	,	PUNCT
dpc-3385	85	23	hiv	hiv	PROPN
dpc-3385	85	24	infection	infection	NOUN
dpc-3385	85	25	and	and	CCONJ
dpc-3385	85	26	pregnancy	pregnancy	NOUN
dpc-3385	85	27	.	.	PUNCT
dpc-3385	86	1	four	four	NUM
dpc-3385	86	2	patients	patient	NOUN
dpc-3385	86	3	had	have	VERB
dpc-3385	86	4	a	a	DET
dpc-3385	86	5	history	history	NOUN
dpc-3385	86	6	of	of	ADP
dpc-3385	86	7	drug	drug	NOUN
dpc-3385	86	8	use	use	NOUN
dpc-3385	86	9	(	(	PUNCT
dpc-3385	86	10	analgesics	analgesic	NOUN
dpc-3385	86	11	,	,	PUNCT
dpc-3385	86	12	oral	oral	ADJ
dpc-3385	86	13	contraceptives	contraceptive	NOUN
dpc-3385	86	14	,	,	PUNCT
dpc-3385	86	15	antibiotics	antibiotic	NOUN
dpc-3385	86	16	,	,	PUNCT
dpc-3385	86	17	escitalopram	escitalopram	PROPN
dpc-3385	86	18	,	,	PUNCT
dpc-3385	86	19	1	1	NUM
dpc-3385	86	20	case	case	NOUN
dpc-3385	86	21	of	of	ADP
dpc-3385	86	22	each	each	PRON
dpc-3385	86	23	of	of	ADP
dpc-3385	86	24	them	they	PRON
dpc-3385	86	25	)	)	PUNCT
dpc-3385	86	26	.	.	PUNCT
dpc-3385	87	1	two	two	NUM
dpc-3385	87	2	patients	patient	NOUN
dpc-3385	87	3	had	have	VERB
dpc-3385	87	4	hashimoto	hashimoto	NOUN
dpc-3385	87	5	thyroiditis	thyroiditis	NOUN
dpc-3385	87	6	.	.	PUNCT
dpc-3385	88	1	malignancy	malignancy	NOUN
dpc-3385	88	2	was	be	AUX
dpc-3385	88	3	detected	detect	VERB
dpc-3385	88	4	in	in	ADP
dpc-3385	88	5	6	6	NUM
dpc-3385	88	6	patients	patient	NOUN
dpc-3385	88	7	(	(	PUNCT
dpc-3385	88	8	gastric	gastric	ADJ
dpc-3385	88	9	cancer	cancer	NOUN
dpc-3385	88	10	:	:	PUNCT
dpc-3385	88	11	1	1	NUM
dpc-3385	88	12	,	,	PUNCT
dpc-3385	88	13	cervical	cervical	ADJ
dpc-3385	88	14	cancer	cancer	NOUN
dpc-3385	88	15	:	:	PUNCT
dpc-3385	88	16	1	1	NUM
dpc-3385	88	17	,	,	PUNCT
dpc-3385	88	18	prostate	prostate	NOUN
dpc-3385	88	19	cancer	cancer	NOUN
dpc-3385	88	20	:	:	PUNCT
dpc-3385	88	21	2	2	NUM
dpc-3385	88	22	,	,	PUNCT
dpc-3385	88	23	breast	breast	NOUN
dpc-3385	88	24	cancer	cancer	NOUN
dpc-3385	88	25	:	:	PUNCT
dpc-3385	88	26	1	1	NUM
dpc-3385	88	27	,	,	PUNCT
dpc-3385	88	28	thyroid	thyroid	NOUN
dpc-3385	88	29	cancer	cancer	NOUN
dpc-3385	88	30	:	:	PUNCT
dpc-3385	88	31	1	1	NUM
dpc-3385	88	32	)	)	PUNCT
dpc-3385	88	33	.	.	PUNCT
dpc-3385	89	1	the	the	DET
dpc-3385	89	2	diagnosis	diagnosis	NOUN
dpc-3385	89	3	of	of	ADP
dpc-3385	89	4	malignancy	malignancy	NOUN
dpc-3385	89	5	was	be	AUX
dpc-3385	89	6	made	make	VERB
dpc-3385	89	7	before	before	ADP
dpc-3385	89	8	the	the	DET
dpc-3385	89	9	onset	onset	NOUN
dpc-3385	89	10	of	of	ADP
dpc-3385	89	11	eac	eac	NOUN
dpc-3385	89	12	in	in	ADP
dpc-3385	89	13	5	5	NUM
dpc-3385	89	14	of	of	ADP
dpc-3385	89	15	the	the	DET
dpc-3385	89	16	patients	patient	NOUN
dpc-3385	89	17	while	while	SCONJ
dpc-3385	89	18	in	in	ADP
dpc-3385	89	19	one	one	NUM
dpc-3385	89	20	patient	patient	NOUN
dpc-3385	89	21	it	it	PRON
dpc-3385	89	22	was	be	AUX
dpc-3385	89	23	made	make	VERB
dpc-3385	89	24	concurrently	concurrently	ADV
dpc-3385	89	25	with	with	ADP
dpc-3385	89	26	eac	eac	PROPN
dpc-3385	89	27	.	.	PUNCT
dpc-3385	90	1	of	of	ADP
dpc-3385	90	2	these	these	DET
dpc-3385	90	3	patients	patient	NOUN
dpc-3385	90	4	,	,	PUNCT
dpc-3385	90	5	3	3	NUM
dpc-3385	90	6	were	be	AUX
dpc-3385	90	7	in	in	ADP
dpc-3385	90	8	remission	remission	NOUN
dpc-3385	90	9	or	or	CCONJ
dpc-3385	90	10	cured	cure	VERB
dpc-3385	90	11	,	,	PUNCT
dpc-3385	90	12	while	while	SCONJ
dpc-3385	90	13	in	in	ADP
dpc-3385	90	14	3	3	NUM
dpc-3385	90	15	patients	patient	NOUN
dpc-3385	90	16	the	the	DET
dpc-3385	90	17	disease	disease	NOUN
dpc-3385	90	18	was	be	AUX
dpc-3385	90	19	active	active	ADJ
dpc-3385	90	20	and	and	CCONJ
dpc-3385	90	21	they	they	PRON
dpc-3385	90	22	were	be	AUX
dpc-3385	90	23	receiving	receive	VERB
dpc-3385	90	24	chemotherapy	chemotherapy	NOUN
dpc-3385	90	25	.	.	PUNCT
dpc-3385	91	1	four	four	NUM
dpc-3385	91	2	patients	patient	NOUN
dpc-3385	91	3	were	be	AUX
dpc-3385	91	4	diagnosed	diagnose	VERB
dpc-3385	91	5	with	with	ADP
dpc-3385	91	6	rheumatic	rheumatic	ADJ
dpc-3385	91	7	diseases	disease	NOUN
dpc-3385	91	8	(	(	PUNCT
dpc-3385	91	9	juvenile	juvenile	ADJ
dpc-3385	91	10	rheumatoid	rheumatoid	NOUN
dpc-3385	91	11	arthritis	arthritis	NOUN
dpc-3385	91	12	,	,	PUNCT
dpc-3385	91	13	palindromic	palindromic	ADJ
dpc-3385	91	14	rheumatism	rheumatism	NOUN
dpc-3385	91	15	,	,	PUNCT
dpc-3385	91	16	rheumatoid	rheumatoid	NOUN
dpc-3385	91	17	arthritis	arthritis	NOUN
dpc-3385	91	18	,	,	PUNCT
dpc-3385	91	19	granulomatosis	granulomatosis	VERB
dpc-3385	91	20	with	with	ADP
dpc-3385	91	21	polyangiitis	polyangiitis	ADJ
dpc-3385	91	22	,	,	PUNCT
dpc-3385	91	23	1	1	NUM
dpc-3385	91	24	case	case	NOUN
dpc-3385	91	25	of	of	ADP
dpc-3385	91	26	each	each	PRON
dpc-3385	91	27	of	of	ADP
dpc-3385	91	28	them	they	PRON
dpc-3385	91	29	)	)	PUNCT
dpc-3385	91	30	.	.	PUNCT
dpc-3385	92	1	the	the	DET
dpc-3385	92	2	most	most	ADV
dpc-3385	92	3	common	common	ADJ
dpc-3385	92	4	concomitant	concomitant	ADJ
dpc-3385	92	5	diseases	disease	NOUN
dpc-3385	92	6	were	be	AUX
dpc-3385	92	7	gastritis	gastritis	NOUN
dpc-3385	92	8	(	(	PUNCT
dpc-3385	92	9	n	n	NOUN
dpc-3385	92	10	=	=	NUM
dpc-3385	92	11	10	10	NUM
dpc-3385	92	12	)	)	PUNCT
dpc-3385	92	13	,	,	PUNCT
dpc-3385	92	14	diabetes	diabetes	NOUN
dpc-3385	92	15	(	(	PUNCT
dpc-3385	92	16	n	n	NOUN
dpc-3385	92	17	=	=	SYM
dpc-3385	92	18	7	7	NUM
dpc-3385	92	19	)	)	PUNCT
dpc-3385	92	20	,	,	PUNCT
dpc-3385	92	21	hypothyroidism	hypothyroidism	NOUN
dpc-3385	92	22	(	(	PUNCT
dpc-3385	92	23	n	n	NOUN
dpc-3385	92	24	=	=	SYM
dpc-3385	92	25	6	6	NUM
dpc-3385	92	26	)	)	PUNCT
dpc-3385	92	27	,	,	PUNCT
dpc-3385	92	28	malignancy	malignancy	NOUN
dpc-3385	92	29	(	(	PUNCT
dpc-3385	92	30	n	n	NOUN
dpc-3385	92	31	=	=	SYM
dpc-3385	92	32	6	6	NUM
dpc-3385	92	33	)	)	PUNCT
dpc-3385	92	34	and	and	CCONJ
dpc-3385	92	35	rheumatic	rheumatic	ADJ
dpc-3385	92	36	disease	disease	NOUN
dpc-3385	92	37	(	(	PUNCT
dpc-3385	92	38	n	n	NOUN
dpc-3385	92	39	=	=	NOUN
dpc-3385	92	40	  	  	SPACE
dpc-3385	92	41	4	4	NUM
dpc-3385	92	42	)	)	PUNCT
dpc-3385	92	43	respectively	respectively	ADV
dpc-3385	92	44	.	.	PUNCT
dpc-3385	93	1	concomitant	concomitant	ADJ
dpc-3385	93	2	diseases	disease	NOUN
dpc-3385	93	3	are	be	AUX
dpc-3385	93	4	shown	show	VERB
dpc-3385	93	5	in	in	ADP
dpc-3385	93	6	table	table	NOUN
dpc-3385	93	7	 	 	SPACE
dpc-3385	93	8	3	3	NUM
dpc-3385	93	9	.	.	PUNCT
dpc-3385	94	1	in	in	ADP
dpc-3385	94	2	our	our	PRON
dpc-3385	94	3	study	study	NOUN
dpc-3385	94	4	,	,	PUNCT
dpc-3385	94	5	when	when	SCONJ
dpc-3385	94	6	superficial	superficial	ADJ
dpc-3385	94	7	and	and	CCONJ
dpc-3385	94	8	deep	deep	ADJ
dpc-3385	94	9	types	type	NOUN
dpc-3385	94	10	were	be	AUX
dpc-3385	94	11	compared	compare	VERB
dpc-3385	94	12	based	base	VERB
dpc-3385	94	13	on	on	ADP
dpc-3385	94	14	the	the	DET
dpc-3385	94	15	clinical	clinical	ADJ
dpc-3385	94	16	and	and	CCONJ
dpc-3385	94	17	histological	histological	ADJ
dpc-3385	94	18	classification	classification	NOUN
dpc-3385	94	19	,	,	PUNCT
dpc-3385	94	20	figure	figure	NOUN
dpc-3385	94	21	1	1	NUM
dpc-3385	94	22	.	.	PUNCT
dpc-3385	95	1	our	our	PRON
dpc-3385	95	2	patient	patient	NOUN
dpc-3385	95	3	with	with	ADP
dpc-3385	95	4	deep	deep	ADJ
dpc-3385	95	5	type	type	NOUN
dpc-3385	95	6	of	of	ADP
dpc-3385	95	7	eac	eac	PROPN
dpc-3385	95	8	.	.	PUNCT
dpc-3385	96	1	non	non	ADJ
dpc-3385	96	2	-	-	ADJ
dpc-3385	96	3	scaly	scaly	ADJ
dpc-3385	96	4	erythematous	erythematous	ADJ
dpc-3385	96	5	annular	annular	ADJ
dpc-3385	96	6	plaques	plaque	NOUN
dpc-3385	96	7	with	with	ADP
dpc-3385	96	8	central	central	ADJ
dpc-3385	96	9	clearence	clearence	NOUN
dpc-3385	96	10	.	.	PUNCT
dpc-3385	97	1	table	table	NOUN
dpc-3385	97	2	1	1	NUM
dpc-3385	97	3	.	.	PUNCT
dpc-3385	97	4	localizations	localization	NOUN
dpc-3385	97	5	of	of	ADP
dpc-3385	97	6	the	the	DET
dpc-3385	97	7	lesions	lesion	NOUN
dpc-3385	97	8	in	in	ADP
dpc-3385	97	9	the	the	DET
dpc-3385	97	10	patients	patient	NOUN
dpc-3385	97	11	.	.	PUNCT
dpc-3385	98	1	localizations	localization	NOUN
dpc-3385	98	2	of	of	ADP
dpc-3385	98	3	the	the	DET
dpc-3385	98	4	lesions	lesion	NOUN
dpc-3385	98	5	n	n	PRON
dpc-3385	98	6	(	(	PUNCT
dpc-3385	98	7	%	%	INTJ
dpc-3385	98	8	)	)	PUNCT
dpc-3385	98	9	trunk	trunk	NOUN
dpc-3385	98	10	31	31	NUM
dpc-3385	98	11	(	(	PUNCT
dpc-3385	98	12	49.2	49.2	NUM
dpc-3385	98	13	)	)	PUNCT
dpc-3385	98	14	thigh	thigh	NOUN
dpc-3385	98	15	21	21	NUM
dpc-3385	98	16	(	(	PUNCT
dpc-3385	98	17	33.3	33.3	NUM
dpc-3385	98	18	)	)	PUNCT
dpc-3385	98	19	arm	arm	NOUN
dpc-3385	98	20	14	14	NUM
dpc-3385	98	21	(	(	PUNCT
dpc-3385	98	22	22.2	22.2	NUM
dpc-3385	98	23	)	)	PUNCT
dpc-3385	98	24	gluteal	gluteal	NOUN
dpc-3385	98	25	area	area	NOUN
dpc-3385	98	26	7	7	NUM
dpc-3385	98	27	(	(	PUNCT
dpc-3385	98	28	11.1	11.1	NUM
dpc-3385	98	29	)	)	PUNCT
dpc-3385	98	30	neck	neck	NOUN
dpc-3385	98	31	1	1	NUM
dpc-3385	98	32	(	(	PUNCT
dpc-3385	98	33	1.6	1.6	NUM
dpc-3385	98	34	)	)	PUNCT
dpc-3385	98	35	figure	figure	NOUN
dpc-3385	98	36	3	3	NUM
dpc-3385	98	37	.	.	PUNCT
dpc-3385	99	1	our	our	PRON
dpc-3385	99	2	patient	patient	NOUN
dpc-3385	99	3	with	with	ADP
dpc-3385	99	4	histopathologically	histopathologically	ADV
dpc-3385	99	5	deep	deep	ADJ
dpc-3385	99	6	type	type	NOUN
dpc-3385	99	7	of	of	ADP
dpc-3385	99	8	eac	eac	NOUN
dpc-3385	99	9	(	(	PUNCT
dpc-3385	99	10	who	who	PRON
dpc-3385	99	11	was	be	AUX
dpc-3385	99	12	also	also	ADV
dpc-3385	99	13	clinically	clinically	ADV
dpc-3385	99	14	consistent	consistent	ADJ
dpc-3385	99	15	with	with	ADP
dpc-3385	99	16	deep	deep	ADJ
dpc-3385	99	17	type	type	NOUN
dpc-3385	99	18	of	of	ADP
dpc-3385	99	19	eac	eac	PROPN
dpc-3385	99	20	)	)	PUNCT
dpc-3385	99	21	.	.	PUNCT
dpc-3385	100	1	tight	tight	ADJ
dpc-3385	100	2	perivascular	perivascular	ADJ
dpc-3385	100	3	mononuclear	mononuclear	ADJ
dpc-3385	100	4	cellular	cellular	ADJ
dpc-3385	100	5	infiltrate	infiltrate	NOUN
dpc-3385	100	6	in	in	ADP
dpc-3385	100	7	both	both	CCONJ
dpc-3385	100	8	upper	upper	ADJ
dpc-3385	100	9	and	and	CCONJ
dpc-3385	100	10	lower	low	ADJ
dpc-3385	100	11	dermis	dermis	NOUN
dpc-3385	100	12	without	without	ADP
dpc-3385	100	13	prominent	prominent	ADJ
dpc-3385	100	14	epidermal	epidermal	ADJ
dpc-3385	100	15	changes	change	NOUN
dpc-3385	100	16	and	and	CCONJ
dpc-3385	100	17	edema	edema	NOUN
dpc-3385	100	18	of	of	ADP
dpc-3385	100	19	the	the	DET
dpc-3385	100	20	papillary	papillary	ADJ
dpc-3385	100	21	dermis	dermis	NOUN
dpc-3385	100	22	(	(	PUNCT
dpc-3385	100	23	h&e	h&e	PROPN
dpc-3385	100	24	,	,	PUNCT
dpc-3385	100	25	x40	x40	PROPN
dpc-3385	100	26	)	)	PUNCT
dpc-3385	100	27	.	.	PUNCT
dpc-3385	101	1	from	from	ADP
dpc-3385	101	2	the	the	DET
dpc-3385	101	3	archive	archive	NOUN
dpc-3385	101	4	of	of	ADP
dpc-3385	101	5	dr	dr	PROPN
dpc-3385	101	6	.	.	PROPN
dpc-3385	101	7	nuran	nuran	PROPN
dpc-3385	101	8	süngü	süngü	PROPN
dpc-3385	101	9	,	,	PUNCT
dpc-3385	101	10	ankara	ankara	PROPN
dpc-3385	101	11	city	city	PROPN
dpc-3385	101	12	hospital	hospital	PROPN
dpc-3385	101	13	,	,	PUNCT
dpc-3385	101	14	department	department	NOUN
dpc-3385	101	15	of	of	ADP
dpc-3385	101	16	pathology	pathology	PROPN
dpc-3385	101	17	.	.	PUNCT
dpc-3385	102	1	figure	figure	NOUN
dpc-3385	102	2	2	2	NUM
dpc-3385	102	3	.	.	PUNCT
dpc-3385	103	1	our	our	PRON
dpc-3385	103	2	patient	patient	NOUN
dpc-3385	103	3	with	with	ADP
dpc-3385	103	4	superficial	superficial	ADJ
dpc-3385	103	5	eac	eac	PROPN
dpc-3385	103	6	.	.	PUNCT
dpc-3385	104	1	erythematous	erythematous	ADJ
dpc-3385	104	2	and	and	CCONJ
dpc-3385	104	3	annular	annular	ADJ
dpc-3385	104	4	plaques	plaque	NOUN
dpc-3385	104	5	with	with	ADP
dpc-3385	104	6	a	a	DET
dpc-3385	104	7	trailing	trail	VERB
dpc-3385	104	8	scale	scale	NOUN
dpc-3385	104	9	.	.	PUNCT
dpc-3385	105	1	figure	figure	NOUN
dpc-3385	105	2	4	4	NUM
dpc-3385	105	3	.	.	PUNCT
dpc-3385	106	1	perivascular	perivascular	ADJ
dpc-3385	106	2	mononuclear	mononuclear	ADJ
dpc-3385	106	3	infiltrate	infiltrate	ADJ
dpc-3385	106	4	,	,	PUNCT
dpc-3385	106	5	tightly	tightly	ADV
dpc-3385	106	6	adherent	adherent	ADJ
dpc-3385	106	7	to	to	ADP
dpc-3385	106	8	vascular	vascular	ADJ
dpc-3385	106	9	plexus	plexus	NOUN
dpc-3385	106	10	in	in	ADP
dpc-3385	106	11	“	"	PUNCT
dpc-3385	106	12	coat	coat	NOUN
dpc-3385	106	13	sleeve	sleeve	NOUN
dpc-3385	106	14	pattern	pattern	NOUN
dpc-3385	106	15	”	"	PUNCT
dpc-3385	106	16	(	(	PUNCT
dpc-3385	106	17	h&e	h&e	PROPN
dpc-3385	106	18	,	,	PUNCT
dpc-3385	106	19	x100	x100	PROPN
dpc-3385	106	20	)	)	PUNCT
dpc-3385	106	21	.	.	PUNCT
dpc-3385	107	1	from	from	ADP
dpc-3385	107	2	the	the	DET
dpc-3385	107	3	archive	archive	NOUN
dpc-3385	107	4	of	of	ADP
dpc-3385	107	5	dr	dr	PROPN
dpc-3385	107	6	.	.	PROPN
dpc-3385	107	7	nuran	nuran	PROPN
dpc-3385	107	8	süngü	süngü	PROPN
dpc-3385	107	9	,	,	PUNCT
dpc-3385	107	10	ankara	ankara	PROPN
dpc-3385	107	11	city	city	PROPN
dpc-3385	107	12	hospital	hospital	PROPN
dpc-3385	107	13	,	,	PUNCT
dpc-3385	107	14	department	department	NOUN
dpc-3385	107	15	of	of	ADP
dpc-3385	107	16	pathology	pathology	PROPN
dpc-3385	107	17	.	.	PUNCT
dpc-3385	108	1	4	4	NUM
dpc-3385	108	2	original	original	ADJ
dpc-3385	108	3	article	article	NOUN
dpc-3385	108	4	|	|	ADV
dpc-3385	108	5	dermatol	dermatol	ADJ
dpc-3385	108	6	pract	pract	NOUN
dpc-3385	108	7	concept	concept	NOUN
dpc-3385	108	8	.	.	PUNCT
dpc-3385	109	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	109	2	topical	topical	ADJ
dpc-3385	109	3	steroid	steroid	NOUN
dpc-3385	109	4	(	(	PUNCT
dpc-3385	109	5	n	n	NOUN
dpc-3385	109	6	=	=	SYM
dpc-3385	109	7	30	30	NUM
dpc-3385	109	8	)	)	PUNCT
dpc-3385	109	9	,	,	PUNCT
dpc-3385	109	10	topical	topical	ADJ
dpc-3385	109	11	calcineurin	calcineurin	NOUN
dpc-3385	109	12	inhibitor	inhibitor	NOUN
dpc-3385	109	13	(	(	PUNCT
dpc-3385	109	14	n	n	CCONJ
dpc-3385	109	15	 	 	SPACE
dpc-3385	109	16	=	=	NOUN
dpc-3385	109	17	 	 	SPACE
dpc-3385	109	18	8)	8)	NUM
dpc-3385	109	19	,	,	PUNCT
dpc-3385	109	20	terbinafine	terbinafine	NOUN
dpc-3385	109	21	(	(	PUNCT
dpc-3385	109	22	n	n	NOUN
dpc-3385	109	23	=	=	SYM
dpc-3385	109	24	6	6	NUM
dpc-3385	109	25	)	)	PUNCT
dpc-3385	109	26	and	and	CCONJ
dpc-3385	109	27	calcipotriol	calcipotriol	PROPN
dpc-3385	109	28	(	(	PUNCT
dpc-3385	109	29	n	n	NOUN
dpc-3385	109	30	=	=	SYM
dpc-3385	109	31	4	4	NUM
dpc-3385	109	32	)	)	PUNCT
dpc-3385	109	33	were	be	AUX
dpc-3385	109	34	the	the	DET
dpc-3385	109	35	most	most	ADV
dpc-3385	109	36	commonly	commonly	ADV
dpc-3385	109	37	received	receive	VERB
dpc-3385	109	38	treatments	treatment	NOUN
dpc-3385	109	39	by	by	ADP
dpc-3385	109	40	our	our	PRON
dpc-3385	109	41	patients	patient	NOUN
dpc-3385	109	42	(	(	PUNCT
dpc-3385	109	43	table	table	NOUN
dpc-3385	109	44	 	 	SPACE
dpc-3385	109	45	4	4	NUM
dpc-3385	109	46	)	)	PUNCT
dpc-3385	109	47	.	.	PUNCT
dpc-3385	110	1	we	we	PRON
dpc-3385	110	2	 	 	SPACE
dpc-3385	110	3	determined	determine	VERB
dpc-3385	110	4	that	that	SCONJ
dpc-3385	110	5	26.9	26.9	NUM
dpc-3385	110	6	%	%	NOUN
dpc-3385	110	7	(	(	PUNCT
dpc-3385	110	8	n	n	NOUN
dpc-3385	110	9	=	=	SYM
dpc-3385	110	10	17	17	NUM
dpc-3385	110	11	)	)	PUNCT
dpc-3385	110	12	of	of	ADP
dpc-3385	110	13	the	the	DET
dpc-3385	110	14	patients	patient	NOUN
dpc-3385	110	15	did	do	AUX
dpc-3385	110	16	not	not	PART
dpc-3385	110	17	receive	receive	VERB
dpc-3385	110	18	any	any	DET
dpc-3385	110	19	treatment	treatment	NOUN
dpc-3385	110	20	.	.	PUNCT
dpc-3385	111	1	the	the	DET
dpc-3385	111	2	lesions	lesion	NOUN
dpc-3385	111	3	resolved	resolve	VERB
dpc-3385	111	4	in	in	ADP
dpc-3385	111	5	some	some	PRON
dpc-3385	111	6	of	of	ADP
dpc-3385	111	7	these	these	DET
dpc-3385	111	8	patients	patient	NOUN
dpc-3385	111	9	while	while	SCONJ
dpc-3385	111	10	waiting	wait	VERB
dpc-3385	111	11	for	for	ADP
dpc-3385	111	12	the	the	DET
dpc-3385	111	13	results	result	NOUN
dpc-3385	111	14	of	of	ADP
dpc-3385	111	15	skin	skin	NOUN
dpc-3385	111	16	biopsy	biopsy	NOUN
dpc-3385	111	17	or	or	CCONJ
dpc-3385	111	18	the	the	DET
dpc-3385	111	19	laboratory	laboratory	NOUN
dpc-3385	111	20	tests	test	NOUN
dpc-3385	111	21	made	make	VERB
dpc-3385	111	22	for	for	ADP
dpc-3385	111	23	revealing	reveal	VERB
dpc-3385	111	24	precipitating	precipitating	NOUN
dpc-3385	111	25	factors	factor	NOUN
dpc-3385	111	26	.	.	PUNCT
dpc-3385	112	1	also	also	ADV
dpc-3385	112	2	,	,	PUNCT
dpc-3385	112	3	some	some	PRON
dpc-3385	112	4	of	of	ADP
dpc-3385	112	5	the	the	DET
dpc-3385	112	6	patients	patient	NOUN
dpc-3385	112	7	did	do	AUX
dpc-3385	112	8	not	not	PART
dpc-3385	112	9	apply	apply	VERB
dpc-3385	112	10	their	their	PRON
dpc-3385	112	11	treatments	treatment	NOUN
dpc-3385	112	12	.	.	PUNCT
dpc-3385	113	1	treatment	treatment	NOUN
dpc-3385	113	2	responses	response	NOUN
dpc-3385	113	3	could	could	AUX
dpc-3385	113	4	not	not	PART
dpc-3385	113	5	be	be	AUX
dpc-3385	113	6	evaluated	evaluate	VERB
dpc-3385	113	7	in	in	ADP
dpc-3385	113	8	our	our	PRON
dpc-3385	113	9	study	study	NOUN
dpc-3385	113	10	because	because	SCONJ
dpc-3385	113	11	of	of	ADP
dpc-3385	113	12	the	the	DET
dpc-3385	113	13	self	self	NOUN
dpc-3385	113	14	-	-	PUNCT
dpc-3385	113	15	healing	healing	NOUN
dpc-3385	113	16	tendency	tendency	NOUN
dpc-3385	113	17	of	of	ADP
dpc-3385	113	18	eac	eac	NOUN
dpc-3385	113	19	and	and	CCONJ
dpc-3385	113	20	dropout	dropout	NOUN
dpc-3385	113	21	of	of	ADP
dpc-3385	113	22	some	some	DET
dpc-3385	113	23	patients	patient	NOUN
dpc-3385	113	24	from	from	ADP
dpc-3385	113	25	treatment	treatment	NOUN
dpc-3385	113	26	.	.	PUNCT
dpc-3385	114	1	conclusions	conclusion	NOUN
dpc-3385	114	2	in	in	ADP
dpc-3385	114	3	our	our	PRON
dpc-3385	114	4	study	study	NOUN
dpc-3385	114	5	,	,	PUNCT
dpc-3385	114	6	62	62	NUM
dpc-3385	114	7	%	%	NOUN
dpc-3385	114	8	of	of	ADP
dpc-3385	114	9	the	the	DET
dpc-3385	114	10	patients	patient	NOUN
dpc-3385	114	11	were	be	AUX
dpc-3385	114	12	female	female	ADJ
dpc-3385	114	13	and	and	CCONJ
dpc-3385	114	14	38	38	NUM
dpc-3385	114	15	%	%	NOUN
dpc-3385	114	16	were	be	AUX
dpc-3385	114	17	male	male	ADJ
dpc-3385	114	18	.	.	PUNCT
dpc-3385	115	1	the	the	DET
dpc-3385	115	2	mean	mean	ADJ
dpc-3385	115	3	age	age	NOUN
dpc-3385	115	4	of	of	ADP
dpc-3385	115	5	the	the	DET
dpc-3385	115	6	patients	patient	NOUN
dpc-3385	115	7	in	in	ADP
dpc-3385	115	8	our	our	PRON
dpc-3385	115	9	study	study	NOUN
dpc-3385	115	10	was	be	AUX
dpc-3385	115	11	47.8±11.2	47.8±11.2	NUM
dpc-3385	115	12	years	year	NOUN
dpc-3385	115	13	and	and	CCONJ
dpc-3385	115	14	the	the	DET
dpc-3385	115	15	mean	mean	ADJ
dpc-3385	115	16	disease	disease	NOUN
dpc-3385	115	17	duration	duration	NOUN
dpc-3385	115	18	was	be	AUX
dpc-3385	115	19	15.54±12	15.54±12	NUM
dpc-3385	115	20	months	month	NOUN
dpc-3385	115	21	.	.	PUNCT
dpc-3385	116	1	in	in	ADP
dpc-3385	116	2	a	a	DET
dpc-3385	116	3	study	study	NOUN
dpc-3385	116	4	by	by	ADP
dpc-3385	116	5	kim	kim	PROPN
dpc-3385	116	6	et	et	PROPN
dpc-3385	116	7	al	al	PROPN
dpc-3385	116	8	evaluating	evaluate	VERB
dpc-3385	116	9	the	the	DET
dpc-3385	116	10	demographic	demographic	ADJ
dpc-3385	116	11	and	and	CCONJ
dpc-3385	116	12	clinical	clinical	ADJ
dpc-3385	116	13	characteristics	characteristic	NOUN
dpc-3385	116	14	of	of	ADP
dpc-3385	116	15	39	39	NUM
dpc-3385	116	16	patients	patient	NOUN
dpc-3385	116	17	with	with	ADP
dpc-3385	116	18	eac	eac	PROPN
dpc-3385	116	19	,	,	PUNCT
dpc-3385	116	20	64	64	NUM
dpc-3385	116	21	%	%	NOUN
dpc-3385	116	22	of	of	ADP
dpc-3385	116	23	the	the	DET
dpc-3385	116	24	patients	patient	NOUN
dpc-3385	116	25	were	be	AUX
dpc-3385	116	26	female	female	ADJ
dpc-3385	116	27	and	and	CCONJ
dpc-3385	116	28	36	36	NUM
dpc-3385	116	29	%	%	NOUN
dpc-3385	116	30	were	be	AUX
dpc-3385	116	31	male	male	ADJ
dpc-3385	116	32	[	[	X
dpc-3385	116	33	5	5	NUM
dpc-3385	116	34	]	]	PUNCT
dpc-3385	116	35	.	.	PUNCT
dpc-3385	117	1	in	in	ADP
dpc-3385	117	2	another	another	DET
dpc-3385	117	3	study	study	NOUN
dpc-3385	117	4	,	,	PUNCT
dpc-3385	117	5	24	24	NUM
dpc-3385	117	6	(	(	PUNCT
dpc-3385	117	7	36	36	NUM
dpc-3385	117	8	%	%	NOUN
dpc-3385	117	9	)	)	PUNCT
dpc-3385	117	10	of	of	ADP
dpc-3385	117	11	66	66	NUM
dpc-3385	117	12	patients	patient	NOUN
dpc-3385	117	13	with	with	ADP
dpc-3385	117	14	eac	eac	PROPN
dpc-3385	117	15	were	be	AUX
dpc-3385	117	16	male	male	ADJ
dpc-3385	117	17	and	and	CCONJ
dpc-3385	117	18	42	42	NUM
dpc-3385	117	19	(	(	PUNCT
dpc-3385	117	20	64	64	NUM
dpc-3385	117	21	%	%	NOUN
dpc-3385	117	22	)	)	PUNCT
dpc-3385	117	23	were	be	AUX
dpc-3385	117	24	female	female	ADJ
dpc-3385	117	25	.	.	PUNCT
dpc-3385	118	1	in	in	ADP
dpc-3385	118	2	the	the	DET
dpc-3385	118	3	same	same	ADJ
dpc-3385	118	4	study	study	NOUN
dpc-3385	118	5	,	,	PUNCT
dpc-3385	118	6	the	the	DET
dpc-3385	118	7	mean	mean	ADJ
dpc-3385	118	8	age	age	NOUN
dpc-3385	118	9	was	be	AUX
dpc-3385	118	10	39.7	39.7	NUM
dpc-3385	118	11	years	year	NOUN
dpc-3385	118	12	and	and	CCONJ
dpc-3385	118	13	the	the	DET
dpc-3385	118	14	mean	mean	ADJ
dpc-3385	118	15	disease	disease	NOUN
dpc-3385	118	16	duration	duration	NOUN
dpc-3385	118	17	was	be	AUX
dpc-3385	118	18	2.8	2.8	NUM
dpc-3385	118	19	years	year	NOUN
dpc-3385	119	1	[	[	X
dpc-3385	119	2	6	6	NUM
dpc-3385	119	3	]	]	PUNCT
dpc-3385	119	4	.	.	PUNCT
dpc-3385	120	1	the	the	DET
dpc-3385	120	2	mean	mean	ADJ
dpc-3385	120	3	age	age	NOUN
dpc-3385	120	4	and	and	CCONJ
dpc-3385	120	5	gender	gender	NOUN
dpc-3385	120	6	distribution	distribution	NOUN
dpc-3385	120	7	in	in	ADP
dpc-3385	120	8	these	these	DET
dpc-3385	120	9	studies	study	NOUN
dpc-3385	120	10	were	be	AUX
dpc-3385	120	11	similar	similar	ADJ
dpc-3385	120	12	to	to	ADP
dpc-3385	120	13	our	our	PRON
dpc-3385	120	14	study	study	NOUN
dpc-3385	120	15	.	.	PUNCT
dpc-3385	121	1	we	we	PRON
dpc-3385	121	2	observed	observe	VERB
dpc-3385	121	3	that	that	SCONJ
dpc-3385	121	4	the	the	DET
dpc-3385	121	5	most	most	ADV
dpc-3385	121	6	commonly	commonly	ADV
dpc-3385	121	7	involved	involve	VERB
dpc-3385	121	8	areas	area	NOUN
dpc-3385	121	9	in	in	ADP
dpc-3385	121	10	our	our	PRON
dpc-3385	121	11	patients	patient	NOUN
dpc-3385	121	12	were	be	AUX
dpc-3385	121	13	the	the	DET
dpc-3385	121	14	trunk	trunk	NOUN
dpc-3385	121	15	and	and	CCONJ
dpc-3385	121	16	thigh	thigh	NOUN
dpc-3385	121	17	,	,	PUNCT
dpc-3385	121	18	respectively	respectively	ADV
dpc-3385	121	19	.	.	PUNCT
dpc-3385	122	1	in	in	ADP
dpc-3385	122	2	the	the	DET
dpc-3385	122	3	study	study	NOUN
dpc-3385	122	4	by	by	ADP
dpc-3385	122	5	kim	kim	PROPN
dpc-3385	122	6	et	et	PROPN
dpc-3385	122	7	al	al	PROPN
dpc-3385	122	8	the	the	DET
dpc-3385	122	9	lower	low	ADJ
dpc-3385	122	10	extremities	extremity	NOUN
dpc-3385	122	11	,	,	PUNCT
dpc-3385	122	12	especially	especially	ADV
dpc-3385	122	13	the	the	DET
dpc-3385	122	14	thigh	thigh	NOUN
dpc-3385	122	15	,	,	PUNCT
dpc-3385	122	16	were	be	AUX
dpc-3385	122	17	reported	report	VERB
dpc-3385	122	18	as	as	ADP
dpc-3385	122	19	the	the	DET
dpc-3385	122	20	most	most	ADV
dpc-3385	122	21	commonly	commonly	ADV
dpc-3385	122	22	affected	affect	VERB
dpc-3385	122	23	region	region	NOUN
dpc-3385	122	24	[	[	X
dpc-3385	122	25	6	6	NUM
dpc-3385	122	26	]	]	PUNCT
dpc-3385	122	27	.	.	PUNCT
dpc-3385	123	1	in	in	ADP
dpc-3385	123	2	the	the	DET
dpc-3385	123	3	study	study	NOUN
dpc-3385	123	4	by	by	ADP
dpc-3385	123	5	weyers	weyer	NOUN
dpc-3385	123	6	et	et	NOUN
dpc-3385	123	7	al	al	PROPN
dpc-3385	123	8	it	it	PRON
dpc-3385	123	9	was	be	AUX
dpc-3385	123	10	found	find	VERB
dpc-3385	123	11	that	that	SCONJ
dpc-3385	123	12	the	the	DET
dpc-3385	123	13	main	main	ADJ
dpc-3385	123	14	predilection	predilection	NOUN
dpc-3385	123	15	site	site	NOUN
dpc-3385	123	16	was	be	AUX
dpc-3385	123	17	the	the	DET
dpc-3385	123	18	trunk	trunk	NOUN
dpc-3385	123	19	in	in	ADP
dpc-3385	123	20	both	both	DET
dpc-3385	123	21	types	type	NOUN
dpc-3385	123	22	similar	similar	ADJ
dpc-3385	123	23	to	to	ADP
dpc-3385	123	24	our	our	PRON
dpc-3385	123	25	study	study	NOUN
dpc-3385	123	26	,	,	PUNCT
dpc-3385	123	27	whereas	whereas	SCONJ
dpc-3385	123	28	the	the	DET
dpc-3385	123	29	extremities	extremity	NOUN
dpc-3385	123	30	and	and	CCONJ
dpc-3385	123	31	buttocks	buttock	NOUN
dpc-3385	123	32	were	be	AUX
dpc-3385	123	33	more	more	ADV
dpc-3385	123	34	commonly	commonly	ADV
dpc-3385	123	35	involved	involve	VERB
dpc-3385	123	36	in	in	ADP
dpc-3385	123	37	the	the	DET
dpc-3385	123	38	superficial	superficial	ADJ
dpc-3385	123	39	type	type	NOUN
dpc-3385	123	40	and	and	CCONJ
dpc-3385	123	41	the	the	DET
dpc-3385	123	42	face	face	NOUN
dpc-3385	123	43	and	and	CCONJ
dpc-3385	123	44	neck	neck	NOUN
dpc-3385	123	45	in	in	ADP
dpc-3385	123	46	the	the	DET
dpc-3385	123	47	deep	deep	ADJ
dpc-3385	123	48	type	type	NOUN
dpc-3385	123	49	[	[	X
dpc-3385	123	50	4	4	NUM
dpc-3385	123	51	]	]	PUNCT
dpc-3385	123	52	.	.	PUNCT
dpc-3385	124	1	in	in	ADP
dpc-3385	124	2	our	our	PRON
dpc-3385	124	3	study	study	NOUN
dpc-3385	124	4	,	,	PUNCT
dpc-3385	124	5	the	the	DET
dpc-3385	124	6	number	number	NOUN
dpc-3385	124	7	of	of	ADP
dpc-3385	124	8	attacks	attack	NOUN
dpc-3385	124	9	varied	vary	VERB
dpc-3385	124	10	between	between	ADP
dpc-3385	124	11	1	1	NUM
dpc-3385	124	12	-	-	SYM
dpc-3385	124	13	20	20	NUM
dpc-3385	124	14	attacks	attack	NOUN
dpc-3385	124	15	and	and	CCONJ
dpc-3385	124	16	the	the	DET
dpc-3385	124	17	attacks	attack	NOUN
dpc-3385	124	18	recurred	recur	VERB
dpc-3385	124	19	in	in	ADP
dpc-3385	124	20	a	a	DET
dpc-3385	124	21	mean	mean	NOUN
dpc-3385	124	22	of	of	ADP
dpc-3385	124	23	9.1	9.1	NUM
dpc-3385	124	24	months	month	NOUN
dpc-3385	124	25	.	.	PUNCT
dpc-3385	125	1	in	in	ADP
dpc-3385	125	2	the	the	DET
dpc-3385	125	3	study	study	NOUN
dpc-3385	125	4	by	by	ADP
dpc-3385	125	5	kim	kim	PROPN
dpc-3385	125	6	et	et	PROPN
dpc-3385	125	7	al	al	PROPN
dpc-3385	125	8	the	the	DET
dpc-3385	125	9	mean	mean	ADJ
dpc-3385	125	10	duration	duration	NOUN
dpc-3385	125	11	of	of	ADP
dpc-3385	125	12	persistent	persistent	ADJ
dpc-3385	125	13	lesion	lesion	NOUN
dpc-3385	125	14	was	be	AUX
dpc-3385	125	15	found	find	VERB
dpc-3385	125	16	to	to	PART
dpc-3385	125	17	be	be	AUX
dpc-3385	125	18	4.7	4.7	NUM
dpc-3385	125	19	months	month	NOUN
dpc-3385	125	20	[	[	X
dpc-3385	125	21	5	5	NUM
dpc-3385	125	22	]	]	PUNCT
dpc-3385	125	23	.	.	PUNCT
dpc-3385	126	1	in	in	ADP
dpc-3385	126	2	our	our	PRON
dpc-3385	126	3	study	study	NOUN
dpc-3385	126	4	,	,	PUNCT
dpc-3385	126	5	15.9	15.9	NUM
dpc-3385	126	6	%	%	NOUN
dpc-3385	126	7	and	and	CCONJ
dpc-3385	126	8	84.1	84.1	NUM
dpc-3385	126	9	%	%	NOUN
dpc-3385	126	10	of	of	ADP
dpc-3385	126	11	the	the	DET
dpc-3385	126	12	patients	patient	NOUN
dpc-3385	126	13	had	have	VERB
dpc-3385	126	14	findings	finding	NOUN
dpc-3385	126	15	compatible	compatible	ADJ
dpc-3385	126	16	with	with	ADP
dpc-3385	126	17	deep	deep	ADJ
dpc-3385	126	18	and	and	CCONJ
dpc-3385	126	19	superficial	superficial	ADJ
dpc-3385	126	20	type	type	NOUN
dpc-3385	126	21	eac	eac	PROPN
dpc-3385	126	22	,	,	PUNCT
dpc-3385	126	23	no	no	DET
dpc-3385	126	24	difference	difference	NOUN
dpc-3385	126	25	was	be	AUX
dpc-3385	126	26	found	find	VERB
dpc-3385	126	27	in	in	ADP
dpc-3385	126	28	terms	term	NOUN
dpc-3385	126	29	of	of	ADP
dpc-3385	126	30	age	age	NOUN
dpc-3385	126	31	,	,	PUNCT
dpc-3385	126	32	gender	gender	NOUN
dpc-3385	126	33	,	,	PUNCT
dpc-3385	126	34	lesion	lesion	NOUN
dpc-3385	126	35	localization	localization	NOUN
dpc-3385	126	36	,	,	PUNCT
dpc-3385	126	37	triggering	trigger	VERB
dpc-3385	126	38	factors	factor	NOUN
dpc-3385	126	39	and	and	CCONJ
dpc-3385	126	40	comorbidities	comorbiditie	NOUN
dpc-3385	126	41	(	(	PUNCT
dpc-3385	126	42	p	p	X
dpc-3385	126	43	>	>	X
dpc-3385	126	44	0.05	0.05	NUM
dpc-3385	126	45	)	)	PUNCT
dpc-3385	126	46	,	,	PUNCT
dpc-3385	126	47	whereas	whereas	SCONJ
dpc-3385	126	48	the	the	DET
dpc-3385	126	49	total	total	ADJ
dpc-3385	126	50	duration	duration	NOUN
dpc-3385	126	51	of	of	ADP
dpc-3385	126	52	the	the	DET
dpc-3385	126	53	disease	disease	NOUN
dpc-3385	126	54	from	from	ADP
dpc-3385	126	55	the	the	DET
dpc-3385	126	56	onset	onset	NOUN
dpc-3385	126	57	of	of	ADP
dpc-3385	126	58	the	the	DET
dpc-3385	126	59	disease	disease	NOUN
dpc-3385	126	60	was	be	AUX
dpc-3385	126	61	longer	long	ADJ
dpc-3385	126	62	(	(	PUNCT
dpc-3385	126	63	12.3	12.3	NUM
dpc-3385	126	64	versus	versus	ADP
dpc-3385	126	65	16.2	16.2	NUM
dpc-3385	126	66	months	month	NOUN
dpc-3385	126	67	)	)	PUNCT
dpc-3385	126	68	and	and	CCONJ
dpc-3385	126	69	the	the	DET
dpc-3385	126	70	number	number	NOUN
dpc-3385	126	71	of	of	ADP
dpc-3385	126	72	attacks	attack	NOUN
dpc-3385	126	73	(	(	PUNCT
dpc-3385	126	74	1.2	1.2	NUM
dpc-3385	126	75	versus	versus	ADP
dpc-3385	126	76	2.8	2.8	NUM
dpc-3385	126	77	attacks	attack	NOUN
dpc-3385	126	78	)	)	PUNCT
dpc-3385	126	79	was	be	AUX
dpc-3385	126	80	higher	high	ADJ
dpc-3385	126	81	in	in	ADP
dpc-3385	126	82	the	the	DET
dpc-3385	126	83	superficial	superficial	ADJ
dpc-3385	126	84	type	type	NOUN
dpc-3385	126	85	compared	compare	VERB
dpc-3385	126	86	to	to	ADP
dpc-3385	126	87	the	the	DET
dpc-3385	126	88	deep	deep	ADJ
dpc-3385	126	89	type	type	NOUN
dpc-3385	126	90	(	(	PUNCT
dpc-3385	126	91	p	p	X
dpc-3385	126	92	=	=	NOUN
dpc-3385	126	93	0.042	0.042	NUM
dpc-3385	126	94	,	,	PUNCT
dpc-3385	126	95	p	p	PROPN
dpc-3385	126	96	=	=	NOUN
dpc-3385	126	97	0.038	0.038	NUM
dpc-3385	126	98	)	)	PUNCT
dpc-3385	126	99	.	.	PUNCT
dpc-3385	127	1	table	table	NOUN
dpc-3385	127	2	2	2	NUM
dpc-3385	127	3	.	.	PUNCT
dpc-3385	127	4	associated	associate	VERB
dpc-3385	127	5	conditions	condition	NOUN
dpc-3385	127	6	which	which	PRON
dpc-3385	127	7	were	be	AUX
dpc-3385	127	8	blamed	blame	VERB
dpc-3385	127	9	for	for	ADP
dpc-3385	127	10	triggering	trigger	VERB
dpc-3385	127	11	erythema	erythema	ADJ
dpc-3385	127	12	annulare	annulare	NOUN
dpc-3385	127	13	centrifugum	centrifugum	NOUN
dpc-3385	127	14	in	in	ADP
dpc-3385	127	15	the	the	DET
dpc-3385	127	16	patients	patient	NOUN
dpc-3385	127	17	.	.	PUNCT
dpc-3385	128	1	associated	associated	ADJ
dpc-3385	128	2	conditions	condition	NOUN
dpc-3385	128	3	,	,	PUNCT
dpc-3385	128	4	n	n	CCONJ
dpc-3385	128	5	(	(	PUNCT
dpc-3385	128	6	%	%	NOUN
dpc-3385	128	7	)	)	PUNCT
dpc-3385	128	8	n	n	PRON
dpc-3385	128	9	infections	infection	NOUN
dpc-3385	128	10	,	,	PUNCT
dpc-3385	128	11	16	16	NUM
dpc-3385	128	12	(	(	PUNCT
dpc-3385	128	13	25.3	25.3	NUM
dpc-3385	128	14	)	)	PUNCT
dpc-3385	128	15	tinea	tinea	NOUN
dpc-3385	128	16	pedis	pedis	NOUN
dpc-3385	128	17	/	/	SYM
dpc-3385	128	18	unguium	unguium	NOUN
dpc-3385	128	19	:	:	PUNCT
dpc-3385	128	20	7	7	NUM
dpc-3385	128	21	vaginal	vaginal	ADJ
dpc-3385	128	22	candidiasis	candidiasis	NOUN
dpc-3385	128	23	:	:	PUNCT
dpc-3385	128	24	1	1	NUM
dpc-3385	128	25	helicobacter	helicobacter	NOUN
dpc-3385	128	26	pylori	pylori	NOUN
dpc-3385	128	27	infection	infection	NOUN
dpc-3385	128	28	:	:	PUNCT
dpc-3385	128	29	4	4	NUM
dpc-3385	128	30	urinary	urinary	ADJ
dpc-3385	128	31	tract	tract	NOUN
dpc-3385	128	32	infection:1	infection:1	PRON
dpc-3385	128	33	upper	upper	ADJ
dpc-3385	128	34	respiratory	respiratory	ADJ
dpc-3385	128	35	tract	tract	NOUN
dpc-3385	128	36	infection	infection	NOUN
dpc-3385	128	37	:	:	PUNCT
dpc-3385	128	38	1	1	NUM
dpc-3385	128	39	covid-19:1	covid-19:1	PROPN
dpc-3385	128	40	hiv	hiv	PROPN
dpc-3385	128	41	infection:1	infection:1	PRON
dpc-3385	128	42	malignancies	malignancy	NOUN
dpc-3385	128	43	,	,	PUNCT
dpc-3385	128	44	6	6	NUM
dpc-3385	128	45	(	(	PUNCT
dpc-3385	128	46	9.5	9.5	NUM
dpc-3385	128	47	)	)	PUNCT
dpc-3385	128	48	prostate	prostate	NOUN
dpc-3385	128	49	cancer:2	cancer:2	NOUN
dpc-3385	128	50	gastric	gastric	ADJ
dpc-3385	128	51	cancer:1	cancer:1	NOUN
dpc-3385	128	52	cervix	cervix	NOUN
dpc-3385	128	53	cancer:1	cancer:1	NOUN
dpc-3385	128	54	breast	breast	NOUN
dpc-3385	128	55	cancer:1	cancer:1	NOUN
dpc-3385	128	56	thyroid	thyroid	NOUN
dpc-3385	128	57	cancer:1	cancer:1	VERB
dpc-3385	128	58	rheumatic	rheumatic	ADJ
dpc-3385	128	59	diseases	disease	NOUN
dpc-3385	128	60	,	,	PUNCT
dpc-3385	128	61	4	4	NUM
dpc-3385	128	62	(	(	PUNCT
dpc-3385	128	63	6.3	6.3	NUM
dpc-3385	128	64	)	)	PUNCT
dpc-3385	128	65	juvenile	juvenile	ADJ
dpc-3385	128	66	romatoid	romatoid	NOUN
dpc-3385	128	67	arthritis:1	arthritis:1	VERB
dpc-3385	128	68	romatoid	romatoid	PROPN
dpc-3385	128	69	arthritis:1	arthritis:1	NUM
dpc-3385	128	70	romatoid	romatoid	NOUN
dpc-3385	128	71	arthritis:1	arthritis:1	NUM
dpc-3385	128	72	granulomatosis	granulomatosis	VERB
dpc-3385	128	73	with	with	ADP
dpc-3385	128	74	polyangiitis:1	polyangiitis:1	NOUN
dpc-3385	128	75	medications	medication	NOUN
dpc-3385	128	76	,	,	PUNCT
dpc-3385	128	77	4	4	NUM
dpc-3385	128	78	(	(	PUNCT
dpc-3385	128	79	6.3	6.3	NUM
dpc-3385	128	80	)	)	PUNCT
dpc-3385	128	81	oral	oral	NOUN
dpc-3385	128	82	contraceptives:1	contraceptives:1	NOUN
dpc-3385	128	83	analgesics:1	analgesics:1	PROPN
dpc-3385	128	84	antibiotics:1	antibiotics:1	PROPN
dpc-3385	128	85	escitalopram:1	escitalopram:1	PROPN
dpc-3385	128	86	endocrinopathies	endocrinopathie	NOUN
dpc-3385	128	87	,	,	PUNCT
dpc-3385	128	88	2(3.1	2(3.1	NUM
dpc-3385	128	89	)	)	PUNCT
dpc-3385	128	90	hashimoto	hashimoto	NOUN
dpc-3385	128	91	thyroidit:2	thyroidit:2	NOUN
dpc-3385	128	92	other	other	ADJ
dpc-3385	128	93	,	,	PUNCT
dpc-3385	128	94	1(1.5	1(1.5	NUM
dpc-3385	128	95	)	)	PUNCT
dpc-3385	128	96	pregnancy:1	pregnancy:1	NOUN
dpc-3385	128	97	table	table	NOUN
dpc-3385	128	98	3	3	NUM
dpc-3385	128	99	.	.	PUNCT
dpc-3385	128	100	concomitant	concomitant	ADJ
dpc-3385	128	101	diseases	disease	NOUN
dpc-3385	128	102	in	in	ADP
dpc-3385	128	103	the	the	DET
dpc-3385	128	104	patients	patient	NOUN
dpc-3385	128	105	.	.	PUNCT
dpc-3385	129	1	concomitant	concomitant	ADJ
dpc-3385	129	2	diseases	disease	NOUN
dpc-3385	129	3	n	n	DET
dpc-3385	129	4	gastritis	gastritis	NOUN
dpc-3385	129	5	,	,	PUNCT
dpc-3385	129	6	dyspepsia	dyspepsia	NOUN
dpc-3385	129	7	10	10	NUM
dpc-3385	129	8	esophagitis	esophagitis	NOUN
dpc-3385	129	9	2	2	NUM
dpc-3385	129	10	diabetes	diabetes	NOUN
dpc-3385	129	11	7	7	NUM
dpc-3385	129	12	hypothyroidism	hypothyroidism	NOUN
dpc-3385	129	13	6	6	NUM
dpc-3385	129	14	malignancy	malignancy	NOUN
dpc-3385	129	15	6	6	NUM
dpc-3385	129	16	rheumatic	rheumatic	ADJ
dpc-3385	129	17	disease	disease	NOUN
dpc-3385	129	18	4	4	NUM
dpc-3385	129	19	hypertension	hypertension	NOUN
dpc-3385	129	20	3	3	NUM
dpc-3385	129	21	asthma	asthma	NOUN
dpc-3385	129	22	,	,	PUNCT
dpc-3385	129	23	allergic	allergic	ADJ
dpc-3385	129	24	rhinitis	rhinitis	NOUN
dpc-3385	129	25	3	3	NUM
dpc-3385	129	26	fibromyalgia	fibromyalgia	NOUN
dpc-3385	129	27	,	,	PUNCT
dpc-3385	129	28	depression	depression	NOUN
dpc-3385	129	29	2	2	NUM
dpc-3385	129	30	chronic	chronic	ADJ
dpc-3385	129	31	renal	renal	ADJ
dpc-3385	129	32	impairment	impairment	NOUN
dpc-3385	129	33	1	1	NUM
dpc-3385	129	34	hiv	hiv	NOUN
dpc-3385	129	35	infection	infection	NOUN
dpc-3385	129	36	1	1	NUM
dpc-3385	129	37	hepatitis	hepatitis	PROPN
dpc-3385	129	38	b	b	PROPN
dpc-3385	129	39	carrier	carrier	NOUN
dpc-3385	129	40	1	1	NUM
dpc-3385	129	41	table	table	NOUN
dpc-3385	129	42	4	4	NUM
dpc-3385	129	43	.	.	PUNCT
dpc-3385	130	1	treatments	treatment	NOUN
dpc-3385	130	2	received	receive	VERB
dpc-3385	130	3	by	by	ADP
dpc-3385	130	4	the	the	DET
dpc-3385	130	5	patients	patient	NOUN
dpc-3385	130	6	.	.	PUNCT
dpc-3385	131	1	treatments	treatment	NOUN
dpc-3385	131	2	n	n	PROPN
dpc-3385	131	3	(	(	PUNCT
dpc-3385	131	4	%	%	INTJ
dpc-3385	131	5	)	)	PUNCT
dpc-3385	131	6	topical	topical	ADJ
dpc-3385	131	7	corticosteroids	corticosteroid	NOUN
dpc-3385	131	8	30	30	NUM
dpc-3385	131	9	(	(	PUNCT
dpc-3385	131	10	47.6	47.6	NUM
dpc-3385	131	11	)	)	PUNCT
dpc-3385	131	12	topical	topical	ADJ
dpc-3385	131	13	calcineurin	calcineurin	NOUN
dpc-3385	131	14	inhibitors	inhibitor	NOUN
dpc-3385	131	15	8	8	NUM
dpc-3385	131	16	(	(	PUNCT
dpc-3385	131	17	12.6	12.6	NUM
dpc-3385	131	18	)	)	PUNCT
dpc-3385	131	19	terbinafine	terbinafine	NOUN
dpc-3385	131	20	6	6	NUM
dpc-3385	131	21	(	(	PUNCT
dpc-3385	131	22	9.5	9.5	NUM
dpc-3385	131	23	)	)	PUNCT
dpc-3385	131	24	calcipotriol	calcipotriol	NOUN
dpc-3385	131	25	4	4	NUM
dpc-3385	131	26	(	(	PUNCT
dpc-3385	131	27	6.3	6.3	NUM
dpc-3385	131	28	)	)	PUNCT
dpc-3385	131	29	azithromycin	azithromycin	NOUN
dpc-3385	131	30	3	3	NUM
dpc-3385	131	31	(	(	PUNCT
dpc-3385	131	32	4.7	4.7	NUM
dpc-3385	131	33	)	)	PUNCT
dpc-3385	131	34	systemic	systemic	ADJ
dpc-3385	131	35	steroid	steroid	NOUN
dpc-3385	131	36	2	2	NUM
dpc-3385	131	37	(	(	PUNCT
dpc-3385	131	38	3.2	3.2	NUM
dpc-3385	131	39	)	)	PUNCT
dpc-3385	131	40	dapsone	dapsone	NOUN
dpc-3385	131	41	1	1	NUM
dpc-3385	131	42	(	(	PUNCT
dpc-3385	131	43	1.6	1.6	NUM
dpc-3385	131	44	)	)	PUNCT
dpc-3385	131	45	fluconazole	fluconazole	NOUN
dpc-3385	131	46	1	1	NUM
dpc-3385	131	47	(	(	PUNCT
dpc-3385	131	48	1.6	1.6	NUM
dpc-3385	131	49	)	)	PUNCT
dpc-3385	131	50	none	none	NOUN
dpc-3385	131	51	17	17	NUM
dpc-3385	131	52	(	(	PUNCT
dpc-3385	131	53	26.9	26.9	NUM
dpc-3385	131	54	)	)	PUNCT
dpc-3385	131	55	original	original	ADJ
dpc-3385	131	56	article	article	NOUN
dpc-3385	131	57	|	|	ADV
dpc-3385	131	58	dermatol	dermatol	ADJ
dpc-3385	131	59	pract	pract	NOUN
dpc-3385	131	60	concept	concept	NOUN
dpc-3385	131	61	.	.	PUNCT
dpc-3385	132	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	132	2	5	5	NUM
dpc-3385	132	3	activation	activation	NOUN
dpc-3385	132	4	and	and	CCONJ
dpc-3385	132	5	lymph	lymph	NOUN
dpc-3385	132	6	node	node	NOUN
dpc-3385	132	7	metastasis	metastasis	NOUN
dpc-3385	132	8	was	be	AUX
dpc-3385	132	9	found	find	VERB
dpc-3385	132	10	[	[	X
dpc-3385	132	11	9	9	NUM
dpc-3385	132	12	]	]	PUNCT
dpc-3385	132	13	.	.	PUNCT
dpc-3385	133	1	in	in	ADP
dpc-3385	133	2	that	that	DET
dpc-3385	133	3	case	case	NOUN
dpc-3385	133	4	,	,	PUNCT
dpc-3385	133	5	it	it	PRON
dpc-3385	133	6	was	be	AUX
dpc-3385	133	7	emphasized	emphasize	VERB
dpc-3385	133	8	that	that	SCONJ
dpc-3385	133	9	if	if	SCONJ
dpc-3385	133	10	eac	eac	PROPN
dpc-3385	133	11	occurred	occur	VERB
dpc-3385	133	12	due	due	ADP
dpc-3385	133	13	to	to	ADP
dpc-3385	133	14	an	an	DET
dpc-3385	133	15	underlying	underlying	ADJ
dpc-3385	133	16	disease	disease	NOUN
dpc-3385	133	17	,	,	PUNCT
dpc-3385	133	18	eac	eac	PROPN
dpc-3385	133	19	may	may	AUX
dpc-3385	133	20	be	be	AUX
dpc-3385	133	21	correlated	correlate	VERB
dpc-3385	133	22	with	with	ADP
dpc-3385	133	23	exacerbations	exacerbation	NOUN
dpc-3385	133	24	of	of	ADP
dpc-3385	133	25	this	this	DET
dpc-3385	133	26	disease	disease	NOUN
dpc-3385	134	1	[	[	X
dpc-3385	134	2	9	9	NUM
dpc-3385	134	3	]	]	PUNCT
dpc-3385	134	4	.	.	PUNCT
dpc-3385	135	1	the	the	DET
dpc-3385	135	2	possible	possible	ADJ
dpc-3385	135	3	activation	activation	NOUN
dpc-3385	135	4	of	of	ADP
dpc-3385	135	5	cancer	cancer	NOUN
dpc-3385	135	6	was	be	AUX
dpc-3385	135	7	also	also	ADV
dpc-3385	135	8	investigated	investigate	VERB
dpc-3385	135	9	in	in	ADP
dpc-3385	135	10	our	our	PRON
dpc-3385	135	11	patients	patient	NOUN
dpc-3385	135	12	who	who	PRON
dpc-3385	135	13	were	be	AUX
dpc-3385	135	14	in	in	ADP
dpc-3385	135	15	remission	remission	NOUN
dpc-3385	135	16	but	but	CCONJ
dpc-3385	135	17	no	no	DET
dpc-3385	135	18	recurrence	recurrence	NOUN
dpc-3385	135	19	of	of	ADP
dpc-3385	135	20	malignancy	malignancy	NOUN
dpc-3385	135	21	was	be	AUX
dpc-3385	135	22	detected	detect	VERB
dpc-3385	135	23	.	.	PUNCT
dpc-3385	136	1	we	we	PRON
dpc-3385	136	2	had	have	VERB
dpc-3385	136	3	2	2	NUM
dpc-3385	136	4	cases	case	NOUN
dpc-3385	136	5	of	of	ADP
dpc-3385	136	6	hashimoto	hashimoto	NOUN
dpc-3385	136	7	thyroiditis	thyroiditis	NOUN
dpc-3385	136	8	.	.	PUNCT
dpc-3385	137	1	a	a	DET
dpc-3385	137	2	case	case	NOUN
dpc-3385	137	3	that	that	PRON
dpc-3385	137	4	started	start	VERB
dpc-3385	137	5	3	3	NUM
dpc-3385	137	6	months	month	NOUN
dpc-3385	137	7	before	before	ADP
dpc-3385	137	8	hashimoto	hashimoto	NOUN
dpc-3385	137	9	thyroiditis	thyroiditis	NOUN
dpc-3385	137	10	and	and	CCONJ
dpc-3385	137	11	was	be	AUX
dpc-3385	137	12	associated	associate	VERB
dpc-3385	137	13	with	with	ADP
dpc-3385	137	14	hashimoto	hashimoto	NOUN
dpc-3385	137	15	thyroiditis	thyroiditis	NOUN
dpc-3385	137	16	has	have	AUX
dpc-3385	137	17	been	be	AUX
dpc-3385	137	18	reported	report	VERB
dpc-3385	137	19	previously	previously	ADV
dpc-3385	137	20	[	[	X
dpc-3385	137	21	16	16	NUM
dpc-3385	137	22	]	]	PUNCT
dpc-3385	137	23	.	.	PUNCT
dpc-3385	138	1	we	we	PRON
dpc-3385	138	2	had	have	VERB
dpc-3385	138	3	one	one	NUM
dpc-3385	138	4	case	case	NOUN
dpc-3385	138	5	associated	associate	VERB
dpc-3385	138	6	with	with	ADP
dpc-3385	138	7	pregnancy	pregnancy	NOUN
dpc-3385	138	8	.	.	PUNCT
dpc-3385	139	1	similar	similar	ADJ
dpc-3385	139	2	to	to	ADP
dpc-3385	139	3	our	our	PRON
dpc-3385	139	4	case	case	NOUN
dpc-3385	139	5	,	,	PUNCT
dpc-3385	139	6	eac	eac	PROPN
dpc-3385	139	7	associated	associate	VERB
dpc-3385	139	8	with	with	ADP
dpc-3385	139	9	pregnancy	pregnancy	NOUN
dpc-3385	139	10	has	have	AUX
dpc-3385	139	11	been	be	AUX
dpc-3385	139	12	reported	report	VERB
dpc-3385	139	13	.	.	PUNCT
dpc-3385	140	1	in	in	ADP
dpc-3385	140	2	that	that	DET
dpc-3385	140	3	patient	patient	NOUN
dpc-3385	140	4	,	,	PUNCT
dpc-3385	140	5	eac	eac	PROPN
dpc-3385	140	6	developed	develop	VERB
dpc-3385	140	7	in	in	ADP
dpc-3385	140	8	pregnancy	pregnancy	NOUN
dpc-3385	140	9	and	and	CCONJ
dpc-3385	140	10	completely	completely	ADV
dpc-3385	140	11	disappeared	disappear	VERB
dpc-3385	140	12	1	1	NUM
dpc-3385	140	13	week	week	NOUN
dpc-3385	140	14	after	after	ADP
dpc-3385	140	15	delivery	delivery	NOUN
dpc-3385	140	16	without	without	ADP
dpc-3385	140	17	treatment	treatment	NOUN
dpc-3385	140	18	and	and	CCONJ
dpc-3385	140	19	did	do	AUX
dpc-3385	140	20	not	not	PART
dpc-3385	140	21	recur	recur	VERB
dpc-3385	140	22	in	in	ADP
dpc-3385	140	23	1	1	NUM
dpc-3385	140	24	-	-	PUNCT
dpc-3385	140	25	year	year	NOUN
dpc-3385	140	26	follow	follow	NOUN
dpc-3385	140	27	-	-	PUNCT
dpc-3385	140	28	up	up	NOUN
dpc-3385	140	29	[	[	X
dpc-3385	140	30	17	17	NUM
dpc-3385	140	31	]	]	PUNCT
dpc-3385	140	32	.	.	PUNCT
dpc-3385	141	1	although	although	SCONJ
dpc-3385	141	2	11.1	11.1	NUM
dpc-3385	141	3	%	%	NOUN
dpc-3385	141	4	of	of	ADP
dpc-3385	141	5	the	the	DET
dpc-3385	141	6	patients	patient	NOUN
dpc-3385	141	7	in	in	ADP
dpc-3385	141	8	our	our	PRON
dpc-3385	141	9	study	study	NOUN
dpc-3385	141	10	had	have	VERB
dpc-3385	141	11	a	a	DET
dpc-3385	141	12	history	history	NOUN
dpc-3385	141	13	of	of	ADP
dpc-3385	141	14	diabetes	diabetes	NOUN
dpc-3385	141	15	mellitus	mellitus	NOUN
dpc-3385	141	16	,	,	PUNCT
dpc-3385	141	17	no	no	DET
dpc-3385	141	18	direct	direct	ADJ
dpc-3385	141	19	association	association	NOUN
dpc-3385	141	20	with	with	ADP
dpc-3385	141	21	the	the	DET
dpc-3385	141	22	disease	disease	NOUN
dpc-3385	141	23	was	be	AUX
dpc-3385	141	24	established	establish	VERB
dpc-3385	141	25	and	and	CCONJ
dpc-3385	141	26	no	no	DET
dpc-3385	141	27	such	such	ADJ
dpc-3385	141	28	association	association	NOUN
dpc-3385	141	29	has	have	AUX
dpc-3385	141	30	been	be	AUX
dpc-3385	141	31	found	find	VERB
dpc-3385	141	32	in	in	ADP
dpc-3385	141	33	the	the	DET
dpc-3385	141	34	literature	literature	NOUN
dpc-3385	141	35	.	.	PUNCT
dpc-3385	142	1	when	when	SCONJ
dpc-3385	142	2	we	we	PRON
dpc-3385	142	3	compared	compare	VERB
dpc-3385	142	4	superficial	superficial	ADJ
dpc-3385	142	5	and	and	CCONJ
dpc-3385	142	6	deep	deep	ADJ
dpc-3385	142	7	types	type	NOUN
dpc-3385	142	8	based	base	VERB
dpc-3385	142	9	on	on	ADP
dpc-3385	142	10	both	both	CCONJ
dpc-3385	142	11	clinical	clinical	ADJ
dpc-3385	142	12	and	and	CCONJ
dpc-3385	142	13	histological	histological	ADJ
dpc-3385	142	14	classification	classification	NOUN
dpc-3385	142	15	,	,	PUNCT
dpc-3385	142	16	we	we	PRON
dpc-3385	142	17	found	find	VERB
dpc-3385	142	18	that	that	SCONJ
dpc-3385	142	19	the	the	DET
dpc-3385	142	20	total	total	ADJ
dpc-3385	142	21	disease	disease	NOUN
dpc-3385	142	22	duration	duration	NOUN
dpc-3385	142	23	from	from	ADP
dpc-3385	142	24	the	the	DET
dpc-3385	142	25	onset	onset	NOUN
dpc-3385	142	26	of	of	ADP
dpc-3385	142	27	the	the	DET
dpc-3385	142	28	disease	disease	NOUN
dpc-3385	142	29	was	be	AUX
dpc-3385	142	30	longer	long	ADJ
dpc-3385	142	31	and	and	CCONJ
dpc-3385	142	32	the	the	DET
dpc-3385	142	33	number	number	NOUN
dpc-3385	142	34	of	of	ADP
dpc-3385	142	35	attacks	attack	NOUN
dpc-3385	142	36	was	be	AUX
dpc-3385	142	37	higher	high	ADJ
dpc-3385	142	38	in	in	ADP
dpc-3385	142	39	the	the	DET
dpc-3385	142	40	superficial	superficial	ADJ
dpc-3385	142	41	type	type	NOUN
dpc-3385	142	42	compared	compare	VERB
dpc-3385	142	43	to	to	ADP
dpc-3385	142	44	the	the	DET
dpc-3385	142	45	deep	deep	ADJ
dpc-3385	142	46	type	type	NOUN
dpc-3385	142	47	.	.	PUNCT
dpc-3385	143	1	in	in	ADP
dpc-3385	143	2	the	the	DET
dpc-3385	143	3	study	study	NOUN
dpc-3385	143	4	by	by	ADP
dpc-3385	143	5	kim	kim	PROPN
dpc-3385	143	6	et	et	PROPN
dpc-3385	143	7	al	al	PROPN
dpc-3385	143	8	the	the	DET
dpc-3385	143	9	detection	detection	NOUN
dpc-3385	143	10	of	of	ADP
dpc-3385	143	11	higher	high	ADJ
dpc-3385	143	12	recurrence	recurrence	NOUN
dpc-3385	143	13	rate	rate	NOUN
dpc-3385	143	14	in	in	ADP
dpc-3385	143	15	the	the	DET
dpc-3385	143	16	superficial	superficial	ADJ
dpc-3385	143	17	type	type	NOUN
dpc-3385	143	18	supports	support	VERB
dpc-3385	143	19	our	our	PRON
dpc-3385	143	20	findings	finding	NOUN
dpc-3385	143	21	[	[	X
dpc-3385	143	22	5	5	NUM
dpc-3385	143	23	]	]	PUNCT
dpc-3385	143	24	;	;	PUNCT
dpc-3385	143	25	however	however	ADV
dpc-3385	143	26	,	,	PUNCT
dpc-3385	143	27	it	it	PRON
dpc-3385	143	28	should	should	AUX
dpc-3385	143	29	be	be	AUX
dpc-3385	143	30	kept	keep	VERB
dpc-3385	143	31	in	in	ADP
dpc-3385	143	32	mind	mind	NOUN
dpc-3385	143	33	that	that	SCONJ
dpc-3385	143	34	the	the	DET
dpc-3385	143	35	number	number	NOUN
dpc-3385	143	36	of	of	ADP
dpc-3385	143	37	deep	deep	ADJ
dpc-3385	143	38	-	-	PUNCT
dpc-3385	143	39	type	type	NOUN
dpc-3385	143	40	eac	eac	NOUN
dpc-3385	143	41	cases	case	NOUN
dpc-3385	143	42	was	be	AUX
dpc-3385	143	43	very	very	ADV
dpc-3385	143	44	low	low	ADJ
dpc-3385	143	45	in	in	ADP
dpc-3385	143	46	both	both	DET
dpc-3385	143	47	studies	study	NOUN
dpc-3385	143	48	.	.	PUNCT
dpc-3385	144	1	the	the	DET
dpc-3385	144	2	most	most	ADV
dpc-3385	144	3	important	important	ADJ
dpc-3385	144	4	limitations	limitation	NOUN
dpc-3385	144	5	of	of	ADP
dpc-3385	144	6	our	our	PRON
dpc-3385	144	7	study	study	NOUN
dpc-3385	144	8	are	be	AUX
dpc-3385	144	9	the	the	DET
dpc-3385	144	10	small	small	ADJ
dpc-3385	144	11	number	number	NOUN
dpc-3385	144	12	of	of	ADP
dpc-3385	144	13	patients	patient	NOUN
dpc-3385	144	14	and	and	CCONJ
dpc-3385	144	15	the	the	DET
dpc-3385	144	16	retrospective	retrospective	ADJ
dpc-3385	144	17	design	design	NOUN
dpc-3385	144	18	of	of	ADP
dpc-3385	144	19	our	our	PRON
dpc-3385	144	20	study	study	NOUN
dpc-3385	144	21	which	which	PRON
dpc-3385	144	22	led	lead	VERB
dpc-3385	144	23	to	to	ADP
dpc-3385	144	24	missing	miss	VERB
dpc-3385	144	25	data	datum	NOUN
dpc-3385	144	26	about	about	ADP
dpc-3385	144	27	treatment	treatment	NOUN
dpc-3385	144	28	responses	response	NOUN
dpc-3385	144	29	.	.	PUNCT
dpc-3385	145	1	there	there	PRON
dpc-3385	145	2	is	be	VERB
dpc-3385	145	3	an	an	DET
dpc-3385	145	4	obligatory	obligatory	ADJ
dpc-3385	145	5	overlap	overlap	NOUN
dpc-3385	145	6	between	between	ADP
dpc-3385	145	7	some	some	PRON
dpc-3385	145	8	of	of	ADP
dpc-3385	145	9	associated	associated	ADJ
dpc-3385	145	10	conditions	condition	NOUN
dpc-3385	145	11	and	and	CCONJ
dpc-3385	145	12	concomitant	concomitant	ADJ
dpc-3385	145	13	diseases	disease	NOUN
dpc-3385	145	14	in	in	ADP
dpc-3385	145	15	our	our	PRON
dpc-3385	145	16	study	study	NOUN
dpc-3385	145	17	.	.	PUNCT
dpc-3385	146	1	associated	associated	ADJ
dpc-3385	146	2	condition	condition	NOUN
dpc-3385	146	3	may	may	AUX
dpc-3385	146	4	be	be	AUX
dpc-3385	146	5	a	a	DET
dpc-3385	146	6	concomitant	concomitant	ADJ
dpc-3385	146	7	disease	disease	NOUN
dpc-3385	146	8	and	and	CCONJ
dpc-3385	146	9	vice	vice	NOUN
dpc-3385	146	10	versa	versa	NOUN
dpc-3385	146	11	is	be	AUX
dpc-3385	146	12	also	also	ADV
dpc-3385	146	13	possible	possible	ADJ
dpc-3385	146	14	.	.	PUNCT
dpc-3385	147	1	we	we	PRON
dpc-3385	147	2	favored	favor	VERB
dpc-3385	147	3	to	to	ADP
dpc-3385	147	4	group	group	NOUN
dpc-3385	147	5	associated	associate	VERB
dpc-3385	147	6	conditions	condition	NOUN
dpc-3385	147	7	according	accord	VERB
dpc-3385	147	8	to	to	ADP
dpc-3385	147	9	priorly	priorly	ADV
dpc-3385	147	10	defined	define	VERB
dpc-3385	147	11	causes	cause	NOUN
dpc-3385	147	12	of	of	ADP
dpc-3385	147	13	eac	eac	NOUN
dpc-3385	147	14	in	in	ADP
dpc-3385	147	15	the	the	DET
dpc-3385	147	16	literature	literature	NOUN
dpc-3385	147	17	.	.	PUNCT
dpc-3385	148	1	four	four	NUM
dpc-3385	148	2	of	of	ADP
dpc-3385	148	3	the	the	DET
dpc-3385	148	4	patients	patient	NOUN
dpc-3385	148	5	with	with	ADP
dpc-3385	148	6	gastritis	gastritis	PROPN
dpc-3385	148	7	had	have	VERB
dpc-3385	148	8	also	also	ADV
dpc-3385	148	9	helicobacter	helicobacter	NOUN
dpc-3385	148	10	pylori	pylori	ADJ
dpc-3385	148	11	infection	infection	NOUN
dpc-3385	148	12	.	.	PUNCT
dpc-3385	149	1	after	after	SCONJ
dpc-3385	149	2	helicobacter	helicobacter	NOUN
dpc-3385	149	3	pylori	pylori	NOUN
dpc-3385	149	4	eradication	eradication	NOUN
dpc-3385	149	5	eac	eac	NOUN
dpc-3385	149	6	lesions	lesion	NOUN
dpc-3385	149	7	regressed	regress	VERB
dpc-3385	149	8	,	,	PUNCT
dpc-3385	149	9	so	so	ADV
dpc-3385	149	10	we	we	PRON
dpc-3385	149	11	blamed	blame	VERB
dpc-3385	149	12	it	it	PRON
dpc-3385	149	13	as	as	ADP
dpc-3385	149	14	a	a	DET
dpc-3385	149	15	triggering	trigger	VERB
dpc-3385	149	16	factor	factor	NOUN
dpc-3385	149	17	and	and	CCONJ
dpc-3385	149	18	these	these	DET
dpc-3385	149	19	four	four	NUM
dpc-3385	149	20	patients	patient	NOUN
dpc-3385	149	21	were	be	AUX
dpc-3385	149	22	included	include	VERB
dpc-3385	149	23	in	in	ADP
dpc-3385	149	24	both	both	PRON
dpc-3385	149	25	of	of	ADP
dpc-3385	149	26	associated	associated	ADJ
dpc-3385	149	27	conditions/	conditions/	NUM
dpc-3385	149	28	infections	infection	NOUN
dpc-3385	149	29	and	and	CCONJ
dpc-3385	149	30	concomitant	concomitant	ADJ
dpc-3385	149	31	diseases	disease	NOUN
dpc-3385	149	32	/	/	SYM
dpc-3385	149	33	gastritis	gastritis	NOUN
dpc-3385	149	34	category	category	NOUN
dpc-3385	149	35	.	.	PUNCT
dpc-3385	150	1	similarly	similarly	ADV
dpc-3385	150	2	two	two	NUM
dpc-3385	150	3	patients	patient	NOUN
dpc-3385	150	4	with	with	ADP
dpc-3385	150	5	hashimoto	hashimoto	NOUN
dpc-3385	150	6	thyroiditis	thyroiditis	NOUN
dpc-3385	150	7	were	be	AUX
dpc-3385	150	8	diagnosed	diagnose	VERB
dpc-3385	150	9	concurrently	concurrently	ADV
dpc-3385	150	10	with	with	ADP
dpc-3385	150	11	eac	eac	NOUN
dpc-3385	150	12	and	and	CCONJ
dpc-3385	150	13	they	they	PRON
dpc-3385	150	14	were	be	AUX
dpc-3385	150	15	included	include	VERB
dpc-3385	150	16	in	in	ADP
dpc-3385	150	17	both	both	PRON
dpc-3385	150	18	of	of	ADP
dpc-3385	150	19	the	the	DET
dpc-3385	150	20	categories	category	NOUN
dpc-3385	150	21	as	as	ADP
dpc-3385	150	22	associated	associated	ADJ
dpc-3385	150	23	conditions	condition	NOUN
dpc-3385	150	24	/	/	SYM
dpc-3385	150	25	endocrinopathies	endocrinopathie	NOUN
dpc-3385	150	26	and	and	CCONJ
dpc-3385	150	27	concomitant	concomitant	ADJ
dpc-3385	150	28	diseases	disease	NOUN
dpc-3385	150	29	/	/	SYM
dpc-3385	150	30	hypothyroidism	hypothyroidism	NOUN
dpc-3385	150	31	.	.	PUNCT
dpc-3385	151	1	remaining	remain	VERB
dpc-3385	151	2	four	four	NUM
dpc-3385	151	3	patients	patient	NOUN
dpc-3385	151	4	with	with	ADP
dpc-3385	151	5	hypothyroidism	hypothyroidism	NOUN
dpc-3385	151	6	suffered	suffer	VERB
dpc-3385	151	7	from	from	ADP
dpc-3385	151	8	the	the	DET
dpc-3385	151	9	disease	disease	NOUN
dpc-3385	151	10	for	for	ADP
dpc-3385	151	11	many	many	ADJ
dpc-3385	151	12	years	year	NOUN
dpc-3385	151	13	and	and	CCONJ
dpc-3385	151	14	they	they	PRON
dpc-3385	151	15	were	be	AUX
dpc-3385	151	16	stable	stable	ADJ
dpc-3385	151	17	under	under	ADP
dpc-3385	151	18	treatment	treatment	NOUN
dpc-3385	151	19	.	.	PUNCT
dpc-3385	152	1	we	we	PRON
dpc-3385	152	2	could	could	AUX
dpc-3385	152	3	not	not	PART
dpc-3385	152	4	establish	establish	VERB
dpc-3385	152	5	a	a	DET
dpc-3385	152	6	cause	cause	VERB
dpc-3385	152	7	-	-	PUNCT
dpc-3385	152	8	and	and	CCONJ
dpc-3385	152	9	-	-	PUNCT
dpc-3385	152	10	effect	effect	NOUN
dpc-3385	152	11	relationship	relationship	NOUN
dpc-3385	152	12	and	and	CCONJ
dpc-3385	152	13	put	put	VERB
dpc-3385	152	14	them	they	PRON
dpc-3385	152	15	only	only	ADV
dpc-3385	152	16	in	in	ADP
dpc-3385	152	17	concomitant	concomitant	ADJ
dpc-3385	152	18	diseases	disease	NOUN
dpc-3385	152	19	group	group	NOUN
dpc-3385	152	20	.	.	PUNCT
dpc-3385	153	1	we	we	PRON
dpc-3385	153	2	described	describe	VERB
dpc-3385	153	3	the	the	DET
dpc-3385	153	4	demographic	demographic	ADJ
dpc-3385	153	5	and	and	CCONJ
dpc-3385	153	6	clinical	clinical	ADJ
dpc-3385	153	7	characteristics	characteristic	NOUN
dpc-3385	153	8	of	of	ADP
dpc-3385	153	9	patients	patient	NOUN
dpc-3385	153	10	with	with	ADP
dpc-3385	153	11	eac	eac	PROPN
dpc-3385	153	12	in	in	ADP
dpc-3385	153	13	our	our	PRON
dpc-3385	153	14	study	study	NOUN
dpc-3385	153	15	.	.	PUNCT
dpc-3385	154	1	we	we	PRON
dpc-3385	154	2	would	would	AUX
dpc-3385	154	3	like	like	VERB
dpc-3385	154	4	to	to	PART
dpc-3385	154	5	point	point	VERB
dpc-3385	154	6	out	out	ADP
dpc-3385	154	7	that	that	SCONJ
dpc-3385	154	8	the	the	DET
dpc-3385	154	9	association	association	NOUN
dpc-3385	154	10	with	with	ADP
dpc-3385	154	11	helicobacter	helicobacter	NOUN
dpc-3385	154	12	pylori	pylori	NOUN
dpc-3385	154	13	infection	infection	NOUN
dpc-3385	154	14	,	,	PUNCT
dpc-3385	154	15	which	which	PRON
dpc-3385	154	16	we	we	PRON
dpc-3385	154	17	observed	observe	VERB
dpc-3385	154	18	in	in	ADP
dpc-3385	154	19	our	our	PRON
dpc-3385	154	20	study	study	NOUN
dpc-3385	154	21	may	may	AUX
dpc-3385	154	22	be	be	AUX
dpc-3385	154	23	significant	significant	ADJ
dpc-3385	154	24	.	.	PUNCT
dpc-3385	155	1	we	we	PRON
dpc-3385	155	2	also	also	ADV
dpc-3385	155	3	found	find	VERB
dpc-3385	155	4	that	that	SCONJ
dpc-3385	155	5	the	the	DET
dpc-3385	155	6	superficial	superficial	ADJ
dpc-3385	155	7	type	type	NOUN
dpc-3385	155	8	had	have	VERB
dpc-3385	155	9	a	a	DET
dpc-3385	155	10	longer	long	ADJ
dpc-3385	155	11	disease	disease	NOUN
dpc-3385	155	12	respectively	respectively	ADV
dpc-3385	155	13	.	.	PUNCT
dpc-3385	156	1	similar	similar	ADJ
dpc-3385	156	2	to	to	ADP
dpc-3385	156	3	our	our	PRON
dpc-3385	156	4	study	study	NOUN
dpc-3385	156	5	,	,	PUNCT
dpc-3385	156	6	82.1	82.1	NUM
dpc-3385	156	7	%	%	NOUN
dpc-3385	156	8	of	of	ADP
dpc-3385	156	9	the	the	DET
dpc-3385	156	10	cases	case	NOUN
dpc-3385	156	11	were	be	AUX
dpc-3385	156	12	evaluated	evaluate	VERB
dpc-3385	156	13	as	as	ADP
dpc-3385	156	14	superficial	superficial	ADJ
dpc-3385	156	15	type	type	NOUN
dpc-3385	156	16	and	and	CCONJ
dpc-3385	156	17	17.9	17.9	NUM
dpc-3385	156	18	%	%	NOUN
dpc-3385	156	19	as	as	ADP
dpc-3385	156	20	deep	deep	ADJ
dpc-3385	156	21	type	type	NOUN
dpc-3385	156	22	in	in	ADP
dpc-3385	156	23	the	the	DET
dpc-3385	156	24	study	study	NOUN
dpc-3385	156	25	by	by	ADP
dpc-3385	156	26	kim	kim	PROPN
dpc-3385	156	27	et	et	PROPN
dpc-3385	156	28	al	al	PROPN
dpc-3385	157	1	[	[	X
dpc-3385	157	2	5	5	NUM
dpc-3385	157	3	]	]	PUNCT
dpc-3385	157	4	.	.	PUNCT
dpc-3385	158	1	in	in	ADP
dpc-3385	158	2	another	another	DET
dpc-3385	158	3	study	study	NOUN
dpc-3385	158	4	,	,	PUNCT
dpc-3385	158	5	it	it	PRON
dpc-3385	158	6	was	be	AUX
dpc-3385	158	7	also	also	ADV
dpc-3385	158	8	found	find	VERB
dpc-3385	158	9	that	that	SCONJ
dpc-3385	158	10	78	78	NUM
dpc-3385	158	11	%	%	NOUN
dpc-3385	158	12	of	of	ADP
dpc-3385	158	13	the	the	DET
dpc-3385	158	14	patients	patient	NOUN
dpc-3385	158	15	with	with	ADP
dpc-3385	158	16	available	available	ADJ
dpc-3385	158	17	data	datum	NOUN
dpc-3385	158	18	had	have	VERB
dpc-3385	158	19	superficial	superficial	ADJ
dpc-3385	158	20	type	type	NOUN
dpc-3385	158	21	eas	ea	NOUN
dpc-3385	158	22	and	and	CCONJ
dpc-3385	158	23	22	22	NUM
dpc-3385	158	24	%	%	NOUN
dpc-3385	158	25	had	have	VERB
dpc-3385	158	26	deep	deep	ADJ
dpc-3385	158	27	type	type	NOUN
dpc-3385	158	28	eac	eac	NOUN
dpc-3385	159	1	[	[	X
dpc-3385	159	2	6	6	NUM
dpc-3385	159	3	]	]	PUNCT
dpc-3385	159	4	.	.	PUNCT
dpc-3385	160	1	we	we	PRON
dpc-3385	160	2	identified	identify	VERB
dpc-3385	160	3	associated	associated	ADJ
dpc-3385	160	4	conditions	condition	NOUN
dpc-3385	160	5	in	in	ADP
dpc-3385	160	6	52.3	52.3	NUM
dpc-3385	160	7	%	%	NOUN
dpc-3385	160	8	of	of	ADP
dpc-3385	160	9	the	the	DET
dpc-3385	160	10	patients	patient	NOUN
dpc-3385	160	11	in	in	ADP
dpc-3385	160	12	our	our	PRON
dpc-3385	160	13	study	study	NOUN
dpc-3385	160	14	,	,	PUNCT
dpc-3385	160	15	while	while	SCONJ
dpc-3385	160	16	we	we	PRON
dpc-3385	160	17	evaluated	evaluate	VERB
dpc-3385	160	18	that	that	SCONJ
dpc-3385	160	19	47.6	47.6	NUM
dpc-3385	160	20	%	%	NOUN
dpc-3385	160	21	were	be	AUX
dpc-3385	160	22	idiopathic	idiopathic	ADJ
dpc-3385	160	23	.	.	PUNCT
dpc-3385	161	1	in	in	ADP
dpc-3385	161	2	the	the	DET
dpc-3385	161	3	study	study	NOUN
dpc-3385	161	4	of	of	ADP
dpc-3385	161	5	kim	kim	PROPN
dpc-3385	161	6	et	et	PROPN
dpc-3385	161	7	al	al	PROPN
dpc-3385	161	8	33.3	33.3	NUM
dpc-3385	161	9	%	%	NOUN
dpc-3385	161	10	of	of	ADP
dpc-3385	161	11	the	the	DET
dpc-3385	161	12	patients	patient	NOUN
dpc-3385	161	13	were	be	AUX
dpc-3385	161	14	found	find	VERB
dpc-3385	161	15	to	to	PART
dpc-3385	161	16	have	have	VERB
dpc-3385	161	17	potentially	potentially	ADV
dpc-3385	161	18	related	relate	VERB
dpc-3385	161	19	factors	factor	NOUN
dpc-3385	161	20	(	(	PUNCT
dpc-3385	161	21	cutaneous	cutaneous	ADJ
dpc-3385	161	22	fungal	fungal	ADJ
dpc-3385	161	23	infections	infection	NOUN
dpc-3385	161	24	,	,	PUNCT
dpc-3385	161	25	pregnancy	pregnancy	NOUN
dpc-3385	161	26	,	,	PUNCT
dpc-3385	161	27	malignancy	malignancy	NOUN
dpc-3385	161	28	,	,	PUNCT
dpc-3385	161	29	autoimmune	autoimmune	ADJ
dpc-3385	161	30	diseases	disease	NOUN
dpc-3385	161	31	and	and	CCONJ
dpc-3385	161	32	drugs	drug	NOUN
dpc-3385	161	33	)	)	PUNCT
dpc-3385	162	1	[	[	X
dpc-3385	162	2	5	5	NUM
dpc-3385	162	3	]	]	PUNCT
dpc-3385	162	4	.	.	PUNCT
dpc-3385	163	1	in	in	ADP
dpc-3385	163	2	the	the	DET
dpc-3385	163	3	study	study	NOUN
dpc-3385	163	4	by	by	ADP
dpc-3385	163	5	weyers	weyer	NOUN
dpc-3385	163	6	et	et	PROPN
dpc-3385	163	7	al	al	PROPN
dpc-3385	163	8	infections	infection	NOUN
dpc-3385	163	9	,	,	PUNCT
dpc-3385	163	10	rheumatoid	rheumatoid	NOUN
dpc-3385	163	11	arthritis	arthritis	NOUN
dpc-3385	163	12	,	,	PUNCT
dpc-3385	163	13	thrombocythemia	thrombocythemia	NOUN
dpc-3385	163	14	,	,	PUNCT
dpc-3385	163	15	malignancies	malignancy	NOUN
dpc-3385	163	16	,	,	PUNCT
dpc-3385	163	17	allergic	allergic	ADJ
dpc-3385	163	18	asthma	asthma	NOUN
dpc-3385	163	19	and	and	CCONJ
dpc-3385	163	20	drug	drug	NOUN
dpc-3385	163	21	reactions	reaction	NOUN
dpc-3385	163	22	were	be	AUX
dpc-3385	163	23	blamed	blame	VERB
dpc-3385	163	24	in	in	ADP
dpc-3385	163	25	36	36	NUM
dpc-3385	163	26	percent	percent	NOUN
dpc-3385	163	27	of	of	ADP
dpc-3385	163	28	the	the	DET
dpc-3385	163	29	patients	patient	NOUN
dpc-3385	163	30	[	[	X
dpc-3385	163	31	4	4	NUM
dpc-3385	163	32	]	]	PUNCT
dpc-3385	163	33	.	.	PUNCT
dpc-3385	164	1	in	in	ADP
dpc-3385	164	2	the	the	DET
dpc-3385	164	3	study	study	NOUN
dpc-3385	164	4	by	by	ADP
dpc-3385	164	5	kim	kim	PROPN
dpc-3385	164	6	et	et	PROPN
dpc-3385	164	7	al	al	PROPN
dpc-3385	164	8	72	72	NUM
dpc-3385	164	9	%	%	NOUN
dpc-3385	164	10	of	of	ADP
dpc-3385	164	11	patients	patient	NOUN
dpc-3385	164	12	had	have	VERB
dpc-3385	164	13	comorbidities	comorbiditie	NOUN
dpc-3385	164	14	.	.	PUNCT
dpc-3385	165	1	associated	associate	VERB
dpc-3385	165	2	diseases	disease	NOUN
dpc-3385	165	3	were	be	AUX
dpc-3385	165	4	categorized	categorize	VERB
dpc-3385	165	5	as	as	ADP
dpc-3385	165	6	cutaneous	cutaneous	ADJ
dpc-3385	165	7	fungal	fungal	ADJ
dpc-3385	165	8	infections	infection	NOUN
dpc-3385	165	9	(	(	PUNCT
dpc-3385	165	10	48	48	NUM
dpc-3385	165	11	%	%	NOUN
dpc-3385	165	12	)	)	PUNCT
dpc-3385	165	13	,	,	PUNCT
dpc-3385	165	14	other	other	ADJ
dpc-3385	165	15	skin	skin	NOUN
dpc-3385	165	16	diseases	disease	NOUN
dpc-3385	165	17	(	(	PUNCT
dpc-3385	165	18	18	18	NUM
dpc-3385	165	19	%	%	NOUN
dpc-3385	165	20	)	)	PUNCT
dpc-3385	165	21	,	,	PUNCT
dpc-3385	165	22	malignancies	malignancy	NOUN
dpc-3385	165	23	(	(	PUNCT
dpc-3385	165	24	13	13	NUM
dpc-3385	165	25	%	%	NOUN
dpc-3385	165	26	)	)	PUNCT
dpc-3385	165	27	and	and	CCONJ
dpc-3385	165	28	other	other	ADJ
dpc-3385	165	29	systemic	systemic	ADJ
dpc-3385	165	30	diseases	disease	NOUN
dpc-3385	165	31	(	(	PUNCT
dpc-3385	165	32	21	21	NUM
dpc-3385	165	33	%	%	NOUN
dpc-3385	165	34	)	)	PUNCT
dpc-3385	166	1	[	[	X
dpc-3385	166	2	6	6	NUM
dpc-3385	166	3	]	]	PUNCT
dpc-3385	166	4	.	.	PUNCT
dpc-3385	167	1	due	due	ADP
dpc-3385	167	2	to	to	ADP
dpc-3385	167	3	the	the	DET
dpc-3385	167	4	paucity	paucity	NOUN
dpc-3385	167	5	of	of	ADP
dpc-3385	167	6	data	datum	NOUN
dpc-3385	167	7	in	in	ADP
dpc-3385	167	8	the	the	DET
dpc-3385	167	9	literature	literature	NOUN
dpc-3385	167	10	on	on	ADP
dpc-3385	167	11	eac	eac	PROPN
dpc-3385	167	12	,	,	PUNCT
dpc-3385	167	13	the	the	DET
dpc-3385	167	14	underlying	underlie	VERB
dpc-3385	167	15	causes	cause	NOUN
dpc-3385	167	16	are	be	AUX
dpc-3385	167	17	not	not	PART
dpc-3385	167	18	fully	fully	ADV
dpc-3385	167	19	known	know	VERB
dpc-3385	167	20	and	and	CCONJ
dpc-3385	167	21	are	be	AUX
dpc-3385	167	22	of	of	ADP
dpc-3385	167	23	great	great	ADJ
dpc-3385	167	24	interest	interest	NOUN
dpc-3385	167	25	.	.	PUNCT
dpc-3385	168	1	the	the	DET
dpc-3385	168	2	associations	association	NOUN
dpc-3385	168	3	detected	detect	VERB
dpc-3385	168	4	after	after	ADP
dpc-3385	168	5	the	the	DET
dpc-3385	168	6	diagnosis	diagnosis	NOUN
dpc-3385	168	7	of	of	ADP
dpc-3385	168	8	the	the	DET
dpc-3385	168	9	disease	disease	NOUN
dpc-3385	168	10	have	have	AUX
dpc-3385	168	11	been	be	AUX
dpc-3385	168	12	generally	generally	ADV
dpc-3385	168	13	reported	report	VERB
dpc-3385	168	14	as	as	ADP
dpc-3385	168	15	cases	case	NOUN
dpc-3385	168	16	to	to	ADP
dpc-3385	168	17	date	date	NOUN
dpc-3385	168	18	,	,	PUNCT
dpc-3385	168	19	and	and	CCONJ
dpc-3385	168	20	a	a	DET
dpc-3385	168	21	clear	clear	ADJ
dpc-3385	168	22	relationship	relationship	NOUN
dpc-3385	168	23	is	be	AUX
dpc-3385	168	24	usually	usually	ADV
dpc-3385	168	25	not	not	PART
dpc-3385	168	26	established	establish	VERB
dpc-3385	168	27	.	.	PUNCT
dpc-3385	169	1	in	in	ADP
dpc-3385	169	2	our	our	PRON
dpc-3385	169	3	study	study	NOUN
dpc-3385	169	4	,	,	PUNCT
dpc-3385	169	5	the	the	DET
dpc-3385	169	6	most	most	ADV
dpc-3385	169	7	frequently	frequently	ADV
dpc-3385	169	8	associated	associate	VERB
dpc-3385	169	9	conditions	condition	NOUN
dpc-3385	169	10	with	with	ADP
dpc-3385	169	11	eac	eac	PROPN
dpc-3385	169	12	were	be	AUX
dpc-3385	169	13	infections	infection	NOUN
dpc-3385	169	14	,	,	PUNCT
dpc-3385	169	15	malignancies	malignancy	NOUN
dpc-3385	169	16	,	,	PUNCT
dpc-3385	169	17	rheumatologic	rheumatologic	NOUN
dpc-3385	169	18	diseases	disease	NOUN
dpc-3385	169	19	and	and	CCONJ
dpc-3385	169	20	drugs	drug	NOUN
dpc-3385	169	21	,	,	PUNCT
dpc-3385	169	22	respectively	respectively	ADV
dpc-3385	169	23	.	.	PUNCT
dpc-3385	170	1	this	this	DET
dpc-3385	170	2	result	result	NOUN
dpc-3385	170	3	was	be	AUX
dpc-3385	170	4	similar	similar	ADJ
dpc-3385	170	5	to	to	ADP
dpc-3385	170	6	aforementioned	aforementioned	ADJ
dpc-3385	170	7	studies	study	NOUN
dpc-3385	170	8	.	.	PUNCT
dpc-3385	171	1	also	also	ADV
dpc-3385	171	2	the	the	DET
dpc-3385	171	3	most	most	ADV
dpc-3385	171	4	common	common	ADJ
dpc-3385	171	5	infection	infection	NOUN
dpc-3385	171	6	was	be	AUX
dpc-3385	171	7	superficial	superficial	ADJ
dpc-3385	171	8	fungal	fungal	ADJ
dpc-3385	171	9	infections	infection	NOUN
dpc-3385	171	10	in	in	ADP
dpc-3385	171	11	concordance	concordance	NOUN
dpc-3385	171	12	with	with	ADP
dpc-3385	171	13	previous	previous	ADJ
dpc-3385	171	14	studies	study	NOUN
dpc-3385	171	15	.	.	PUNCT
dpc-3385	172	1	helicobacter	helicobacter	NOUN
dpc-3385	172	2	pylori	pylori	NOUN
dpc-3385	172	3	infection	infection	NOUN
dpc-3385	172	4	was	be	AUX
dpc-3385	172	5	the	the	DET
dpc-3385	172	6	second	second	ADJ
dpc-3385	172	7	most	most	ADV
dpc-3385	172	8	common	common	ADJ
dpc-3385	172	9	infection	infection	NOUN
dpc-3385	172	10	detected	detect	VERB
dpc-3385	172	11	in	in	ADP
dpc-3385	172	12	our	our	PRON
dpc-3385	172	13	study	study	NOUN
dpc-3385	172	14	.	.	PUNCT
dpc-3385	173	1	since	since	SCONJ
dpc-3385	173	2	our	our	PRON
dpc-3385	173	3	study	study	NOUN
dpc-3385	173	4	allowed	allow	VERB
dpc-3385	173	5	a	a	DET
dpc-3385	173	6	4	4	NUM
dpc-3385	173	7	-	-	PUNCT
dpc-3385	173	8	year	year	NOUN
dpc-3385	173	9	follow	follow	NOUN
dpc-3385	173	10	-	-	PUNCT
dpc-3385	173	11	up	up	NOUN
dpc-3385	173	12	of	of	ADP
dpc-3385	173	13	medical	medical	ADJ
dpc-3385	173	14	records	record	NOUN
dpc-3385	173	15	,	,	PUNCT
dpc-3385	173	16	we	we	PRON
dpc-3385	173	17	observed	observe	VERB
dpc-3385	173	18	that	that	SCONJ
dpc-3385	173	19	most	most	ADJ
dpc-3385	173	20	of	of	ADP
dpc-3385	173	21	our	our	PRON
dpc-3385	173	22	patients	patient	NOUN
dpc-3385	173	23	had	have	VERB
dpc-3385	173	24	complaints	complaint	NOUN
dpc-3385	173	25	of	of	ADP
dpc-3385	173	26	dyspepsia	dyspepsia	NOUN
dpc-3385	173	27	and	and	CCONJ
dpc-3385	173	28	heartburn	heartburn	NOUN
dpc-3385	173	29	.	.	PUNCT
dpc-3385	174	1	they	they	PRON
dpc-3385	174	2	were	be	AUX
dpc-3385	174	3	evaluated	evaluate	VERB
dpc-3385	174	4	for	for	ADP
dpc-3385	174	5	gastritis	gastritis	NOUN
dpc-3385	174	6	in	in	ADP
dpc-3385	174	7	internal	internal	ADJ
dpc-3385	174	8	medicine	medicine	NOUN
dpc-3385	174	9	and	and	CCONJ
dpc-3385	174	10	gastroenterology	gastroenterology	NOUN
dpc-3385	174	11	departments	department	NOUN
dpc-3385	174	12	close	close	ADV
dpc-3385	174	13	to	to	ADP
dpc-3385	174	14	or	or	CCONJ
dpc-3385	174	15	immediately	immediately	ADV
dpc-3385	174	16	after	after	ADP
dpc-3385	174	17	the	the	DET
dpc-3385	174	18	onset	onset	NOUN
dpc-3385	174	19	of	of	ADP
dpc-3385	174	20	the	the	DET
dpc-3385	174	21	disease	disease	NOUN
dpc-3385	174	22	,	,	PUNCT
dpc-3385	174	23	and	and	CCONJ
dpc-3385	174	24	endoscopic	endoscopic	ADJ
dpc-3385	174	25	examinations	examination	NOUN
dpc-3385	174	26	were	be	AUX
dpc-3385	174	27	performed	perform	VERB
dpc-3385	174	28	in	in	ADP
dpc-3385	174	29	some	some	DET
dpc-3385	174	30	patients	patient	NOUN
dpc-3385	174	31	.	.	PUNCT
dpc-3385	175	1	as	as	ADP
dpc-3385	175	2	a	a	DET
dpc-3385	175	3	matter	matter	NOUN
dpc-3385	175	4	of	of	ADP
dpc-3385	175	5	fact	fact	NOUN
dpc-3385	175	6	,	,	PUNCT
dpc-3385	175	7	gastritis	gastritis	PROPN
dpc-3385	175	8	was	be	AUX
dpc-3385	175	9	the	the	DET
dpc-3385	175	10	most	most	ADV
dpc-3385	175	11	common	common	ADJ
dpc-3385	175	12	disease	disease	NOUN
dpc-3385	175	13	found	find	VERB
dpc-3385	175	14	in	in	ADP
dpc-3385	175	15	the	the	DET
dpc-3385	175	16	patients	patient	NOUN
dpc-3385	175	17	history	history	NOUN
dpc-3385	175	18	.	.	PUNCT
dpc-3385	176	1	indeed	indeed	ADV
dpc-3385	176	2	we	we	PRON
dpc-3385	176	3	discovered	discover	VERB
dpc-3385	176	4	that	that	SCONJ
dpc-3385	176	5	eac	eac	PROPN
dpc-3385	176	6	disappeared	disappear	VERB
dpc-3385	176	7	after	after	ADP
dpc-3385	176	8	antibiotic	antibiotic	ADJ
dpc-3385	176	9	treatment	treatment	NOUN
dpc-3385	176	10	for	for	ADP
dpc-3385	176	11	helicobacter	helicobacter	NOUN
dpc-3385	176	12	pylori	pylori	ADJ
dpc-3385	176	13	infection	infection	NOUN
dpc-3385	176	14	in	in	ADP
dpc-3385	176	15	our	our	PRON
dpc-3385	176	16	patients	patient	NOUN
dpc-3385	176	17	and	and	CCONJ
dpc-3385	176	18	did	do	AUX
dpc-3385	176	19	not	not	PART
dpc-3385	176	20	recur	recur	VERB
dpc-3385	176	21	as	as	ADV
dpc-3385	176	22	far	far	ADV
dpc-3385	176	23	as	as	SCONJ
dpc-3385	176	24	we	we	PRON
dpc-3385	176	25	could	could	AUX
dpc-3385	176	26	follow	follow	VERB
dpc-3385	176	27	up	up	ADP
dpc-3385	176	28	.	.	PUNCT
dpc-3385	177	1	we	we	PRON
dpc-3385	177	2	think	think	VERB
dpc-3385	177	3	that	that	SCONJ
dpc-3385	177	4	there	there	PRON
dpc-3385	177	5	may	may	AUX
dpc-3385	177	6	be	be	AUX
dpc-3385	177	7	a	a	DET
dpc-3385	177	8	causal	causal	ADJ
dpc-3385	177	9	relationship	relationship	NOUN
dpc-3385	177	10	between	between	ADP
dpc-3385	177	11	eac	eac	PROPN
dpc-3385	177	12	and	and	CCONJ
dpc-3385	177	13	helicobacter	helicobacter	NOUN
dpc-3385	177	14	pylori	pylori	ADJ
dpc-3385	177	15	infection	infection	NOUN
dpc-3385	177	16	,	,	PUNCT
dpc-3385	177	17	which	which	PRON
dpc-3385	177	18	we	we	PRON
dpc-3385	177	19	observed	observe	VERB
dpc-3385	177	20	in	in	ADP
dpc-3385	177	21	our	our	PRON
dpc-3385	177	22	study	study	NOUN
dpc-3385	177	23	.	.	PUNCT
dpc-3385	178	1	in	in	ADP
dpc-3385	178	2	our	our	PRON
dpc-3385	178	3	study	study	NOUN
dpc-3385	178	4	,	,	PUNCT
dpc-3385	178	5	all	all	PRON
dpc-3385	178	6	of	of	ADP
dpc-3385	178	7	the	the	DET
dpc-3385	178	8	patients	patient	NOUN
dpc-3385	178	9	with	with	ADP
dpc-3385	178	10	associated	associated	ADJ
dpc-3385	178	11	malignancy	malignancy	NOUN
dpc-3385	178	12	had	have	VERB
dpc-3385	178	13	solid	solid	ADJ
dpc-3385	178	14	tumors	tumor	NOUN
dpc-3385	178	15	.	.	PUNCT
dpc-3385	179	1	in	in	ADP
dpc-3385	179	2	a	a	DET
dpc-3385	179	3	case	case	NOUN
dpc-3385	179	4	series	series	NOUN
dpc-3385	179	5	of	of	ADP
dpc-3385	179	6	40	40	NUM
dpc-3385	179	7	patients	patient	NOUN
dpc-3385	179	8	followed	follow	VERB
dpc-3385	179	9	up	up	ADP
dpc-3385	179	10	with	with	ADP
dpc-3385	179	11	a	a	DET
dpc-3385	179	12	diagnosis	diagnosis	NOUN
dpc-3385	179	13	of	of	ADP
dpc-3385	179	14	peace	peace	NOUN
dpc-3385	179	15	,	,	PUNCT
dpc-3385	179	16	association	association	NOUN
dpc-3385	179	17	with	with	ADP
dpc-3385	179	18	lymphoproliferative	lymphoproliferative	ADJ
dpc-3385	179	19	diseases	disease	NOUN
dpc-3385	179	20	(	(	PUNCT
dpc-3385	179	21	most	most	ADV
dpc-3385	179	22	frequently	frequently	ADV
dpc-3385	179	23	leukemia	leukemia	VERB
dpc-3385	179	24	and	and	CCONJ
dpc-3385	179	25	lymphoma	lymphoma	NOUN
dpc-3385	179	26	)	)	PUNCT
dpc-3385	179	27	was	be	AUX
dpc-3385	179	28	observed	observe	VERB
dpc-3385	179	29	in	in	ADP
dpc-3385	179	30	62.5	62.5	NUM
dpc-3385	179	31	%	%	NOUN
dpc-3385	179	32	of	of	ADP
dpc-3385	179	33	the	the	DET
dpc-3385	179	34	patients	patient	NOUN
dpc-3385	179	35	and	and	CCONJ
dpc-3385	179	36	with	with	ADP
dpc-3385	179	37	solid	solid	ADJ
dpc-3385	179	38	tumors	tumor	NOUN
dpc-3385	179	39	in	in	ADP
dpc-3385	179	40	37.5	37.5	NUM
dpc-3385	179	41	%	%	NOUN
dpc-3385	180	1	[	[	X
dpc-3385	180	2	8	8	NUM
dpc-3385	180	3	]	]	PUNCT
dpc-3385	180	4	.	.	PUNCT
dpc-3385	181	1	in	in	ADP
dpc-3385	181	2	the	the	DET
dpc-3385	181	3	study	study	NOUN
dpc-3385	181	4	of	of	ADP
dpc-3385	181	5	kim	kim	PROPN
dpc-3385	181	6	et	et	PROPN
dpc-3385	181	7	al	al	PROPN
dpc-3385	181	8	2	2	NUM
dpc-3385	181	9	of	of	ADP
dpc-3385	181	10	39	39	NUM
dpc-3385	181	11	patients	patient	NOUN
dpc-3385	181	12	had	have	VERB
dpc-3385	181	13	thyroid	thyroid	NOUN
dpc-3385	181	14	cancer	cancer	NOUN
dpc-3385	181	15	[	[	X
dpc-3385	181	16	5	5	NUM
dpc-3385	181	17	]	]	PUNCT
dpc-3385	181	18	.	.	PUNCT
dpc-3385	182	1	in	in	ADP
dpc-3385	182	2	the	the	DET
dpc-3385	182	3	study	study	NOUN
dpc-3385	182	4	by	by	ADP
dpc-3385	182	5	weyers	weyer	NOUN
dpc-3385	182	6	et	et	NOUN
dpc-3385	182	7	al	al	PROPN
dpc-3385	182	8	the	the	DET
dpc-3385	182	9	number	number	NOUN
dpc-3385	182	10	of	of	ADP
dpc-3385	182	11	patients	patient	NOUN
dpc-3385	182	12	with	with	ADP
dpc-3385	182	13	associated	associated	ADJ
dpc-3385	182	14	malignancy	malignancy	NOUN
dpc-3385	182	15	was	be	AUX
dpc-3385	182	16	6	6	NUM
dpc-3385	182	17	(	(	PUNCT
dpc-3385	182	18	13.33	13.33	NUM
dpc-3385	182	19	%	%	NOUN
dpc-3385	182	20	of	of	ADP
dpc-3385	182	21	those	those	PRON
dpc-3385	182	22	with	with	ADP
dpc-3385	182	23	an	an	DET
dpc-3385	182	24	associated	associated	ADJ
dpc-3385	182	25	disease	disease	NOUN
dpc-3385	182	26	)	)	PUNCT
dpc-3385	182	27	and	and	CCONJ
dpc-3385	182	28	the	the	DET
dpc-3385	182	29	disease	disease	NOUN
dpc-3385	182	30	was	be	AUX
dpc-3385	182	31	active	active	ADJ
dpc-3385	182	32	in	in	ADP
dpc-3385	182	33	only	only	ADV
dpc-3385	182	34	one	one	NUM
dpc-3385	182	35	of	of	ADP
dpc-3385	182	36	these	these	DET
dpc-3385	182	37	patients	patient	NOUN
dpc-3385	182	38	[	[	X
dpc-3385	182	39	4	4	NUM
dpc-3385	182	40	]	]	PUNCT
dpc-3385	182	41	.	.	PUNCT
dpc-3385	183	1	in	in	ADP
dpc-3385	183	2	a	a	DET
dpc-3385	183	3	patient	patient	NOUN
dpc-3385	183	4	diagnosed	diagnose	VERB
dpc-3385	183	5	with	with	ADP
dpc-3385	183	6	breast	breast	NOUN
dpc-3385	183	7	cancer	cancer	NOUN
dpc-3385	183	8	eac	eac	PROPN
dpc-3385	183	9	was	be	AUX
dpc-3385	183	10	associated	associate	VERB
dpc-3385	183	11	with	with	ADP
dpc-3385	183	12	disease	disease	NOUN
dpc-3385	183	13	6	6	NUM
dpc-3385	183	14	original	original	ADJ
dpc-3385	183	15	article	article	NOUN
dpc-3385	183	16	|	|	ADV
dpc-3385	183	17	dermatol	dermatol	ADJ
dpc-3385	183	18	pract	pract	NOUN
dpc-3385	183	19	concept	concept	NOUN
dpc-3385	183	20	.	.	PUNCT
dpc-3385	184	1	2024;14(1):e2024039	2024;14(1):e2024039	NUM
dpc-3385	184	2	2012;13(4):239	2012;13(4):239	NUM
dpc-3385	184	3	-	-	PUNCT
dpc-3385	184	4	246	246	NUM
dpc-3385	184	5	.	.	PUNCT
dpc-3385	185	1	doi	doi	NOUN
dpc-3385	185	2	:	:	PUNCT
dpc-3385	185	3	10.2165/11596580	10.2165/11596580	NUM
dpc-3385	185	4	-	-	PUNCT
dpc-3385	185	5	000000000	000000000	NUM
dpc-3385	185	6	-	-	PUNCT
dpc-3385	185	7	00000	00000	NUM
dpc-3385	185	8	.	.	PUNCT
dpc-3385	186	1	pmid	pmid	NOUN
dpc-3385	186	2	:	:	PUNCT
dpc-3385	186	3	22320680	22320680	NUM
dpc-3385	186	4	.	.	PUNCT
dpc-3385	187	1	9	9	X
dpc-3385	187	2	.	.	X
dpc-3385	187	3	topal	topal	PROPN
dpc-3385	187	4	io	io	PROPN
dpc-3385	187	5	,	,	PUNCT
dpc-3385	187	6	topal	topal	PROPN
dpc-3385	187	7	y	y	PROPN
dpc-3385	187	8	,	,	PUNCT
dpc-3385	187	9	sargan	sargan	VERB
dpc-3385	187	10	a	a	PRON
dpc-3385	187	11	,	,	PUNCT
dpc-3385	187	12	et	et	PROPN
dpc-3385	187	13	al	al	PROPN
dpc-3385	187	14	.	.	PROPN
dpc-3385	187	15	erythema	erythema	PROPN
dpc-3385	187	16	annulare	annulare	NOUN
dpc-3385	187	17	centrifugum	centrifugum	NOUN
dpc-3385	187	18	as	as	ADP
dpc-3385	187	19	presenting	present	VERB
dpc-3385	187	20	sign	sign	NOUN
dpc-3385	187	21	of	of	ADP
dpc-3385	187	22	activation	activation	NOUN
dpc-3385	187	23	of	of	ADP
dpc-3385	187	24	breast	breast	NOUN
dpc-3385	187	25	cancer	cancer	NOUN
dpc-3385	187	26	.	.	PUNCT
dpc-3385	188	1	an	an	DET
dpc-3385	188	2	bras	bras	NOUN
dpc-3385	188	3	dermatol	dermatol	NOUN
dpc-3385	188	4	.	.	PUNCT
dpc-3385	189	1	2015;90(6):925	2015;90(6):925	NUM
dpc-3385	189	2	-	-	SYM
dpc-3385	189	3	927	927	NUM
dpc-3385	189	4	.	.	PUNCT
dpc-3385	190	1	doi	doi	NOUN
dpc-3385	190	2	:	:	PUNCT
dpc-3385	190	3	10.1590	10.1590	NUM
dpc-3385	190	4	/	/	SYM
dpc-3385	190	5	abd1806	abd1806	NOUN
dpc-3385	190	6	-	-	SYM
dpc-3385	190	7	4841	4841	NUM
dpc-3385	190	8	.20154785	.20154785	PROPN
dpc-3385	190	9	.	.	PUNCT
dpc-3385	191	1	pmid	pmid	NOUN
dpc-3385	191	2	:	:	PUNCT
dpc-3385	191	3	26734884	26734884	NUM
dpc-3385	191	4	.	.	PUNCT
dpc-3385	192	1	pmcid	pmcid	NOUN
dpc-3385	192	2	:	:	PUNCT
dpc-3385	192	3	pmc4689091	pmc4689091	VERB
dpc-3385	192	4	.	.	PUNCT
dpc-3385	193	1	10	10	NUM
dpc-3385	193	2	.	.	PUNCT
dpc-3385	194	1	kruse	kruse	PROPN
dpc-3385	194	2	ll	ll	PROPN
dpc-3385	194	3	,	,	PUNCT
dpc-3385	194	4	kenner	kenner	PROPN
dpc-3385	194	5	-	-	PUNCT
dpc-3385	194	6	bell	bell	PROPN
dpc-3385	194	7	bm	bm	PROPN
dpc-3385	194	8	,	,	PUNCT
dpc-3385	194	9	mancini	mancini	PROPN
dpc-3385	194	10	aj	aj	PROPN
dpc-3385	194	11	.	.	PROPN
dpc-3385	194	12	pediatric	pediatric	ADJ
dpc-3385	194	13	erythema	erythema	ADJ
dpc-3385	194	14	annulare	annulare	NOUN
dpc-3385	194	15	centrifugum	centrifugum	NOUN
dpc-3385	194	16	treated	treat	VERB
dpc-3385	194	17	with	with	ADP
dpc-3385	194	18	oral	oral	ADJ
dpc-3385	194	19	fluconazole	fluconazole	NOUN
dpc-3385	194	20	:	:	PUNCT
dpc-3385	194	21	a	a	DET
dpc-3385	194	22	retrospective	retrospective	ADJ
dpc-3385	194	23	series	series	NOUN
dpc-3385	194	24	.	.	PUNCT
dpc-3385	195	1	pediatr	pediatr	ADJ
dpc-3385	195	2	dermatol	dermatol	NOUN
dpc-3385	195	3	.	.	PUNCT
dpc-3385	196	1	2016;33(5):501	2016;33(5):501	NUM
dpc-3385	196	2	-	-	PUNCT
dpc-3385	196	3	506	506	NUM
dpc-3385	196	4	.	.	PUNCT
dpc-3385	197	1	doi	doi	NOUN
dpc-3385	197	2	:	:	PUNCT
dpc-3385	197	3	10.1111	10.1111	NUM
dpc-3385	197	4	/	/	SYM
dpc-3385	197	5	pde.12909	pde.12909	NOUN
dpc-3385	197	6	.	.	PUNCT
dpc-3385	198	1	pmid	pmid	NOUN
dpc-3385	198	2	:	:	PUNCT
dpc-3385	198	3	27339688	27339688	NUM
dpc-3385	198	4	.	.	PUNCT
dpc-3385	199	1	11	11	NUM
dpc-3385	199	2	.	.	X
dpc-3385	200	1	chuang	chuang	PROPN
dpc-3385	200	2	fc	fc	PROPN
dpc-3385	200	3	,	,	PUNCT
dpc-3385	200	4	lin	lin	PROPN
dpc-3385	200	5	sh	sh	PROPN
dpc-3385	200	6	,	,	PUNCT
dpc-3385	200	7	wu	wu	PROPN
dpc-3385	200	8	wm	wm	PROPN
dpc-3385	200	9	.	.	PROPN
dpc-3385	200	10	erythromycin	erythromycin	PROPN
dpc-3385	200	11	as	as	ADP
dpc-3385	200	12	a	a	DET
dpc-3385	200	13	safe	safe	ADJ
dpc-3385	200	14	and	and	CCONJ
dpc-3385	200	15	effective	effective	ADJ
dpc-3385	200	16	treatment	treatment	NOUN
dpc-3385	200	17	option	option	NOUN
dpc-3385	200	18	for	for	ADP
dpc-3385	200	19	erythema	erythema	ADJ
dpc-3385	200	20	annulare	annulare	NOUN
dpc-3385	200	21	centrifugum	centrifugum	NOUN
dpc-3385	200	22	.	.	PUNCT
dpc-3385	201	1	indian	indian	PROPN
dpc-3385	201	2	j	j	PROPN
dpc-3385	201	3	dermatol	dermatol	NOUN
dpc-3385	201	4	.	.	PUNCT
dpc-3385	202	1	2015;60(5):519	2015;60(5):519	NUM
dpc-3385	202	2	.	.	PUNCT
dpc-3385	203	1	doi	doi	NOUN
dpc-3385	203	2	:	:	PUNCT
dpc-3385	203	3	10.4103/0019	10.4103/0019	NUM
dpc-3385	203	4	-	-	SYM
dpc-3385	203	5	5154	5154	NUM
dpc-3385	203	6	.159633	.159633	NOUN
dpc-3385	203	7	.	.	PUNCT
dpc-3385	204	1	pmid	pmid	NOUN
dpc-3385	204	2	:	:	PUNCT
dpc-3385	204	3	26538713	26538713	NUM
dpc-3385	204	4	.	.	PUNCT
dpc-3385	205	1	pmcid	pmcid	NOUN
dpc-3385	205	2	:	:	PUNCT
dpc-3385	205	3	pmc4601434	pmc4601434	NOUN
dpc-3385	205	4	.	.	PUNCT
dpc-3385	206	1	12	12	NUM
dpc-3385	206	2	.	.	PUNCT
dpc-3385	206	3	gniadecki	gniadecki	PROPN
dpc-3385	206	4	r.	r.	PROPN
dpc-3385	206	5	calcipotriol	calcipotriol	PROPN
dpc-3385	206	6	for	for	ADP
dpc-3385	206	7	erythema	erythema	ADJ
dpc-3385	206	8	annulare	annulare	NOUN
dpc-3385	206	9	centrifugum	centrifugum	NOUN
dpc-3385	206	10	.	.	PUNCT
dpc-3385	207	1	br	br	PROPN
dpc-3385	207	2	j	j	PROPN
dpc-3385	207	3	dermatol	dermatol	NOUN
dpc-3385	207	4	.	.	PUNCT
dpc-3385	208	1	2002;146(2):317	2002;146(2):317	NUM
dpc-3385	208	2	-	-	SYM
dpc-3385	208	3	319	319	NUM
dpc-3385	208	4	.	.	PUNCT
dpc-3385	208	5	doi	doi	NOUN
dpc-3385	208	6	:	:	PUNCT
dpc-3385	208	7	10.1046	10.1046	NUM
dpc-3385	208	8	/	/	SYM
dpc-3385	208	9	j.0007	j.0007	NOUN
dpc-3385	208	10	-	-	PUNCT
dpc-3385	208	11	0963	0963	NUM
dpc-3385	208	12	.2001.04572.x	.2001.04572.x	NOUN
dpc-3385	208	13	.	.	PUNCT
dpc-3385	209	1	pmid	pmid	NOUN
dpc-3385	209	2	:	:	PUNCT
dpc-3385	209	3	11903248	11903248	NUM
dpc-3385	209	4	.	.	PUNCT
dpc-3385	210	1	13	13	NUM
dpc-3385	210	2	.	.	X
dpc-3385	210	3	de	de	X
dpc-3385	210	4	aloe	aloe	PROPN
dpc-3385	210	5	g	g	PROPN
dpc-3385	210	6	,	,	PUNCT
dpc-3385	210	7	rubegni	rubegni	NOUN
dpc-3385	210	8	p	p	NOUN
dpc-3385	210	9	,	,	PUNCT
dpc-3385	210	10	risulo	risulo	PROPN
dpc-3385	210	11	m	m	PROPN
dpc-3385	210	12	,	,	PUNCT
dpc-3385	210	13	sbano	sbano	PROPN
dpc-3385	210	14	p	p	X
dpc-3385	210	15	,	,	PUNCT
dpc-3385	210	16	poggiali	poggiali	PROPN
dpc-3385	210	17	s	s	PROPN
dpc-3385	210	18	,	,	PUNCT
dpc-3385	210	19	fimiani	fimiani	PROPN
dpc-3385	210	20	m.	m.	NOUN
dpc-3385	210	21	erythema	erythema	PROPN
dpc-3385	210	22	annulare	annulare	NOUN
dpc-3385	210	23	centrifugum	centrifugum	NOUN
dpc-3385	210	24	successfully	successfully	ADV
dpc-3385	210	25	treated	treat	VERB
dpc-3385	210	26	with	with	ADP
dpc-3385	210	27	metronidazole	metronidazole	NOUN
dpc-3385	210	28	.	.	PUNCT
dpc-3385	211	1	clin	clin	PROPN
dpc-3385	211	2	exp	exp	NOUN
dpc-3385	211	3	dermatol	dermatol	NOUN
dpc-3385	211	4	.	.	PUNCT
dpc-3385	212	1	2005;30(5):583	2005;30(5):583	NUM
dpc-3385	212	2	-	-	SYM
dpc-3385	212	3	584	584	NUM
dpc-3385	212	4	.	.	PUNCT
dpc-3385	212	5	doi	doi	NOUN
dpc-3385	212	6	:	:	PUNCT
dpc-3385	212	7	10.1111	10.1111	NUM
dpc-3385	212	8	/	/	SYM
dpc-3385	212	9	j.1365	j.1365	NOUN
dpc-3385	212	10	-	-	PUNCT
dpc-3385	212	11	2230.2005.01796.x	2230.2005.01796.x	NUM
dpc-3385	212	12	.	.	PUNCT
dpc-3385	213	1	pmid	pmid	NOUN
dpc-3385	213	2	:	:	PUNCT
dpc-3385	213	3	16045701	16045701	NUM
dpc-3385	213	4	.	.	PUNCT
dpc-3385	214	1	14	14	NUM
dpc-3385	214	2	.	.	PUNCT
dpc-3385	215	1	guillet	guillet	PROPN
dpc-3385	215	2	mh	mh	PROPN
dpc-3385	215	3	,	,	PUNCT
dpc-3385	215	4	dorval	dorval	PROPN
dpc-3385	215	5	jc	jc	PROPN
dpc-3385	215	6	,	,	PUNCT
dpc-3385	215	7	larrégue	larrégue	PROPN
dpc-3385	215	8	m	m	PROPN
dpc-3385	215	9	,	,	PUNCT
dpc-3385	215	10	guillet	guillet	VERB
dpc-3385	215	11	g.	g.	PROPN
dpc-3385	215	12	erythème	erythème	PROPN
dpc-3385	215	13	annulaire	annulaire	NOUN
dpc-3385	215	14	centrifuge	centrifuge	NOUN
dpc-3385	215	15	de	de	X
dpc-3385	215	16	darier	darier	X
dpc-3385	215	17	à	à	X
dpc-3385	215	18	ddebut	ddebut	PROPN
dpc-3385	215	19	néonatal	néonatal	PROPN
dpc-3385	215	20	avec	avec	X
dpc-3385	215	21	15	15	NUM
dpc-3385	215	22	ans	ans	X
dpc-3385	215	23	de	de	X
dpc-3385	215	24	suivi	suivi	PROPN
dpc-3385	215	25	.	.	PUNCT
dpc-3385	216	1	efficacité	efficacité	PROPN
dpc-3385	216	2	de	de	X
dpc-3385	216	3	l’interféron	l’interféron	PROPN
dpc-3385	216	4	et	et	PROPN
dpc-3385	216	5	rôle	rôle	X
dpc-3385	216	6	de	de	X
dpc-3385	216	7	cytokines	cytokine	NOUN
dpc-3385	216	8	[	[	X
dpc-3385	216	9	darier	darier	X
dpc-3385	216	10	’s	’	VERB
dpc-3385	216	11	erythema	erythema	ADJ
dpc-3385	216	12	annulare	annulare	NOUN
dpc-3385	216	13	centrifugum	centrifugum	NOUN
dpc-3385	216	14	of	of	ADP
dpc-3385	216	15	neonatal	neonatal	ADJ
dpc-3385	216	16	onset	onset	NOUN
dpc-3385	216	17	with	with	ADP
dpc-3385	216	18	a	a	DET
dpc-3385	216	19	15	15	NUM
dpc-3385	216	20	years	year	NOUN
dpc-3385	216	21	’	'	PUNCT
dpc-3385	216	22	follow	follow	VERB
dpc-3385	216	23	-	-	PUNCT
dpc-3385	216	24	up	up	NOUN
dpc-3385	216	25	.	.	PUNCT
dpc-3385	217	1	efficacy	efficacy	NOUN
dpc-3385	217	2	of	of	ADP
dpc-3385	217	3	interferon	interferon	NOUN
dpc-3385	217	4	and	and	CCONJ
dpc-3385	217	5	role	role	NOUN
dpc-3385	217	6	of	of	ADP
dpc-3385	217	7	cytokines	cytokine	NOUN
dpc-3385	217	8	]	]	PUNCT
dpc-3385	217	9	.	.	PUNCT
dpc-3385	218	1	ann	ann	PROPN
dpc-3385	218	2	dermatol	dermatol	NOUN
dpc-3385	218	3	venereol	venereol	NOUN
dpc-3385	218	4	.	.	PUNCT
dpc-3385	219	1	1995;122(6	1995;122(6	X
dpc-3385	219	2	-	-	PUNCT
dpc-3385	219	3	7):422	7):422	NUM
dpc-3385	219	4	-	-	PUNCT
dpc-3385	219	5	426	426	NUM
dpc-3385	219	6	.	.	PUNCT
dpc-3385	220	1	pmid	pmid	NOUN
dpc-3385	220	2	:	:	PUNCT
dpc-3385	220	3	8526425	8526425	NUM
dpc-3385	220	4	.	.	PUNCT
dpc-3385	221	1	15	15	NUM
dpc-3385	221	2	.	.	PUNCT
dpc-3385	221	3	lee	lee	PROPN
dpc-3385	221	4	ms	ms	PROPN
dpc-3385	221	5	,	,	PUNCT
dpc-3385	221	6	klebanov	klebanov	ADJ
dpc-3385	221	7	n	n	SYM
dpc-3385	221	8	,	,	PUNCT
dpc-3385	221	9	yanes	yane	NOUN
dpc-3385	221	10	d	d	NOUN
dpc-3385	221	11	,	,	PUNCT
dpc-3385	221	12	stavert	stavert	PROPN
dpc-3385	221	13	r.	r.	PROPN
dpc-3385	221	14	refractory	refractory	PROPN
dpc-3385	221	15	erythema	erythema	PROPN
dpc-3385	221	16	annulare	annulare	NOUN
dpc-3385	221	17	centrifugum	centrifugum	NOUN
dpc-3385	221	18	treated	treat	VERB
dpc-3385	221	19	with	with	ADP
dpc-3385	221	20	apremilast	apremilast	NOUN
dpc-3385	221	21	.	.	PUNCT
dpc-3385	222	1	jaad	jaad	NOUN
dpc-3385	222	2	case	case	NOUN
dpc-3385	222	3	rep	rep	PROPN
dpc-3385	222	4	.	.	PROPN
dpc-3385	222	5	2021;15:100	2021;15:100	PROPN
dpc-3385	222	6	-	-	SYM
dpc-3385	222	7	103	103	NUM
dpc-3385	222	8	.	.	PUNCT
dpc-3385	223	1	doi	doi	NOUN
dpc-3385	223	2	:	:	PUNCT
dpc-3385	223	3	10.1016	10.1016	NUM
dpc-3385	223	4	/	/	SYM
dpc-3385	223	5	j.jdcr.2021.07.012	j.jdcr.2021.07.012	PROPN
dpc-3385	223	6	.	.	PUNCT
dpc-3385	224	1	pmid	pmid	NOUN
dpc-3385	224	2	:	:	PUNCT
dpc-3385	224	3	34466643	34466643	NUM
dpc-3385	224	4	.	.	PUNCT
dpc-3385	225	1	pmcid	pmcid	NOUN
dpc-3385	225	2	:	:	PUNCT
dpc-3385	225	3	pmc8387728	pmc8387728	NOUN
dpc-3385	225	4	.	.	PUNCT
dpc-3385	226	1	16	16	NUM
dpc-3385	226	2	.	.	PUNCT
dpc-3385	227	1	jalil	jalil	PROPN
dpc-3385	227	2	p	p	PROPN
dpc-3385	227	3	,	,	PUNCT
dpc-3385	227	4	masood	masood	PROPN
dpc-3385	227	5	s	s	PROPN
dpc-3385	227	6	,	,	PUNCT
dpc-3385	227	7	fatima	fatima	PROPN
dpc-3385	227	8	s.	s.	PROPN
dpc-3385	227	9	erythema	erythema	PROPN
dpc-3385	227	10	annulare	annulare	PROPN
dpc-3385	227	11	centrifugum	centrifugum	NOUN
dpc-3385	227	12	:	:	PUNCT
dpc-3385	227	13	a	a	DET
dpc-3385	227	14	rare	rare	ADJ
dpc-3385	227	15	skin	skin	NOUN
dpc-3385	227	16	manifestation	manifestation	NOUN
dpc-3385	227	17	of	of	ADP
dpc-3385	227	18	hashimoto	hashimoto	NOUN
dpc-3385	227	19	thyroiditis	thyroiditis	NOUN
dpc-3385	227	20	.	.	PUNCT
dpc-3385	228	1	cureus	cureus	NOUN
dpc-3385	228	2	.	.	PUNCT
dpc-3385	229	1	2020;12(8):e9906	2020;12(8):e9906	X
dpc-3385	229	2	.	.	NOUN
dpc-3385	229	3	doi	doi	NOUN
dpc-3385	229	4	:	:	PUNCT
dpc-3385	229	5	10.7759	10.7759	NUM
dpc-3385	229	6	/	/	SYM
dpc-3385	229	7	cureus.9906	cureus.9906	PROPN
dpc-3385	229	8	.	.	NOUN
dpc-3385	229	9	pmid	pmid	PROPN
dpc-3385	229	10	:	:	PUNCT
dpc-3385	229	11	32968569	32968569	NUM
dpc-3385	229	12	.	.	PUNCT
dpc-3385	230	1	pmcid	pmcid	ADJ
dpc-3385	230	2	:	:	PUNCT
dpc-3385	230	3	pmc7505531	pmc7505531	NOUN
dpc-3385	230	4	.	.	PUNCT
dpc-3385	231	1	17	17	NUM
dpc-3385	231	2	.	.	PUNCT
dpc-3385	232	1	chiang	chiang	PROPN
dpc-3385	232	2	ch	ch	PROPN
dpc-3385	232	3	,	,	PUNCT
dpc-3385	232	4	lai	lai	PROPN
dpc-3385	232	5	fj	fj	PROPN
dpc-3385	232	6	.	.	PUNCT
dpc-3385	233	1	pregnancy	pregnancy	NOUN
dpc-3385	233	2	-	-	PUNCT
dpc-3385	233	3	associated	associate	VERB
dpc-3385	233	4	erythema	erythema	ADJ
dpc-3385	233	5	annulare	annulare	NOUN
dpc-3385	233	6	centrifugum	centrifugum	NOUN
dpc-3385	233	7	.	.	PUNCT
dpc-3385	234	1	j	j	PROPN
dpc-3385	234	2	formos	formos	PROPN
dpc-3385	234	3	med	med	PROPN
dpc-3385	234	4	assoc	assoc	PROPN
dpc-3385	234	5	.	.	PUNCT
dpc-3385	235	1	2015;114(7):670	2015;114(7):670	NUM
dpc-3385	235	2	-	-	SYM
dpc-3385	235	3	671	671	NUM
dpc-3385	235	4	.	.	PUNCT
dpc-3385	236	1	doi	doi	NOUN
dpc-3385	236	2	:	:	PUNCT
dpc-3385	236	3	10.1016	10.1016	NUM
dpc-3385	236	4	/	/	SYM
dpc-3385	236	5	j.jfma.2014.01.004	j.jfma.2014.01.004	PROPN
dpc-3385	236	6	.	.	PUNCT
dpc-3385	237	1	pmid	pmid	NOUN
dpc-3385	237	2	:	:	PUNCT
dpc-3385	237	3	24548620	24548620	NUM
dpc-3385	237	4	.	.	PUNCT
dpc-3385	238	1	duration	duration	NOUN
dpc-3385	238	2	and	and	CCONJ
dpc-3385	238	3	a	a	DET
dpc-3385	238	4	higher	high	ADJ
dpc-3385	238	5	number	number	NOUN
dpc-3385	238	6	of	of	ADP
dpc-3385	238	7	attacks	attack	NOUN
dpc-3385	238	8	compared	compare	VERB
dpc-3385	238	9	to	to	ADP
dpc-3385	238	10	the	the	DET
dpc-3385	238	11	deep	deep	ADJ
dpc-3385	238	12	type	type	NOUN
dpc-3385	238	13	.	.	PUNCT
dpc-3385	239	1	however	however	ADV
dpc-3385	239	2	,	,	PUNCT
dpc-3385	239	3	all	all	DET
dpc-3385	239	4	the	the	DET
dpc-3385	239	5	data	datum	NOUN
dpc-3385	239	6	we	we	PRON
dpc-3385	239	7	have	have	AUX
dpc-3385	239	8	obtained	obtain	VERB
dpc-3385	239	9	should	should	AUX
dpc-3385	239	10	be	be	AUX
dpc-3385	239	11	confirmed	confirm	VERB
dpc-3385	239	12	by	by	ADP
dpc-3385	239	13	future	future	ADJ
dpc-3385	239	14	studies	study	NOUN
dpc-3385	239	15	with	with	ADP
dpc-3385	239	16	a	a	DET
dpc-3385	239	17	larger	large	ADJ
dpc-3385	239	18	number	number	NOUN
dpc-3385	239	19	of	of	ADP
dpc-3385	239	20	patients	patient	NOUN
dpc-3385	239	21	.	.	PUNCT
dpc-3385	240	1	acknowledgement	acknowledgement	NOUN
dpc-3385	240	2	:	:	PUNCT
dpc-3385	240	3	we	we	PRON
dpc-3385	240	4	express	express	VERB
dpc-3385	240	5	our	our	PRON
dpc-3385	240	6	gratitude	gratitude	NOUN
dpc-3385	240	7	to	to	ADP
dpc-3385	240	8	dr	dr	PROPN
dpc-3385	240	9	.	.	PROPN
dpc-3385	240	10	nuran	nuran	PROPN
dpc-3385	240	11	süngü	süngü	NOUN
dpc-3385	240	12	for	for	ADP
dpc-3385	240	13	granting	grant	VERB
dpc-3385	240	14	us	we	PRON
dpc-3385	240	15	permission	permission	NOUN
dpc-3385	240	16	to	to	PART
dpc-3385	240	17	access	access	VERB
dpc-3385	240	18	the	the	DET
dpc-3385	240	19	pathology	pathology	NOUN
dpc-3385	240	20	images	image	NOUN
dpc-3385	240	21	.	.	PUNCT
dpc-3385	241	1	references	reference	NOUN
dpc-3385	241	2	1	1	NUM
dpc-3385	241	3	.	.	PUNCT
dpc-3385	241	4	mcdaniel	mcdaniel	PROPN
dpc-3385	241	5	b	b	PROPN
dpc-3385	241	6	,	,	PUNCT
dpc-3385	241	7	cook	cook	VERB
dpc-3385	241	8	c.	c.	PROPN
dpc-3385	241	9	erythema	erythema	ADJ
dpc-3385	241	10	annulare	annulare	PROPN
dpc-3385	241	11	centrifugum	centrifugum	NOUN
dpc-3385	241	12	.	.	PUNCT
dpc-3385	242	1	2022	2022	NUM
dpc-3385	242	2	in	in	ADP
dpc-3385	242	3	:	:	PUNCT
dpc-3385	242	4	statpearls	statpearl	NOUN
dpc-3385	243	1	[	[	X
dpc-3385	243	2	internet	internet	NOUN
dpc-3385	243	3	]	]	PUNCT
dpc-3385	243	4	.	.	PUNCT
dpc-3385	244	1	treasure	treasure	NOUN
dpc-3385	244	2	island	island	NOUN
dpc-3385	244	3	(	(	PUNCT
dpc-3385	244	4	fl	fl	PROPN
dpc-3385	244	5	):	):	PUNCT
dpc-3385	244	6	statpearls	statpearl	NOUN
dpc-3385	244	7	publishing	publishing	NOUN
dpc-3385	244	8	;	;	PUNCT
dpc-3385	244	9	2023	2023	NUM
dpc-3385	244	10	.	.	PUNCT
dpc-3385	245	1	pmid	pmid	NOUN
dpc-3385	245	2	:	:	PUNCT
dpc-3385	245	3	29494101	29494101	NUM
dpc-3385	245	4	.	.	PUNCT
dpc-3385	246	1	2	2	X
dpc-3385	246	2	.	.	X
dpc-3385	246	3	mandel	mandel	PROPN
dpc-3385	246	4	vd	vd	PROPN
dpc-3385	246	5	,	,	PUNCT
dpc-3385	246	6	ferrari	ferrari	PROPN
dpc-3385	246	7	b	b	PROPN
dpc-3385	246	8	,	,	PUNCT
dpc-3385	246	9	manfredini	manfredini	PROPN
dpc-3385	246	10	m	m	PROPN
dpc-3385	246	11	,	,	PUNCT
dpc-3385	246	12	giusti	giusti	PROPN
dpc-3385	246	13	f	f	PROPN
dpc-3385	246	14	,	,	PUNCT
dpc-3385	246	15	pellacani	pellacani	PROPN
dpc-3385	246	16	g.	g.	PROPN
dpc-3385	246	17	annually	annually	ADV
dpc-3385	246	18	recurring	recur	VERB
dpc-3385	246	19	erythema	erythema	ADJ
dpc-3385	246	20	annulare	annulare	NOUN
dpc-3385	246	21	centrifugum	centrifugum	NOUN
dpc-3385	246	22	:	:	PUNCT
dpc-3385	246	23	a	a	DET
dpc-3385	246	24	case	case	NOUN
dpc-3385	246	25	report	report	NOUN
dpc-3385	246	26	.	.	PUNCT
dpc-3385	247	1	j	j	PROPN
dpc-3385	247	2	med	med	PROPN
dpc-3385	247	3	case	case	PROPN
dpc-3385	247	4	rep	rep	PROPN
dpc-3385	247	5	.	.	PROPN
dpc-3385	247	6	2015;22;9:236	2015;22;9:236	NUM
dpc-3385	247	7	.	.	PUNCT
dpc-3385	248	1	doi	doi	NOUN
dpc-3385	248	2	:	:	PUNCT
dpc-3385	248	3	10.1186	10.1186	NUM
dpc-3385	248	4	/	/	SYM
dpc-3385	248	5	s13256	s13256	PROPN
dpc-3385	248	6	-	-	PUNCT
dpc-3385	248	7	0150718	0150718	NUM
dpc-3385	248	8	-	-	PUNCT
dpc-3385	248	9	1	1	NUM
dpc-3385	248	10	.	.	PUNCT
dpc-3385	249	1	pmid	pmid	NOUN
dpc-3385	249	2	:	:	PUNCT
dpc-3385	249	3	26496986	26496986	NUM
dpc-3385	249	4	.	.	PUNCT
dpc-3385	250	1	pmcid	pmcid	NOUN
dpc-3385	250	2	:	:	PUNCT
dpc-3385	250	3	pmc4619197	pmc4619197	NOUN
dpc-3385	250	4	.	.	PUNCT
dpc-3385	251	1	3	3	X
dpc-3385	251	2	.	.	X
dpc-3385	251	3	darier	darier	PROPN
dpc-3385	251	4	j.	j.	PROPN
dpc-3385	251	5	de	de	PROPN
dpc-3385	251	6	l’erytheme	l’erytheme	PROPN
dpc-3385	251	7	annulaire	annulaire	NOUN
dpc-3385	251	8	centrifuge	centrifuge	NOUN
dpc-3385	251	9	.	.	PUNCT
dpc-3385	252	1	ann	ann	PROPN
dpc-3385	252	2	dermatol	dermatol	PROPN
dpc-3385	252	3	syphilol	syphilol	PROPN
dpc-3385	252	4	.	.	PUNCT
dpc-3385	253	1	1916	1916	NUM
dpc-3385	253	2	;	;	PUNCT
dpc-3385	254	1	6	6	NUM
dpc-3385	254	2	:	:	SYM
dpc-3385	254	3	57	57	NUM
dpc-3385	254	4	-	-	SYM
dpc-3385	254	5	76	76	NUM
dpc-3385	254	6	.	.	PUNCT
dpc-3385	255	1	4	4	X
dpc-3385	255	2	.	.	X
dpc-3385	255	3	weyers	weyer	NOUN
dpc-3385	255	4	w	w	PROPN
dpc-3385	255	5	,	,	PUNCT
dpc-3385	255	6	diaz	diaz	PROPN
dpc-3385	255	7	-	-	PUNCT
dpc-3385	255	8	cascajo	cascajo	PROPN
dpc-3385	255	9	c	c	PROPN
dpc-3385	255	10	,	,	PUNCT
dpc-3385	255	11	weyers	weyer	NOUN
dpc-3385	255	12	i.	i.	PROPN
dpc-3385	255	13	erythema	erythema	PROPN
dpc-3385	255	14	annulare	annulare	PROPN
dpc-3385	255	15	centrifugum	centrifugum	NOUN
dpc-3385	255	16	:	:	PUNCT
dpc-3385	255	17	results	result	NOUN
dpc-3385	255	18	of	of	ADP
dpc-3385	255	19	a	a	DET
dpc-3385	255	20	clinicopathologic	clinicopathologic	ADJ
dpc-3385	255	21	study	study	NOUN
dpc-3385	255	22	of	of	ADP
dpc-3385	255	23	73	73	NUM
dpc-3385	255	24	patients	patient	NOUN
dpc-3385	255	25	.	.	PUNCT
dpc-3385	256	1	am	be	AUX
dpc-3385	256	2	j	j	PROPN
dpc-3385	256	3	dermatopathol	dermatopathol	NOUN
dpc-3385	256	4	.	.	PUNCT
dpc-3385	257	1	2003;25(6):451	2003;25(6):451	NUM
dpc-3385	257	2	-	-	SYM
dpc-3385	257	3	462	462	NUM
dpc-3385	257	4	.	.	PUNCT
dpc-3385	258	1	doi	doi	NOUN
dpc-3385	258	2	:	:	PUNCT
dpc-3385	258	3	10.1097/00000372	10.1097/00000372	NUM
dpc-3385	258	4	-200312000	-200312000	PROPN
dpc-3385	258	5	-	-	PUNCT
dpc-3385	258	6	00001	00001	NUM
dpc-3385	258	7	.	.	PUNCT
dpc-3385	259	1	pmid	pmid	NOUN
dpc-3385	259	2	:	:	PUNCT
dpc-3385	259	3	14631185	14631185	NUM
dpc-3385	259	4	.	.	PUNCT
dpc-3385	260	1	5	5	X
dpc-3385	260	2	.	.	X
dpc-3385	260	3	kim	kim	PROPN
dpc-3385	260	4	dh	dh	PROPN
dpc-3385	260	5	,	,	PUNCT
dpc-3385	260	6	lee	lee	PROPN
dpc-3385	260	7	jh	jh	PROPN
dpc-3385	260	8	,	,	PUNCT
dpc-3385	260	9	lee	lee	PROPN
dpc-3385	260	10	jy	jy	PROPN
dpc-3385	260	11	,	,	PUNCT
dpc-3385	260	12	park	park	PROPN
dpc-3385	260	13	ym	ym	PROPN
dpc-3385	260	14	.	.	PUNCT
dpc-3385	261	1	erythema	erythema	PROPN
dpc-3385	261	2	annulare	annulare	PROPN
dpc-3385	261	3	centrifugum	centrifugum	NOUN
dpc-3385	261	4	:	:	PUNCT
dpc-3385	261	5	analysis	analysis	NOUN
dpc-3385	261	6	of	of	ADP
dpc-3385	261	7	associated	associated	ADJ
dpc-3385	261	8	diseases	disease	NOUN
dpc-3385	261	9	and	and	CCONJ
dpc-3385	261	10	clinical	clinical	ADJ
dpc-3385	261	11	outcomes	outcome	NOUN
dpc-3385	261	12	according	accord	VERB
dpc-3385	261	13	to	to	ADP
dpc-3385	261	14	histopathologic	histopathologic	ADJ
dpc-3385	261	15	classification	classification	NOUN
dpc-3385	261	16	.	.	PUNCT
dpc-3385	262	1	ann	ann	PROPN
dpc-3385	262	2	dermatol	dermatol	NOUN
dpc-3385	262	3	.	.	PUNCT
dpc-3385	263	1	2016;28(2):257	2016;28(2):257	NOUN
dpc-3385	263	2	-	-	SYM
dpc-3385	263	3	259	259	NUM
dpc-3385	263	4	.	.	PUNCT
dpc-3385	263	5	doi	doi	NOUN
dpc-3385	263	6	:	:	PUNCT
dpc-3385	263	7	10.5021	10.5021	NUM
dpc-3385	263	8	/	/	SYM
dpc-3385	263	9	ad.2016.28.2.257	ad.2016.28.2.257	PROPN
dpc-3385	263	10	.	.	PUNCT
dpc-3385	264	1	pmid	pmid	NOUN
dpc-3385	264	2	:	:	PUNCT
dpc-3385	264	3	27081281	27081281	NUM
dpc-3385	264	4	.	.	PUNCT
dpc-3385	265	1	pmcid	pmcid	NOUN
dpc-3385	265	2	:	:	PUNCT
dpc-3385	265	3	pmc4828397	pmc4828397	NOUN
dpc-3385	265	4	.	.	PUNCT
dpc-3385	266	1	6	6	X
dpc-3385	266	2	.	.	X
dpc-3385	266	3	kim	kim	PROPN
dpc-3385	266	4	kj	kj	PROPN
dpc-3385	266	5	,	,	PUNCT
dpc-3385	266	6	chang	chang	PROPN
dpc-3385	266	7	se	se	PROPN
dpc-3385	266	8	,	,	PUNCT
dpc-3385	266	9	choi	choi	PROPN
dpc-3385	266	10	jh	jh	PROPN
dpc-3385	266	11	,	,	PUNCT
dpc-3385	266	12	sung	sing	VERB
dpc-3385	266	13	kj	kj	PROPN
dpc-3385	266	14	,	,	PUNCT
dpc-3385	266	15	moon	moon	PROPN
dpc-3385	266	16	kc	kc	PROPN
dpc-3385	266	17	,	,	PUNCT
dpc-3385	266	18	koh	koh	PROPN
dpc-3385	266	19	jk	jk	PROPN
dpc-3385	266	20	.	.	PUNCT
dpc-3385	266	21	clinicopathologic	clinicopathologic	ADJ
dpc-3385	266	22	analysis	analysis	NOUN
dpc-3385	266	23	of	of	ADP
dpc-3385	266	24	66	66	NUM
dpc-3385	266	25	cases	case	NOUN
dpc-3385	266	26	of	of	ADP
dpc-3385	266	27	erythema	erythema	ADJ
dpc-3385	266	28	annulare	annulare	NOUN
dpc-3385	266	29	centrifugum	centrifugum	NOUN
dpc-3385	266	30	.	.	PUNCT
dpc-3385	267	1	j	j	PROPN
dpc-3385	267	2	dermatol	dermatol	NOUN
dpc-3385	267	3	.	.	PUNCT
dpc-3385	268	1	2002;29(2):61	2002;29(2):61	NUM
dpc-3385	268	2	-	-	SYM
dpc-3385	268	3	67	67	NUM
dpc-3385	268	4	.	.	PUNCT
dpc-3385	269	1	doi	doi	NOUN
dpc-3385	269	2	:	:	PUNCT
dpc-3385	269	3	10.1111	10.1111	NUM
dpc-3385	269	4	/	/	SYM
dpc-3385	269	5	j.1346	j.1346	VERB
dpc-3385	269	6	-	-	PUNCT
dpc-3385	269	7	8138	8138	NUM
dpc-3385	269	8	.2002.tb00167.x	.2002.tb00167.x	PUNCT
dpc-3385	269	9	.	.	PUNCT
dpc-3385	270	1	pmid	pmid	NOUN
dpc-3385	270	2	:	:	PUNCT
dpc-3385	270	3	11890297	11890297	NUM
dpc-3385	270	4	.	.	PUNCT
dpc-3385	271	1	7	7	X
dpc-3385	271	2	.	.	X
dpc-3385	271	3	sardana	sardana	PROPN
dpc-3385	272	1	k	k	NOUN
dpc-3385	272	2	,	,	PUNCT
dpc-3385	272	3	chugh	chugh	NOUN
dpc-3385	272	4	s	s	PROPN
dpc-3385	272	5	,	,	PUNCT
dpc-3385	272	6	mahajan	mahajan	PROPN
dpc-3385	272	7	k.	k.	PROPN
dpc-3385	273	1	an	an	DET
dpc-3385	273	2	observational	observational	ADJ
dpc-3385	273	3	study	study	NOUN
dpc-3385	273	4	of	of	ADP
dpc-3385	273	5	the	the	DET
dpc-3385	273	6	efficacy	efficacy	NOUN
dpc-3385	273	7	of	of	ADP
dpc-3385	273	8	azithromycin	azithromycin	PROPN
dpc-3385	273	9	in	in	ADP
dpc-3385	273	10	erythema	erythema	ADJ
dpc-3385	273	11	annulare	annulare	NOUN
dpc-3385	273	12	centrifugum	centrifugum	NOUN
dpc-3385	273	13	.	.	PUNCT
dpc-3385	274	1	clin	clin	PROPN
dpc-3385	274	2	exp	exp	NOUN
dpc-3385	274	3	dermatol	dermatol	NOUN
dpc-3385	274	4	.	.	PUNCT
dpc-3385	275	1	2018;43(3):296	2018;43(3):296	PROPN
dpc-3385	275	2	-	-	SYM
dpc-3385	275	3	299	299	NUM
dpc-3385	275	4	.	.	PUNCT
dpc-3385	276	1	doi	doi	NOUN
dpc-3385	276	2	:	:	PUNCT
dpc-3385	276	3	10.1111	10.1111	NUM
dpc-3385	276	4	/	/	SYM
dpc-3385	276	5	ced.13334	ced.13334	PROPN
dpc-3385	276	6	.	.	PUNCT
dpc-3385	277	1	pmid	pmid	NOUN
dpc-3385	277	2	:	:	PUNCT
dpc-3385	277	3	29297941	29297941	NUM
dpc-3385	277	4	8	8	NUM
dpc-3385	277	5	.	.	PUNCT
dpc-3385	278	1	chodkiewicz	chodkiewicz	VERB
dpc-3385	278	2	hm	hm	INTJ
dpc-3385	278	3	,	,	PUNCT
dpc-3385	278	4	cohen	cohen	PROPN
dpc-3385	278	5	pr	pr	PROPN
dpc-3385	278	6	.	.	PUNCT
dpc-3385	279	1	paraneoplastic	paraneoplastic	ADJ
dpc-3385	279	2	erythema	erythema	ADJ
dpc-3385	279	3	annulare	annulare	NOUN
dpc-3385	279	4	centrifugum	centrifugum	NOUN
dpc-3385	279	5	eruption	eruption	NOUN
dpc-3385	279	6	:	:	PUNCT
dpc-3385	279	7	peace	peace	NOUN
dpc-3385	279	8	.	.	PUNCT
dpc-3385	280	1	am	be	AUX
dpc-3385	280	2	j	j	PROPN
dpc-3385	280	3	clin	clin	PROPN
dpc-3385	280	4	dermatol	dermatol	NOUN
dpc-3385	280	5	.	.	PUNCT